<?xml version="1.0" encoding="ISO-8859-1"?><COCHRANE_REVIEW DESCRIPTION="For publication" DOI="10.1002/14651858.CD006850.pub3" GROUP_ID="BACK" ID="466306011616223802" MERGED_FROM="" MODIFIED="2015-06-16 15:08:36 +0100" MODIFIED_BY="Claire Munhall" REVIEW_NO="" REVMAN_SUB_VERSION="5.3.4 " REVMAN_VERSION="5" SPLIT_FROM="" STAGE="R" STATUS="A" TYPE="INTERVENTION" VERSION_NO="5.0">
<COVER_SHEET MODIFIED="2015-06-16 15:08:36 +0100" MODIFIED_BY="Claire Munhall">
<TITLE MODIFIED="2015-05-30 16:30:45 -0400" MODIFIED_BY="Anne Lawson">Braces for idiopathic scoliosis in adolescents</TITLE>
<CONTACT MODIFIED="2015-06-16 15:08:36 +0100" MODIFIED_BY="Claire Munhall"><PERSON ID="11522" ROLE="AUTHOR"><PREFIX>Prof</PREFIX><FIRST_NAME>Stefano</FIRST_NAME><LAST_NAME>Negrini</LAST_NAME><POSITION>Director</POSITION><EMAIL_1>stefano.negrini@isico.it</EMAIL_1><ADDRESS><DEPARTMENT>Physical and Rehabilitation Medicine</DEPARTMENT><ORGANISATION>University of Brescia - IRCCS Fondazione Don Gnocchi Milan</ORGANISATION><ADDRESS_1>Viale Europa</ADDRESS_1><CITY>Brescia</CITY><ZIP>25121</ZIP><COUNTRY CODE="IT">Italy</COUNTRY><PHONE_1>+39 393 9411523</PHONE_1></ADDRESS></PERSON></CONTACT>
<CREATORS MODIFIED="2015-06-16 15:08:36 +0100" MODIFIED_BY="Claire Munhall"><PERSON ID="11522" ROLE="AUTHOR"><PREFIX>Prof</PREFIX><FIRST_NAME>Stefano</FIRST_NAME><LAST_NAME>Negrini</LAST_NAME><POSITION>Director</POSITION><EMAIL_1>stefano.negrini@isico.it</EMAIL_1><ADDRESS><DEPARTMENT>Physical and Rehabilitation Medicine</DEPARTMENT><ORGANISATION>University of Brescia - IRCCS Fondazione Don Gnocchi Milan</ORGANISATION><ADDRESS_1>Viale Europa</ADDRESS_1><CITY>Brescia</CITY><ZIP>25121</ZIP><COUNTRY CODE="IT">Italy</COUNTRY><PHONE_1>+39 393 9411523</PHONE_1></ADDRESS></PERSON><PERSON ID="6297" ROLE="AUTHOR"><PREFIX>Dr</PREFIX><FIRST_NAME>Silvia</FIRST_NAME><LAST_NAME>Minozzi</LAST_NAME><EMAIL_1>minozzi.silvia@gmail.com</EMAIL_1><ADDRESS><DEPARTMENT>Department of Epidemiology</DEPARTMENT><ORGANISATION>Lazio Regional Health Service</ORGANISATION><ADDRESS_1>Via di Santa Costanza, 53</ADDRESS_1><CITY>Rome</CITY><ZIP>00198</ZIP><COUNTRY CODE="IT">Italy</COUNTRY></ADDRESS></PERSON><PERSON ID="E183F77882E26AA2001B9B036947E58D" ROLE="AUTHOR"><PREFIX>Dr</PREFIX><FIRST_NAME>Josette</FIRST_NAME><LAST_NAME>Bettany-Saltikov</LAST_NAME><SUFFIX>PhD  MSc  MCSP</SUFFIX><POSITION>Senior Lecturer in Research Methods</POSITION><EMAIL_1>j.b.saltikov@tees.ac.uk</EMAIL_1><MOBILE_PHONE>00-44-7725-20-80-15</MOBILE_PHONE><ADDRESS><DEPARTMENT>School of Health and Social Care</DEPARTMENT><ORGANISATION>University of Teesside</ORGANISATION><ADDRESS_1>Victoria Road</ADDRESS_1><CITY>Middlesbrough</CITY><ZIP>TS13BA</ZIP><REGION>Cleveland</REGION><COUNTRY CODE="GB">UK</COUNTRY><PHONE_1>+44 1642-384985</PHONE_1></ADDRESS></PERSON><PERSON ID="125D02A482E26AA200CFA52E3E610412" ROLE="AUTHOR"><PREFIX>Prof</PREFIX><FIRST_NAME>Nachiappan</FIRST_NAME><LAST_NAME>Chockalingam</LAST_NAME><EMAIL_1>N.Chockalingam@staffs.ac.uk</EMAIL_1><ADDRESS><DEPARTMENT>Faculty of Health</DEPARTMENT><ORGANISATION>Staffordshire University</ORGANISATION><ADDRESS_1>Leek Road</ADDRESS_1><CITY>Stoke-on-Trent</CITY><ZIP>ST4 2DF</ZIP><COUNTRY CODE="GB">UK</COUNTRY><PHONE_1>+44 1782 295853</PHONE_1><FAX_1>+44 1782 294321</FAX_1></ADDRESS></PERSON><PERSON ID="F8B383F282E26AA20078D4E681F7F5B5" ROLE="AUTHOR"><PREFIX>Dr</PREFIX><FIRST_NAME>Theodoros B.</FIRST_NAME><LAST_NAME>Grivas</LAST_NAME><SUFFIX>MD PhD</SUFFIX><POSITION>Director</POSITION><EMAIL_1>tgri69@otenet.gr</EMAIL_1><MOBILE_PHONE>0030 6944897585</MOBILE_PHONE><ADDRESS><DEPARTMENT>Department of Trauma and Orthopaedics</DEPARTMENT><ORGANISATION>"Tzanio" General Hospital of Piraeus</ORGANISATION><CITY>Piraeus</CITY><ZIP>18536</ZIP><REGION>Attica</REGION><COUNTRY CODE="GR">Greece</COUNTRY><PHONE_1>+30 694 4897585</PHONE_1></ADDRESS></PERSON><PERSON ID="0996C66082E26AA200C1C7C413F44993" ROLE="AUTHOR"><PREFIX>Dr</PREFIX><FIRST_NAME>Tomasz</FIRST_NAME><LAST_NAME>Kotwicki</LAST_NAME><EMAIL_1>kotwicki@amp.edu.pl</EMAIL_1><ADDRESS><DEPARTMENT>Department of Pediatric Orthopedics and Traumatology</DEPARTMENT><ORGANISATION>University of Medical Sciences</ORGANISATION><ADDRESS_1>ul. 28 Czerwca 1956 nr 135</ADDRESS_1><CITY>Poznan</CITY><ZIP>61-545</ZIP><COUNTRY CODE="PL">Poland</COUNTRY><PHONE_1>+48 602 61 30 54</PHONE_1><FAX_1>+48 61 83 10 173</FAX_1></ADDRESS></PERSON><PERSON ID="F95C4D7B82E26AA20078D4E65C785844" ROLE="AUTHOR"><PREFIX>Dr</PREFIX><FIRST_NAME>Toru</FIRST_NAME><LAST_NAME>Maruyama</LAST_NAME><POSITION>Associate Professor</POSITION><EMAIL_1>tmaruyama17@yahoo.co.jp</EMAIL_1><ADDRESS><DEPARTMENT>Department of Orthopaedic Surgery</DEPARTMENT><ORGANISATION>Saitama Medical University</ORGANISATION><ADDRESS_1>1981 Kamoda</ADDRESS_1><CITY>Kawagoe</CITY><ZIP>350-8550</ZIP><REGION>Saitama</REGION><COUNTRY CODE="JP">Japan</COUNTRY><PHONE_1>+81 49-228-3627</PHONE_1><FAX_1>+81 49-223-8426</FAX_1></ADDRESS></PERSON><PERSON ID="F86CF2A382E26AA20078D4E652A6E77A" ROLE="AUTHOR"><PREFIX>Mr</PREFIX><FIRST_NAME>Michele</FIRST_NAME><LAST_NAME>Romano</LAST_NAME><POSITION>P.T. Chief</POSITION><EMAIL_1>michele.romano@isico.it</EMAIL_1><ADDRESS><ORGANISATION>ISICO (Italian Scientific Spine Institute)</ORGANISATION><ADDRESS_1>Via Roberto Bellarmino 13/1</ADDRESS_1><CITY>Milan</CITY><ZIP>20141</ZIP><COUNTRY CODE="IT">Italy</COUNTRY><PHONE_1>+39 02 58320947</PHONE_1><FAX_1>+39 02 58320953</FAX_1></ADDRESS></PERSON><PERSON ID="88D8895E82E26AA20078D4E6760112D3" ROLE="AUTHOR"><PREFIX>Dr</PREFIX><FIRST_NAME>Fabio</FIRST_NAME><LAST_NAME>Zaina</LAST_NAME><EMAIL_1>fabio.zaina@isico.it</EMAIL_1><URL>www.fabiozaina.com</URL><MOBILE_PHONE>00393287892236</MOBILE_PHONE><ADDRESS><ORGANISATION>ISICO (Italian Scientific Spine Institute)</ORGANISATION><ADDRESS_1>Via Roberto Bellarmino 13/1</ADDRESS_1><CITY>Milan</CITY><ZIP>20141</ZIP><COUNTRY CODE="IT">Italy</COUNTRY><PHONE_1>+39 0381 310851</PHONE_1><PHONE_2>+39 3287892236</PHONE_2><FAX_1>+39 02 58320953</FAX_1></ADDRESS></PERSON></CREATORS>
<DATES MODIFIED="2015-05-06 15:26:08 -0400" MODIFIED_BY="[Empty name]">
<UP_TO_DATE>
<DATE DAY="17" MONTH="2" YEAR="2015"/>
</UP_TO_DATE>
<LAST_SEARCH>
<DATE DAY="17" MONTH="2" YEAR="2015"/>
</LAST_SEARCH>
<NEXT_STAGE>
<DATE DAY="17" MONTH="2" YEAR="2017"/>
</NEXT_STAGE>
<PROTOCOL_PUBLISHED ISSUE="4" YEAR="2007"/>
<REVIEW_PUBLISHED ISSUE="1" YEAR="2010"/>
<LAST_CITATION_ISSUE ISSUE="6" YEAR="2015"/>
</DATES>
<WHATS_NEW MODIFIED="2015-06-16 09:32:25 -0400" MODIFIED_BY="[Empty name]">
<WHATS_NEW_ENTRY EVENT="UPDATE" MODIFIED="2015-06-16 09:32:25 -0400" MODIFIED_BY="[Empty name]">
<DATE DAY="19" MONTH="2" YEAR="2015"/>
<DESCRIPTION>
<P>The literature search has been updated. 5 more studies incorporated and 2 studies added to <LINK TAG="AWAITING_STUDIES" TYPE="SECTION">Studies awaiting classification</LINK> (<LINK REF="STD-Guo-2014" TYPE="STUDY">Guo 2014</LINK>; <LINK REF="STD-Wiemann-2014" TYPE="STUDY">Wiemann 2014</LINK>).</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="NEW_CITATION_NEW_CONCLUSIONS" MODIFIED="2014-06-06 10:55:49 -0400" MODIFIED_BY="[Empty name]">
<DATE DAY="27" MONTH="2" YEAR="2014"/>
<DESCRIPTION>
<P>5 new papers have been added: 3 RCTs (<LINK REF="REF-Bunge-2008" TYPE="REFERENCE">Bunge 2008</LINK>, <LINK REF="STD-Lou-2012" TYPE="STUDY">Lou 2012</LINK>, <LINK REF="STD-Coillard-2012" TYPE="STUDY">Coillard 2012</LINK>) and two prospective controlled trials (<LINK REF="STD-Lusini-2013" TYPE="STUDY">Lusini 2013</LINK>, <LINK REF="STD-Weinstein-2013b" TYPE="STUDY">Weinstein 2013b</LINK>). <LINK REF="STD-Weinstein-2013b" TYPE="STUDY">Weinstein 2013b</LINK> also included a randomized arm (<LINK REF="STD-Weinstein-2013a" TYPE="STUDY">Weinstein 2013a</LINK>). Since the last version of the review was published the quality of the evidence increased from very low to a range from moderate to very low. It was concluded that results were consistently in favour of bracing.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
</WHATS_NEW>
<HISTORY/>
<SOURCES_OF_SUPPORT>
<INTERNAL_SOURCES/>
<EXTERNAL_SOURCES/>
</SOURCES_OF_SUPPORT>
<MESH_TERMS VERIFIED="NO"/>
<KEYWORDS/>
</COVER_SHEET>
<MAIN_TEXT MODIFIED="2015-06-16 09:40:18 -0400" MODIFIED_BY="[Empty name]">
<SUMMARY MODIFIED="2015-06-09 04:45:32 -0400" MODIFIED_BY="[Empty name]">
<TITLE MODIFIED="2009-10-06 15:29:05 -0400" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;&lt;span modified=&quot;2015-05-29 18:20:00 +0100&quot; modified_by=&quot;Anne Lawson&quot; class=&quot;inserted&quot;&gt;The highlighted terms should be described using basic language for the non-specialist reader&lt;/span&gt;&lt;/p&gt;" NOTES_MODIFIED="2009-10-06 15:29:05 -0400" NOTES_MODIFIED_BY="[Empty name]">Braces for idiopathic scoliosis in adolescents</TITLE>
<SUMMARY_BODY MODIFIED="2015-06-09 04:45:32 -0400" MODIFIED_BY="[Empty name]">
<P>
<B>Review question</B>
</P>
<P>We reviewed the evidence about the effect of bracing on pulmonary disorders (lung diseases), disability, back pain, quality of life, and psychological and cosmetic issues in adolescent with idiopathic scoliosis. We found seven studies. We looked at randomized controlled trials (RCTs) and prospective controlled cohort studies (CCTs).</P>
<P>
<B>Background</B>
</P>
<P>Scoliosis is a condition where the spine is curved in three dimensions (from the back the spine appears to be shaped like an 's' and the trunk is deformed). It is often idiopathic, which means the cause is unknown. The most common type of scoliosis is generally discovered around 10 years of age or older, and is defined as a curve that measures at least 10° (called a Cobb angle; measured on x-ray). Because of the unknown cause and the age of diagnosis, it is called adolescent idiopathic scoliosis (AIS).</P>
<P>While there are usually no symptoms, the appearance of AIS frequently has a negative impact on adolescents. Increased curvature of the spine can present health risks in adulthood and in older people. Braces are one intervention that may stop further progression of the curve. They generally need to be worn full time, with treatment lasting until the end of growth (most frequently, from a minimum of two to four/five years). However, bracing for this condition is still controversial, and questions remain about how effective it is.</P>
<P>
<B>Study characteristics</B>
</P>
<P>This review included seven studies, with a total of 662 adolescents of both genders. AIS from 15° to more than 45° curves were considered. Elastic, rigid (polyethylene), and very rigid (polycarbonate) braces were studied. The evidence is current to October 2013. Funding sources were not reported or external governmental or scientific agencies.</P>
<P>
<B>Key results</B>
</P>
<P>We did not find any results on pulmonary disorders and disability. Quality of life was not affected during brace treatment (very low quality evidence); quality of life, back pain, and psychological and cosmetic issues did not change in the long term (very low quality evidence). Rigid bracing seems effective in 20° to 40° curves (low quality evidence), elastic bracing in 15° to 30° curves (low quality evidence), and very rigid bracing in high degree curves above 45° (very low quality evidence); rigid was more successful than an elastic bracing (low quality evidence), and a pad pressure control system did not increase results (very low quality evidence). No specific harms were reported.</P>
<P>Primary outcomes such as pulmonary disorders, disability, back pain, psychological and cosmetic issues, and quality of life should be better evaluated in the future. Side effects, as well as the usefulness of exercises and other adjunctive treatments to bracing should be studied too.</P>
<P>
<B>Quality of the evidence</B>
</P>
<P>The evidence was moderate to very low quality. Reason for downgrading were evidence coming from few randomized trials with few participants and many lost at follow-up or from observational prospective controlled studies. An issue in the field of AIS is the high rate of failure of RCTs, since parents want to choose with physicians the preferred treatment for their children. Thus, it is challenging to obtain high quality evidence in this field.</P>
</SUMMARY_BODY>
</SUMMARY>
<ABSTRACT MODIFIED="2015-06-09 13:06:28 -0400" MODIFIED_BY="[Empty name]">
<ABS_BACKGROUND MODIFIED="2014-06-26 17:03:50 -0400" MODIFIED_BY="[Empty name]">
<P>Idiopathic scoliosis is a three-dimensional deformity of the spine. The most common form is diagnosed in adolescence. While adolescent idiopathic scoliosis (AIS) can progress during growth and cause a surface deformity, it is usually not symptomatic. However, in adulthood, if the final spinal curvature surpasses a certain critical threshold, the risk of health problems and curve progression is increased.</P>
</ABS_BACKGROUND>
<ABS_OBJECTIVES MODIFIED="2015-06-09 10:50:51 -0400" MODIFIED_BY="[Empty name]">
<P>To evaluate the efficacy of bracing for adolescents with AIS versus no treatment or other treatments, on quality of life, disability, pulmonary disorders, progression of the curve, and psychological and cosmetic issues.</P>
</ABS_OBJECTIVES>
<ABS_SEARCH_STRATEGY MODIFIED="2015-06-09 13:06:28 -0400" MODIFIED_BY="[Empty name]">
<P>We searched CENTRAL, MEDLINE, EMBASE, five other databases, and two trials registers up to February 2015 for relevant clinical trials. We also checked the reference lists of relevant articles and conducted an extensive handsearch of grey literature.</P>
</ABS_SEARCH_STRATEGY>
<ABS_SELECTION_CRITERIA MODIFIED="2015-06-05 12:24:30 -0400" MODIFIED_BY="[Empty name]">
<P>Randomized controlled trials (RCTs) and prospective controlled cohort studies comparing braces with no treatment, other treatment, surgery, and different types of braces for adolescent with AIS.</P>
</ABS_SELECTION_CRITERIA>
<ABS_DATA_COLLECTION MODIFIED="2015-06-09 12:32:56 -0400" MODIFIED_BY="[Empty name]">
<P>We used standard methodological procedures expected by The Cochrane Collaboration.</P>
</ABS_DATA_COLLECTION>
<ABS_RESULTS MODIFIED="2015-06-05 12:24:54 -0400" MODIFIED_BY="[Empty name]">
<P>We included seven studies (662 participants). Five were planned as RCTs and two as prospective controlled trials. One RCT failed completely, another was continued as an observational study, reporting also the results of the participants that had been randomized.</P>
<P>There was very low quality evidence from one small RCT (111 participants) that quality of life (QoL) during treatment did not differ significantly between rigid bracing and observation (mean difference (MD) -2.10, 95% confidence interval (CI) -7.69 to 3.49). There was very low quality evidence from a subgroup of 77 adolescents from one prospective cohort study showing that QoL, back pain, psychological, and cosmetic issues did not differ significantly between rigid bracing and observation in the long term (16 years).</P>
<P>Results of the secondary outcomes showed that there was low quality evidence that rigid bracing compared with observation significantly increased the success rate in 20° to 40° curves at two years' follow-up (one RCT, 116 participants; risk ratio (RR) 1.79, 95% CI 1.29 to 2.50). There was low quality evidence that elastic bracing increased the success rate in 15° to 30° curves at three years' follow-up (one RCT, 47 participants; RR 1.88, 95% CI 1.11 to 3.20).</P>
<P>There is very low quality evidence from two prospective cohort studies with a control group that rigid bracing increases the success rate (curves not evolving to 50° or above) at two years' follow-up (one study, 242 participants; RR 1.50, 95% CI 1.19 to 1.89) and at three years' follow-up (one study, 240 participants; RR 1.75, 95% CI 1.42 to 2.16). There was very low quality evidence from a prospective cohort study (57 participants) that very rigid bracing increased the success rate (no progression of 5° or more, fusion, or waiting list for fusion) in adolescents with high degree curves (above 45°) (one study, 57 adolescents; RR 1.79, 95% CI 1.04 to 3.07 in the intention-to-treat (ITT) analysis).</P>
<P>There was low quality evidence from one RCT that a rigid brace was more successful than an elastic brace at curbing curve progression when measured in Cobb degrees in low degree curves (20° to 30°), with no significant differences between the two groups in the subjective perception of daily difficulties associated with wearing the brace (43 girls; risk of success at four years' follow-up: RR 1.40, 1.03 to 1.89). Finally, there was very low quality evidence from one RCT (12 participants) that a rigid brace with a pad pressure control system is no better than a standard brace in reducing the risk of progression.</P>
<P>Only one prospective cohort study (236 participants) assessed adverse events: neither the percentage of adolescents with any adverse event (RR 1.27, 95% CI 0.96 to 1.67) nor the percentage of adolescents reporting back pain, the most common adverse event, were different between the groups (RR 0.72, 95% CI 0.47 to 1.10).</P>
</ABS_RESULTS>
<ABS_CONCLUSIONS MODIFIED="2015-06-05 12:25:07 -0400" MODIFIED_BY="[Empty name]">
<P>Due to the important clinical differences among the studies, it was not possible to perform a meta-analysis. Two studies showed that bracing did not change QoL during treatment (low quality), and QoL, back pain, and psychological and cosmetic issues in the long term (16 years) (very low quality). All included papers consistently showed that bracing prevented curve progression (secondary outcome). However, due to the strength of evidence (from low to very low quality), further research is very likely to have an impact on our confidence in the estimate of effect. The high rate of failure of RCTs demonstrates the huge difficulties in performing RCTs in a field where parents reject randomization of their children. This challenge may prevent us from seeing increases in the quality of the evidence over time. Other designs need to be implemented and included in future reviews, including 'expertise-based' trials, prospective controlled cohort studies, prospective studies conducted according to pre-defined criteria such as the Scoliosis Research Society (SRS) and the international Society on Scoliosis Orthopedic and Rehabilitation Treatment (SOSORT) criteria. Future studies should increase their focus on participant outcomes, adverse effects, methods to increase compliance, and usefulness of physiotherapeutic scoliosis specific exercises added to bracing.</P>
</ABS_CONCLUSIONS>
</ABSTRACT>
<BODY MODIFIED="2015-06-16 09:40:18 -0400" MODIFIED_BY="[Empty name]">
<BACKGROUND MODIFIED="2015-06-05 12:29:18 -0400" MODIFIED_BY="[Empty name]">
<P> </P>
<CONDITION MODIFIED="2015-06-05 12:27:50 -0400" MODIFIED_BY="[Empty name]">
<P>Scoliosis is a three-dimensional deformity of the spine and the trunk (<LINK REF="REF-Negrini-2012" TYPE="REFERENCE">Negrini 2012</LINK>). The most common form is idiopathic scoliosis (70% to 80% of cases) (<LINK REF="REF-Hresko-2013" TYPE="REFERENCE">Hresko 2013</LINK>; <LINK REF="REF-Negrini-2012" TYPE="REFERENCE">Negrini 2012</LINK>). Adolescent idiopathic scoliosis (AIS) is discovered at 10 years of age or older (<LINK REF="REF-Hresko-2013" TYPE="REFERENCE">Hresko 2013</LINK>), and is defined as a curve of at least 10°, measured on a standing radiograph using the Cobb technique (<LINK REF="REF-Negrini-2012" TYPE="REFERENCE">Negrini 2012</LINK>). While the prevalence of AIS is 0.9% to 12% in the general population (<LINK REF="REF-Grivas-2006" TYPE="REFERENCE">Grivas 2006</LINK>), almost 10% of people diagnosed with AIS will require some form of treatment. Furthermore, up to 0.1% of the population is at risk of surgery (<LINK REF="REF-Lonstein-2006" TYPE="REFERENCE">Lonstein 2006</LINK>; <LINK REF="REF-Parent-2005" TYPE="REFERENCE">Parent 2005</LINK>). A severe form of AIS is more commonly found in females (80% to 90%). Typically, AIS does not cause any health problems during growth (except for extreme cases). However, the resulting surface deformity frequently has a negative impact on adolescents that can give rise to quality of life (QoL) issues and in the most severe cases, psychological disturbances (<LINK REF="REF-Freidel-2002a" TYPE="REFERENCE">Freidel 2002a</LINK>; <LINK REF="REF-Freidel-2002b" TYPE="REFERENCE">Freidel 2002b</LINK>; <LINK REF="REF-MacLean-1989" TYPE="REFERENCE">MacLean 1989</LINK>; <LINK REF="REF-Reichel-2003" TYPE="REFERENCE">Reichel 2003</LINK>). Adolescents are generally treated in an attempt to halt the progressive nature of the deformity. No treatments succeed in full correction to a normal spine, and even reduction of the deformity is difficult (<LINK REF="STD-Danielsson-2001a" TYPE="STUDY">Danielsson 2001a</LINK>; <LINK REF="REF-Lonstein-2006" TYPE="REFERENCE">Lonstein 2006</LINK>). If scoliosis surpasses a critical threshold, usually considered to be 30° Cobb, at the end of growth, the risk of health problems in adulthood increases significantly (<LINK REF="REF-Lonstein-2006" TYPE="REFERENCE">Lonstein 2006</LINK>; <LINK REF="REF-Negrini-2006a" TYPE="REFERENCE">Negrini 2006a</LINK>; <LINK REF="REF-Weinstein-2003" TYPE="REFERENCE">Weinstein 2003</LINK>). Problems include reduced QoL, disability, pain, increased cosmetic deformity, functional limitations, pulmonary problems, and possible progression during adulthood (<LINK REF="STD-Danielsson-2001a" TYPE="STUDY">Danielsson 2001a</LINK>; <LINK REF="REF-Danielsson-2003a" TYPE="REFERENCE">Danielsson 2003a</LINK>; <LINK REF="REF-Danielsson-2003b" TYPE="REFERENCE">Danielsson 2003b</LINK>; <LINK REF="REF-Grivas-2008" TYPE="REFERENCE">Grivas 2008</LINK>; <LINK REF="REF-Mayo-1994" TYPE="REFERENCE">Mayo 1994</LINK>; <LINK REF="REF-Negrini-2006a" TYPE="REFERENCE">Negrini 2006a</LINK>; <LINK REF="REF-Pehrsson-1992" TYPE="REFERENCE">Pehrsson 1992</LINK>; <LINK REF="REF-Pehrsson-2001" TYPE="REFERENCE">Pehrsson 2001</LINK>; <LINK REF="REF-Vasiliadis-2008" TYPE="REFERENCE">Vasiliadis 2008</LINK>; <LINK REF="REF-Weinstein-2003" TYPE="REFERENCE">Weinstein 2003</LINK>). Because of this, management of scoliosis also includes the prevention of secondary problems associated with the deformity (<LINK REF="REF-Negrini-2006b" TYPE="REFERENCE">Negrini 2006b</LINK>).</P>
</CONDITION>
<INTERVENTION MODIFIED="2015-06-05 12:28:19 -0400" MODIFIED_BY="[Empty name]">
<P>Treatment options for the prevention of AIS progression include exercises, bracing, and surgery (<LINK REF="REF-Fusco-2011" TYPE="REFERENCE">Fusco 2011</LINK>; <LINK REF="REF-Lenssinck-2005" TYPE="REFERENCE">Lenssinck 2005</LINK>; <LINK REF="REF-Negrini-2003" TYPE="REFERENCE">Negrini 2003</LINK>; <LINK REF="REF-Negrini-2005" TYPE="REFERENCE">Negrini 2005</LINK>; <LINK REF="REF-Negrini-2008a" TYPE="REFERENCE">Negrini 2008a</LINK>; <LINK REF="REF-Negrini-2009a" TYPE="REFERENCE">Negrini 2009a</LINK>; <LINK REF="REF-Negrini-2012" TYPE="REFERENCE">Negrini 2012</LINK>; <LINK REF="REF-Rigo-2006" TYPE="REFERENCE">Rigo 2006</LINK>; <LINK REF="REF-Romano-2008" TYPE="REFERENCE">Romano 2008</LINK>; <LINK REF="REF-Romano-2012" TYPE="REFERENCE">Romano 2012</LINK>; <LINK REF="REF-Romano-2013" TYPE="REFERENCE">Romano 2013</LINK>; <LINK REF="STD-Rowe-1997" TYPE="STUDY">Rowe 1997</LINK>). Bracing can be defined as the application of external corrective forces to the trunk. This is usually achieved through rigid supports, but elastic bands are also used (<LINK REF="STD-Coillard-2003" TYPE="STUDY">Coillard 2003</LINK>). Treatment commences when the curve is diagnosed as progressive or exceeds a threshold, which is considered to be above 20° Cobb, usually between 25° and 30° (<LINK REF="REF-Lonstein-2006" TYPE="REFERENCE">Lonstein 2006</LINK>; <LINK REF="REF-Negrini-2005" TYPE="REFERENCE">Negrini 2005</LINK>; <LINK REF="REF-Richards-2005" TYPE="REFERENCE">Richards 2005</LINK>). Braces should generally be worn full-time (at least 20 hours per day) with treatment usually lasting from a minimum of two to four or five years, until the end of bone growth (<LINK REF="REF-Katz-2001" TYPE="REFERENCE">Katz 2001</LINK>; <LINK REF="REF-Landauer-2003" TYPE="REFERENCE">Landauer 2003</LINK>; <LINK REF="STD-Rahman-2005" TYPE="STUDY">Rahman 2005</LINK>; <LINK REF="REF-SRS-2006" TYPE="REFERENCE">SRS 2006</LINK>). All this causes a significant impact on the lives of children and adolescents (<LINK REF="REF-Climent-1999" TYPE="REFERENCE">Climent 1999</LINK>; <LINK REF="REF-Noonan-1997" TYPE="REFERENCE">Noonan 1997</LINK>; <LINK REF="REF-Odermatt-2003" TYPE="REFERENCE">Odermatt 2003</LINK>; <LINK REF="REF-Ugwonali-2004" TYPE="REFERENCE">Ugwonali 2004</LINK>; <LINK REF="REF-Vasiliadis-2006" TYPE="REFERENCE">Vasiliadis 2006</LINK>).</P>
</INTERVENTION>
<THEORY MODIFIED="2015-06-05 12:29:18 -0400" MODIFIED_BY="[Empty name]">
<P>The mechanical forces and the external and proprioceptive inputs of bracing can reduce unnatural loading and asymmetrical movements and improve neuromuscular control. This facilitates proper spinal growth, neuromotor re-organization, and change of motor behaviours (<LINK REF="STD-Castro-2003" TYPE="STUDY">Castro 2003</LINK>; <LINK REF="REF-Coillard-2002" TYPE="REFERENCE">Coillard 2002</LINK>; <LINK REF="REF-Grivas-2008" TYPE="REFERENCE">Grivas 2008</LINK>; <LINK REF="REF-Lupparelli-2002" TYPE="REFERENCE">Lupparelli 2002</LINK>; <LINK REF="REF-Negrini-2006c" TYPE="REFERENCE">Negrini 2006c</LINK>; <LINK REF="REF-Odermatt-2003" TYPE="REFERENCE">Odermatt 2003</LINK>; <LINK REF="REF-Smania-2008" TYPE="REFERENCE">Smania 2008</LINK>; <LINK REF="REF-Stokes-2006" TYPE="REFERENCE">Stokes 2006</LINK>).</P>
</THEORY>
<IMPORTANCE MODIFIED="2015-06-05 12:29:07 -0400" MODIFIED_BY="[Empty name]">
<P>Currently, the bracing of adolescents with AIS is controversial. It is considered standard treatment in continental Europe, but not in many centres of the UK, US, and elsewhere (<LINK REF="REF-Altaf-2013" TYPE="REFERENCE">Altaf 2013</LINK>; <LINK REF="REF-Hresko-2013" TYPE="REFERENCE">Hresko 2013</LINK>). Bracing has been widely criticized because there is a paucity of evidence regarding its benefits (<LINK REF="STD-Dickson-1999a" TYPE="STUDY">Dickson 1999a</LINK>; <LINK REF="REF-Dickson-1999b" TYPE="REFERENCE">Dickson 1999b</LINK>; <LINK REF="REF-Dolan-2007a" TYPE="REFERENCE">Dolan 2007a</LINK>; <LINK REF="REF-Dolan-2007b" TYPE="REFERENCE">Dolan 2007b</LINK>; <LINK REF="REF-Goldberg-1993" TYPE="REFERENCE">Goldberg 1993</LINK>). Moreover, bracing has been linked to reduced QoL and increased psychological issues (<LINK REF="REF-Climent-1999" TYPE="REFERENCE">Climent 1999</LINK>; <LINK REF="STD-F_x00e4_llstr_x00f6_m-1986" TYPE="STUDY">Fällström 1986</LINK>; <LINK REF="REF-Noonan-1997" TYPE="REFERENCE">Noonan 1997</LINK>; <LINK REF="REF-Ugwonali-2004" TYPE="REFERENCE">Ugwonali 2004</LINK>; <LINK REF="REF-Vasiliadis-2006" TYPE="REFERENCE">Vasiliadis 2006</LINK>). To date, reviews on braces have been mainly narrative, have not considered the key issue of evaluating the methodological quality of the studies in the review, and have not included all existing studies (<LINK REF="REF-Dolan-2007b" TYPE="REFERENCE">Dolan 2007b</LINK>; <LINK REF="REF-Lenssinck-2005" TYPE="REFERENCE">Lenssinck 2005</LINK>; <LINK REF="STD-Rowe-1997" TYPE="STUDY">Rowe 1997</LINK>). Our previous Cochrane review was based on only two studies and found inconclusive evidence (<LINK REF="REF-Negrini-2010a" TYPE="REFERENCE">Negrini 2010a</LINK>). An update of this review will help clinicians to decide whether the sacrifices required by children to wear braces are indeed worthwhile.</P>
</IMPORTANCE>
</BACKGROUND>
<OBJECTIVES MODIFIED="2015-06-05 12:29:30 -0400" MODIFIED_BY="[Empty name]">
<P>To evaluate the efficacy of bracing for adolescents with AIS versus no treatment or other treatments, on quality of life, disability, pulmonary disorders, progression of the curve, and psychological and cosmetic issues.</P>
</OBJECTIVES>
<METHODS MODIFIED="2015-06-16 09:32:05 -0400" MODIFIED_BY="[Empty name]">
<SELECTION_CRITERIA MODIFIED="2015-06-09 10:56:31 -0400" MODIFIED_BY="[Empty name]">
<CRIT_STUDIES MODIFIED="2015-06-09 04:45:17 -0400" MODIFIED_BY="[Empty name]">
<P>All randomized controlled trials (RCTs) and prospective controlled cohort studies.</P>
</CRIT_STUDIES>
<CRIT_PARTICIPANTS MODIFIED="2015-06-09 10:50:45 -0400" MODIFIED_BY="[Empty name]">
<P>We included all participants who were 10 years of age or older (until the end of bone growth) when diagnosed as having AIS. We included only studies in which bone maturity was evaluated by the Risser sign, wrist radiographs, or both. We excluded studies in which participants presented with any type of secondary scoliosis (congenital, neurological, metabolic, post-traumatic, etc.) diagnosed according to the Scoliosis Research Society (SRS) (<LINK REF="REF-SRS-2006" TYPE="REFERENCE">SRS 2006</LINK>), and the international Society on Scoliosis Orthopedic and Rehabilitation Treatment (SOSORT) (<LINK REF="REF-Negrini-2012" TYPE="REFERENCE">Negrini 2012</LINK>), criteria.</P>
</CRIT_PARTICIPANTS>
<CRIT_INTERVENTIONS MODIFIED="2015-06-09 10:56:31 -0400" MODIFIED_BY="[Empty name]">
<P>We included all types of rigid, semi-rigid, and elastic braces (defined as devices to apply external corrective forces to the spine and trunk), worn for a specific number of hours per day for a specific number of years. We considered all possible control interventions and comparisons.</P>
</CRIT_INTERVENTIONS>
<CRIT_OUTCOMES MODIFIED="2015-06-05 12:40:21 -0400" MODIFIED_BY="[Empty name]">
<CRIT_OUTCOMES_PRIMARY MODIFIED="2015-06-05 12:40:21 -0400" MODIFIED_BY="[Empty name]">
<P>Pulmonary disorders, disability, back pain, QoL, and psychological and cosmetic issues. We included only validated measures of study outcomes, and we assessed minimal clinically important differences on a case-by-case basis.</P>
</CRIT_OUTCOMES_PRIMARY>
<CRIT_OUTCOMES_SECONDARY MODIFIED="2015-06-05 12:40:21 -0400" MODIFIED_BY="[Empty name]">
<P>Clinical and radiographic parameters (<LINK REF="REF-Negrini-2006a" TYPE="REFERENCE">Negrini 2006a</LINK>; <LINK REF="REF-Negrini-2012" TYPE="REFERENCE">Negrini 2012</LINK>). Very short (any result before the end of bone growth), intermediate (results at the end of bone growth), and long-term (results in adulthood) outcomes. Progression of scoliosis was measured by:</P>
<UL>
<LI>Cobb angle in degrees (absolute values);</LI>
<LI>number of participants who had progressed by more than 5° Cobb (radiographic measurement error, considered as the minimal clinically important difference) (<LINK REF="REF-Negrini-2012" TYPE="REFERENCE">Negrini 2012</LINK>);</LI>
</UL>
<UL>
<LI>risk of success, defined in terms of participants that at the end of treatment were neither treated surgically (fused) nor surpassing specific thresholds considered clinically meaningful (45° or 50°, or both) (<LINK REF="REF-Negrini-2012" TYPE="REFERENCE">Negrini 2012</LINK>; <LINK REF="REF-Richards-2005" TYPE="REFERENCE">Richards 2005</LINK>);</LI>
<LI>Adverse effects, as outlined in identified trials.</LI>
</UL>
</CRIT_OUTCOMES_SECONDARY>
</CRIT_OUTCOMES>
</SELECTION_CRITERIA>
<SEARCH_METHODS MODIFIED="2015-06-10 12:26:42 -0400" MODIFIED_BY="[Empty name]">
<ELECTRONIC_SEARCHES MODIFIED="2015-06-10 12:26:42 -0400" MODIFIED_BY="[Empty name]">
<P>For this update, we searched the following electronic databases to 17 and 18 February 2015 to identify relevant studies:</P>
<UL>
<LI>the Cochrane Register of Controlled Trials (CENTRAL, <I>The Cochrane Library, </I>which includes Cochrane Back Review Group Trials Register; Issue 1 of 12, January 2015);</LI>
<LI>MEDLINE (Ovid SP, 1946 to February week 2 2015);</LI>
<LI>MEDLINE In-Process &amp; Other Non-Indexed Citations (Ovid SP, 13 February 2015);</LI>
<LI>EMBASE (Ovid SP, 1980 to week 7 2015);</LI>
<LI>Cumulative Index to Nursing and Allied Health Literature (CINAHL; EBSCO, 1981 to 18 February 2015);</LI>
<LI>PsycINFO (Ovid SP, 2002 to February week 2 2015);</LI>
<LI>Physiotherapy Evidence Database (<A HREF="http://www.pedro.org.au/">PEDro</A>);</LI>
<LI>Cochrane Back Review Group Trials Register (Reference Manager and Cochrane Register of Studies (CRS));</LI>
<LI>
<A HREF="https://clinicaltrials.gov/ct2/home">ClinicalTrials.gov</A>;</LI>
<LI>World Health Organization (WHO) International Clinical Trials Registry Platform (<A HREF="http://apps.who.int/trialsearch/">WHO ICTRP</A>);</LI>
<LI>
<A HREF="http://www.ncbi.nlm.nih.gov/pubmed">PubMed</A>.</LI>
</UL>
<P>As with the original review, we used the search strategies recommended by the Cochrane Back Review Group for the identification of RCTs (<LINK REF="REF-Furlan-2009" TYPE="REFERENCE">Furlan 2009</LINK>), and adapted them to include cohort studies. The Cochrane Back Review Group Trials Search Co-ordinator developed the strategies and used a combination of controlled vocabulary terms (e.g. MeSH terms) and keywords to describe methodology, disorders, and treatment. These methods were consistent with the Chapter 6 of the <I>Cochrane Handbook for Systematic Reviews of Interventions</I> (<LINK REF="REF-Higgins-2011" TYPE="REFERENCE">Higgins 2011</LINK>). <LINK REF="APP-01" TYPE="APPENDIX">Appendix 1</LINK>, <LINK REF="APP-02" TYPE="APPENDIX">Appendix 2</LINK>, and <LINK REF="APP-03" TYPE="APPENDIX">Appendix 3</LINK> show the strategies for each database.</P>
</ELECTRONIC_SEARCHES>
<OTHER_SEARCHES MODIFIED="2015-06-05 15:19:42 -0400" MODIFIED_BY="[Empty name]">
<P>We also included the following strategies:</P>
<UL>
<LI>reference lists of all relevant papers;</LI>
<LI>main electronic sources of ongoing trials (National Research Register, meta-Register of Controlled Trials; Clinical Trials);</LI>
<LI>grey literature, including conference proceedings, PhD theses, and unpublished work conducted by manufacturers that were likely to contain trials relevant to the review;</LI>
<LI>contacted investigators and authors in this field for information on unpublished or incomplete trials.</LI>
</UL>
<P>All searches included non-English language studies. When considered likely to meet inclusion criteria, we translated studies published in languages other than English.</P>
<P>
<LINK REF="APP-04" TYPE="APPENDIX">Appendix 4</LINK> and <LINK REF="APP-05" TYPE="APPENDIX">Appendix 5</LINK> show the sources handsearched and the years considered.</P>
</OTHER_SEARCHES>
</SEARCH_METHODS>
<DATA_COLLECTION MODIFIED="2015-06-16 09:32:05 -0400" MODIFIED_BY="[Empty name]">
<STUDY_SELECTION MODIFIED="2015-06-05 12:42:46 -0400" MODIFIED_BY="[Empty name]">
<P>Two review authors (JBS, NC) independently evaluated the search results by reading the titles; two other review authors (TB, TM) independently reviewed the abstracts of the remaining papers. We obtained potentially relevant studies in full text and two review authors (TK, FZ) independently assessed them for inclusion. None of the papers was reviewed by any of the authors who may have written the original papers. At all stages, we resolved disagreements through discussion. The lead review author (SN) solved any persisting disagreements.</P>
</STUDY_SELECTION>
<DATA_EXTRACTION MODIFIED="2015-06-09 10:50:37 -0400" MODIFIED_BY="[Empty name]">
<P>We prepared a standardized data extraction form, which we used to extract data from the included papers. Two review authors (SM, FZ) independently extracted data on the population, study characteristics, and results added to Review Manager 5.3 (<LINK REF="REF-RevMan-2012" TYPE="REFERENCE">RevMan 2012</LINK>). We discussed any disagreements, and consulted the lead review author (SN) if disagreements persisted. We summarized key findings in a narrative format and assessed for inclusion in a meta-analysis where possible.</P>
<SUBSECTION>
<HEADING LEVEL="4">Clinical relevance of results</HEADING>
<P>The review authors assessed each trial for its clinical relevance by using the five questions outlined by <LINK REF="REF-Shekelle-1994" TYPE="REFERENCE">Shekelle 1994</LINK>
, and recommended by the Cochrane Back Review Group (<LINK REF="REF-Furlan-2009" TYPE="REFERENCE">Furlan 2009</LINK>; <LINK REF="APP-06" TYPE="APPENDIX">Appendix 6</LINK>). We assessed all important outcomes for each comparison. The main conclusions were clinical, because our main aim was to give clinicians state-of-the-art information, according to relevant studies on this issue.</P>
</SUBSECTION>
</DATA_EXTRACTION>
<QUALITY_ASSESSMENT MODIFIED="2015-06-16 09:32:05 -0400" MODIFIED_BY="[Empty name]">
<P>We assessed the risk of bias of RCTs and controlled clinical trials (CCTs) in this review using the 12 criteria recommended by the Cochrane Back Review Group (<LINK REF="REF-Furlan-2009" TYPE="REFERENCE">Furlan 2009</LINK>; <LINK REF="REF-Higgins-2011" TYPE="REFERENCE">Higgins 2011</LINK>), as outlined in <LINK REF="APP-07" TYPE="APPENDIX">Appendix 7</LINK>. We used the Newcastle-Ottawa Scale (NOS scale) to assess the prospective cohort studies with a control group (<LINK REF="REF-Wells-2008" TYPE="REFERENCE">Wells 2008</LINK>). The NOS scale assesses three broad areas: selection bias, attrition bias, and detection bias. See <LINK REF="APP-08" TYPE="APPENDIX">Appendix 8</LINK> for details. For each included study, each type of bias was rated as high, low, or unclear and entered into the risk of bias table.</P>
<P>Two review authors, one with methodological expertise and one with content expertise, independently assessed the risk of bias of the included studies. The review authors resolved any disagreements by discussion, including input from a third independent review author if required. Risk of bias assessment was not blinded to trial authors, institution, or journal.</P>
</QUALITY_ASSESSMENT>
<EFFECT_MEASURES MODIFIED="2015-06-05 12:46:40 -0400" MODIFIED_BY="[Empty name]">
<P>We analysed dichotomous outcomes by calculating the risk ratio (RR) for each trial, with the uncertainty in each result expressed with 95% confidence intervals (CI). We analysed continuous outcomes by calculating the mean difference (MD) or the standardized mean difference (SMD) with 95% CI.</P>
</EFFECT_MEASURES>
<DATA_SYNTHESIS MODIFIED="2015-06-05 12:46:57 -0400" MODIFIED_BY="[Empty name]">
<P>Meta-analysis was not performed because the retrieved studies were too heterogeneous with regards to the study design, types of comparisons, populations included, and braces applied (elastic, rigid, very rigid). Therefore, we did not perform the pre-planned investigations of heterogeneity, sensitivity analysis excluding studies with high risk of bias, and subgroup analysis for studies at low risk of bias. We assessed the overall quality of the evidence for each outcome. We used an adapted GRADE approach, as recommended by the Cochrane Back Review Group (<LINK REF="REF-Furlan-2009" TYPE="REFERENCE">Furlan 2009</LINK>).</P>
<P>Factors that may decrease the quality of the evidence are study design and risk of bias, inconsistency of results, indirectness (not generalizable), imprecision (sparse data), and other factors (e.g. reporting bias and publication bias). The quality of the evidence for a specific outcome was downgraded by a level, according to the performance of the studies against these five factors.</P>
<UL>
<LI>
<B>High quality evidence: </B>there are consistent findings among at least 75% of RCTs with low risk of bias, consistent, direct, and precise data and no known or suspected publication biases. Further research is unlikely to change either the estimate or our confidence in the results.</LI>
<LI>
<B>Moderate quality evidence: </B>one of the domains is not met. Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.</LI>
<LI>
<B>Low quality evidence: </B>two of the domains are not met. Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.</LI>
<LI>
<B>Very low quality evidence: </B>three of the domains are not met. We are very uncertain about the results.</LI>
<LI>
<B>No evidence: </B>no RCTs were identified that addressed this outcome.</LI>
</UL>
</DATA_SYNTHESIS>
</DATA_COLLECTION>
</METHODS>
<RESULTS MODIFIED="2015-06-16 09:35:22 -0400" MODIFIED_BY="[Empty name]">
<STUDY_DESCRIPTION MODIFIED="2015-06-16 09:35:22 -0400" MODIFIED_BY="[Empty name]">
<SEARCH_RESULTS MODIFIED="2015-06-16 09:35:22 -0400" MODIFIED_BY="[Empty name]">
<P>We found 2479 titles with the electronic search (<LINK REF="FIG-01" TYPE="FIGURE">Figure 1</LINK>), 13 studies with the handsearch, and 40 titles by searching Conference Proceedings and websites. After removing duplicates, we screened 859 titles and excluded 706 based on titles and 10 after reviewing the abstracts. We retrieved 143 full texts. We excluded 135 studies, one of which because we were unable to retrieve the full paper (<LINK REF="STD-Wessberg-2011" TYPE="STUDY">Wessberg 2011</LINK>). We wrote to the principal investigators but they did not respond. Both <LINK REF="STD-Coillard-2012" TYPE="STUDY">Coillard 2012</LINK> and <LINK REF="STD-Lusini-2013" TYPE="STUDY">Lusini 2013</LINK> agreed to send the final versions of articles that were under review for publication. <LINK REF="STD-Lusini-2013" TYPE="STUDY">Lusini 2013</LINK> has since been published. This resulted in seven included studies, two of which were reported in the original version of this review. Two studies added to <LINK TAG="AWAITING_STUDIES" TYPE="SECTION">Studies awaiting classification</LINK> (<LINK REF="STD-Guo-2014" TYPE="STUDY">Guo 2014</LINK>; <LINK REF="STD-Wiemann-2014" TYPE="STUDY">Wiemann 2014</LINK>).</P>
</SEARCH_RESULTS>
<INCLUDED_STUDIES_DESCR MODIFIED="2015-06-09 10:52:28 -0400" MODIFIED_BY="[Empty name]">
<P>Seven articles met our inclusion criteria: five were planned as RCTs (<LINK REF="REF-Bunge-2008" TYPE="REFERENCE">Bunge 2008</LINK>; <LINK REF="STD-Coillard-2012" TYPE="STUDY">Coillard 2012</LINK>; <LINK REF="STD-Lou-2012" TYPE="STUDY">Lou 2012</LINK>; <LINK REF="STD-Weinstein-2013a" TYPE="STUDY">Weinstein 2013a</LINK>; <LINK REF="STD-Wong-2008" TYPE="STUDY">Wong 2008</LINK>), and two as prospective controlled trials (<LINK REF="STD-Lusini-2013" TYPE="STUDY">Lusini 2013</LINK>; <LINK REF="STD-Nachemson-1995" TYPE="STUDY">Nachemson 1995</LINK>). Two RCTs failed due to very low recruitment of participants (<LINK REF="STD-Bunge-2010" TYPE="STUDY">Bunge 2010</LINK>; <LINK REF="STD-Weinstein-2013a" TYPE="STUDY">Weinstein 2013a</LINK>).</P>
<P>The RCT by <LINK REF="STD-Weinstein-2013a" TYPE="STUDY">Weinstein 2013a</LINK> focused on 25° to 40° curves. Unfortunately, 64.7% of adolescents refused to participate and 21% of adolescents and their parents rejected randomization; other adolescents were lost for numerous reasons. The final percentage of participants that could be allocated to the randomized arm was 10.6%, including 0.9% that crossed over groups. Due to this low inclusion rate, the authors extended the inclusion criteria to include adolescents with 20° curves. In addition, they transformed the study into a prospective controlled trial, including a randomized arm. This study was considered both as a prospective non-randomized study with the all sample (<LINK REF="STD-Weinstein-2013a" TYPE="STUDY">Weinstein 2013a</LINK>), and as randomized trial considering only the sub-sample that was randomized (<LINK REF="STD-Weinstein-2013b" TYPE="STUDY">Weinstein 2013b</LINK>).</P>
<P>
<LINK REF="STD-Bunge-2010" TYPE="STUDY">Bunge 2010</LINK> aimed to recruit adolescents and compare braces with observation only; the study failed completely during the recruitment phase; so we excluded it from further consideration.</P>
<P>Thus, we included four randomized controlled trials/arms (<LINK REF="STD-Coillard-2012" TYPE="STUDY">Coillard 2012</LINK>; <LINK REF="STD-Lou-2012" TYPE="STUDY">Lou 2012</LINK>; <LINK REF="STD-Weinstein-2013b" TYPE="STUDY">Weinstein 2013b</LINK>; <LINK REF="STD-Wong-2008" TYPE="STUDY">Wong 2008</LINK>), and three prospective controlled trials (<LINK REF="STD-Lusini-2013" TYPE="STUDY">Lusini 2013</LINK>; <LINK REF="STD-Nachemson-1995" TYPE="STUDY">Nachemson 1995</LINK>; <LINK REF="STD-Weinstein-2013a" TYPE="STUDY">Weinstein 2013a</LINK>). One controlled prospective paper had a follow-up at 16 years in a sub-group of adolescents (<LINK REF="STD-Nachemson-1995" TYPE="STUDY">Nachemson 1995</LINK>).</P>
<P>
<LINK REF="STD-Nachemson-1995" TYPE="STUDY">Nachemson 1995</LINK> was a worldwide collaboration including hospitals from two continents; they observed two groups of clinicians, where the first group believed in the effectiveness of treatment with a brace, and the second group firmly believed that a brace was ineffective and thus managed people with careful observation; two centres of this last group treated adolescents with lateral electrical surface stimulation.</P>
<P>
<B>Types of treatments and comparisons:</B> Braces included elastic bands (<LINK REF="STD-Coillard-2012" TYPE="STUDY">Coillard 2012</LINK>; <LINK REF="STD-Wong-2008" TYPE="STUDY">Wong 2008</LINK>), rigid (polyethylene) (<LINK REF="STD-Lou-2012" TYPE="STUDY">Lou 2012</LINK>; <LINK REF="STD-Nachemson-1995" TYPE="STUDY">Nachemson 1995</LINK>; <LINK REF="STD-Weinstein-2013a" TYPE="STUDY">Weinstein 2013a</LINK>; <LINK REF="STD-Weinstein-2013b" TYPE="STUDY">Weinstein 2013b</LINK>; <LINK REF="STD-Wong-2008" TYPE="STUDY">Wong 2008</LINK>), and very rigid (polycarbonate) thoraco-lumbo-sacral orthosis (<LINK REF="STD-Lusini-2013" TYPE="STUDY">Lusini 2013</LINK>). Two studies compared bracing with observation (<LINK REF="STD-Coillard-2012" TYPE="STUDY">Coillard 2012</LINK>; <LINK REF="STD-Weinstein-2013a" TYPE="STUDY">Weinstein 2013a</LINK>; <LINK REF="STD-Weinstein-2013b" TYPE="STUDY">Weinstein 2013b</LINK>), one study compared bracing plus physiotherapeutic-specific scoliosis exercises versus observation (<LINK REF="STD-Lusini-2013" TYPE="STUDY">Lusini 2013</LINK>). One study compared rigid bracing with observation or electrical stimulation (<LINK REF="STD-Nachemson-1995" TYPE="STUDY">Nachemson 1995</LINK>). Two studies compared two different types of braces: rigid versus an elastic soft brace (<LINK REF="STD-Wong-2008" TYPE="STUDY">Wong 2008</LINK>), and two different rigid braces with the same number of hours wearing the brace every day (<LINK REF="STD-Lou-2012" TYPE="STUDY">Lou 2012</LINK>).</P>
<P>
<B>Duration of the trials: </B>the duration was different among all included studies, with the range being between one and five years. <LINK REF="STD-Coillard-2012" TYPE="STUDY">Coillard 2012</LINK> had a follow-up at five years post-randomization, <LINK REF="STD-Lou-2012" TYPE="STUDY">Lou 2012</LINK> had follow-up at three years, and <LINK REF="STD-Lusini-2013" TYPE="STUDY">Lusini 2013</LINK> had follow-up at two to nine years. In <LINK REF="STD-Nachemson-1995" TYPE="STUDY">Nachemson 1995</LINK>, after being treated until maturity (up to four years), a subset of all Swedish adolescents were followed up for 16 years after treatment (range 10.9 to 19.4 years), including a braced (Malmö; 41 participants) and observed (Göteborg; 65 participants) group.</P>
<P>
<B>Participants:</B> 662 participants were included, of these 483 were treated with a brace, 133 observed, and 46 were prescribed a control treatment different from bracing (electrical stimulation) (<LINK REF="APP-09" TYPE="APPENDIX">Appendix 9</LINK>). Studies were not completely homogeneous in terms of population characteristics. The mean age was approximately 12.5 years for all studies except <LINK REF="STD-Lusini-2013" TYPE="STUDY">Lusini 2013</LINK> (mean age above 14 years). In most studies, Cobb degrees were between 20° and 40°, apart from the studies of <LINK REF="STD-Coillard-2012" TYPE="STUDY">Coillard 2012</LINK> (15° to 30°) and <LINK REF="STD-Lusini-2013" TYPE="STUDY">Lusini 2013</LINK> (greater than 45°). The two studies evaluating elastic bracing focused on low degree curves (15° to 30° (<LINK REF="STD-Coillard-2012" TYPE="STUDY">Coillard 2012</LINK>), and 20° to 30° (<LINK REF="STD-Wong-2008" TYPE="STUDY">Wong 2008</LINK>), while those using very rigid bracing focused on very high degree curves greater than 45° (<LINK REF="STD-Lusini-2013" TYPE="STUDY">Lusini 2013</LINK>). <LINK REF="STD-Lou-2012" TYPE="STUDY">Lou 2012</LINK> described neither the Cobb angles nor the age of the participants.</P>
<P>
<B>Outcomes: </B>of the primary outcomes considered in this review, only QoL modifications due to bracing were considered by three papers: <LINK REF="STD-Weinstein-2013b" TYPE="STUDY">Weinstein 2013b</LINK> used the PedsQL score (<LINK REF="REF-Varni-2001" TYPE="REFERENCE">Varni 2001</LINK>; <LINK REF="REF-Varni-2003" TYPE="REFERENCE">Varni 2003</LINK>), <LINK REF="STD-Nachemson-1995" TYPE="STUDY">Nachemson 1995</LINK> used the SRS22 (<LINK REF="REF-Asher-2003a" TYPE="REFERENCE">Asher 2003a</LINK>; <LINK REF="REF-Asher-2003b" TYPE="REFERENCE">Asher 2003b</LINK>) and the 36-item Short Form (SF=36) (<LINK REF="REF-Ware-1992" TYPE="REFERENCE">Ware 1992</LINK>; <LINK REF="REF-Wiklund-1991" TYPE="REFERENCE">Wiklund 1991</LINK>), and <LINK REF="STD-Wong-2008" TYPE="STUDY">Wong 2008</LINK> used a purpose-designed questionnaire. All the studies focused on the secondary outcome, scoliosis progression.</P>
<P>
<B>Countries in which the studies were conducted:</B> one RCT was conducted in Hong Kong (<LINK REF="STD-Wong-2008" TYPE="STUDY">Wong 2008</LINK>), two in Canada (<LINK REF="STD-Coillard-2012" TYPE="STUDY">Coillard 2012</LINK>; <LINK REF="STD-Lou-2012" TYPE="STUDY">Lou 2012</LINK>), and one was a multicentre study conducted in the US and Canada (<LINK REF="STD-Weinstein-2013b" TYPE="STUDY">Weinstein 2013b</LINK>). One prospective cohort study was a multinational study conducted in three centres in the UK, four centres in the US, one centre in Canada, and two centres in Sweden (<LINK REF="STD-Nachemson-1995" TYPE="STUDY">Nachemson 1995</LINK>). The other prospective study was performed in Italy (<LINK REF="STD-Lusini-2013" TYPE="STUDY">Lusini 2013</LINK>).</P>
<P>See 
<LINK TAG="CHARACTERISTICS_OF_INCLUDED_STUDIES" TYPE="SECTION">Characteristics of included studies</LINK>.</P>
</INCLUDED_STUDIES_DESCR>
<EXCLUDED_STUDIES_DESCR MODIFIED="2015-06-05 12:47:59 -0400" MODIFIED_BY="[Empty name]">
<P>We excluded 136 papers for the following main reasons: 45 were retrospective, 37 were prospective but without concurrent controls, and 53 were excluded for other reasons. <LINK REF="REF-Bunge-2008" TYPE="REFERENCE">Bunge 2008</LINK> was an RCT, but was excluded from the final analysis because of the low numbers of participants that agreed to participate and be randomized.</P>
<P>See <LINK TAG="CHARACTERISTICS_OF_EXCLUDED_STUDIES" TYPE="SECTION">Characteristics of excluded studies</LINK>.</P>
</EXCLUDED_STUDIES_DESCR>
</STUDY_DESCRIPTION>
<STUDY_QUALITY MODIFIED="2015-06-09 04:38:38 -0400" MODIFIED_BY="[Empty name]">
<P>See <LINK REF="FIG-02" TYPE="FIGURE">Figure 2</LINK> and <LINK REF="FIG-03" TYPE="FIGURE">Figure 3</LINK>
</P>
<ALLOCATION MODIFIED="2015-06-05 12:48:11 -0400" MODIFIED_BY="[Empty name]">
<P>We judged the method of random sequence generation as low risk of bias in two RCTs (<LINK REF="STD-Coillard-2012" TYPE="STUDY">Coillard 2012</LINK>; <LINK REF="STD-Weinstein-2013b" TYPE="STUDY">Weinstein 2013b</LINK>). Random sequence generation was unclear in the other two RCTs (<LINK REF="STD-Lou-2012" TYPE="STUDY">Lou 2012</LINK>; <LINK REF="STD-Wong-2008" TYPE="STUDY">Wong 2008</LINK>). The allocation concealment was at low risk of bias in one RCT (<LINK REF="STD-Coillard-2012" TYPE="STUDY">Coillard 2012</LINK>), and unclear in the remaining studies. It was at high risk of bias in the observational studies.</P>
</ALLOCATION>
<BLINDING MODIFIED="2015-06-09 04:38:38 -0400" MODIFIED_BY="[Empty name]">
<P>Neither the RCTs nor the prospective cohort studies could be blinded for participants and providers because of the type of intervention assessed (brace). The risk of detection bias was high for all the studies for subjective outcomes (e.g. QoL or disability) and low for objective outcomes (e.g. Cobb degrees or scoliosis progression). The outcome assessor was not blinded in <LINK REF="STD-Coillard-2012" TYPE="STUDY">Coillard 2012</LINK>, and was blinded in <LINK REF="STD-Weinstein-2013a" TYPE="STUDY">Weinstein 2013a</LINK>, whereas blinding of the assessor was not reported in all other studies. Consequently, for subjective outcomes (e.g. self reported pain), we judged the risk of detection bias to be high for <LINK REF="STD-Coillard-2012" TYPE="STUDY">Coillard 2012</LINK>, low for <LINK REF="STD-Weinstein-2013a" TYPE="STUDY">Weinstein 2013a</LINK>, and unclear in the other studies, For objective outcomes, we rated detection bias as low because they are unlikely to be biased by lack of blinding.</P>
</BLINDING>
<EXCLUSIONS MODIFIED="2015-06-05 12:49:14 -0400" MODIFIED_BY="[Empty name]">
<P>Three RCTs reported no drop-outs (<LINK REF="STD-Lou-2012" TYPE="STUDY">Lou 2012</LINK>; <LINK REF="STD-Weinstein-2013b" TYPE="STUDY">Weinstein 2013b</LINK>; <LINK REF="STD-Wong-2008" TYPE="STUDY">Wong 2008</LINK>). We judged <LINK REF="STD-Coillard-2012" TYPE="STUDY">Coillard 2012</LINK> at high risk of attrition bias because there was a high rate of drop-outs and this was unbalanced between groups. In two of the prospective cohort studies, the percentage of loss at follow-up was unbalanced between groups (21% in the experimental group and 7% in the control group in <LINK REF="STD-Nachemson-1995" TYPE="STUDY">Nachemson 1995</LINK>; 7.7% in the experimental group and 44% in the control group in <LINK REF="STD-Lusini-2013" TYPE="STUDY">Lusini 2013</LINK>). However, <LINK REF="STD-Lusini-2013" TYPE="STUDY">Lusini 2013</LINK> performed an intention-to-treat (ITT) analysis with worst-case analysis considering loss at follow-up as a failure for the outcome 'improvement', and as a success for the outcome 'scoliosis progression/fusion'. Consequently, we judged this study to be at low risk of attrition bias. We judged the <LINK REF="STD-Weinstein-2013a" TYPE="STUDY">Weinstein 2013a</LINK> paper at low risk of bias because there was no loss at follow-up.</P>
</EXCLUSIONS>
<SELECTIVE_REPORTING MODIFIED="2013-10-26 14:09:59 -0400" MODIFIED_BY="VEP  ">
<P>All studies were free of selective reporting.</P>
</SELECTIVE_REPORTING>
<OTHER_BIAS_SOURCES MODIFIED="2015-06-05 12:49:37 -0400" MODIFIED_BY="[Empty name]">
<P>In terms of group similarity at baseline, in two RCTs, groups were similar for the main prognostic factors (<LINK REF="STD-Coillard-2012" TYPE="STUDY">Coillard 2012;</LINK> <LINK REF="STD-Wong-2008" TYPE="STUDY">Wong 2008</LINK>), in one RCT, no information was reported about the baseline characteristics of participants (<LINK REF="STD-Lou-2012" TYPE="STUDY">Lou 2012</LINK>). In one prospective cohort study, the brace group had more participants with severe scoliosis, fewer participants with imbalance, and fewer participants with menarche at baseline compared with the electrical stimulation or observation-only groups (<LINK REF="STD-Nachemson-1995" TYPE="STUDY">Nachemson 1995</LINK>). <LINK REF="STD-Bunge-2010" TYPE="STUDY">Bunge 2010</LINK>, <LINK REF="STD-Lusini-2013" TYPE="STUDY">Lusini 2013</LINK>, and <LINK REF="STD-Weinstein-2013a" TYPE="STUDY">Weinstein 2013a</LINK> reported no information about the similarity or differences of participants at baseline.</P>
<P>Two of the observational studies did not adjust for the most important confounding factors. <LINK REF="STD-Weinstein-2013a" TYPE="STUDY">Weinstein 2013a </LINK>used propensity scores to reduce the effect of treatment selection bias, so we judged this study at low risk of bias due to confounding. Two studies did not report information on compliance and co-interventions. <LINK REF="STD-Weinstein-2013a" TYPE="STUDY">Weinstein 2013a</LINK> assessed compliance by temperature monitor data and self reported diary, so we judged it as being at low risk of bias due to non-compliance. The timing of outcome assessment was similar across groups in all studies.</P>
</OTHER_BIAS_SOURCES>
</STUDY_QUALITY>
<INTERVENTION_EFFECTS MODIFIED="2015-06-09 12:39:00 -0400" MODIFIED_BY="[Empty name]">
<SUBSECTION>
<HEADING LEVEL="3">1. Brace versus observation (randomized controlled trials)</HEADING>
<SUBSECTION>
<HEADING LEVEL="4">Primary outcome measures</HEADING>
<SUBSECTION>
<HEADING LEVEL="5">Pulmonary disorders, disability, back pain, psychological issues, and cosmetic issues</HEADING>
<P>No studies assessed pulmonary disorders, disability, back pain, psychological issues, and cosmetic issues.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Quality of life</HEADING>
<P>
<B>Two years' follow-up:</B> <LINK REF="STD-Weinstein-2013b" TYPE="STUDY">Weinstein 2013b</LINK> (111 participants) found that the mean PedsQL did not differ significantly between bracing and observation (MD -2.10, 95% CI -7.69 to 3.49; <LINK REF="CMP-001.01" TYPE="ANALYSIS">Analysis 1.1</LINK>).</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Secondary outcome measures</HEADING>
<SUBSECTION>
<HEADING LEVEL="5">Progression of scoliosis</HEADING>
<P>
<B>Two years' follow-up:</B> <LINK REF="STD-Weinstein-2013b" TYPE="STUDY">Weinstein 2013b</LINK> found the rate of success (curves remaining below 50°) was 38/51 in the brace group and 27/65 in the observation group (RR 1.79, 95% CI 1.29 to 2.50; <LINK REF="CMP-001.02" TYPE="ANALYSIS">Analysis 1.2</LINK>). The results were in favour of brace.</P>
<P>
<B>Three years' follow-up:</B> <LINK REF="STD-Coillard-2012" TYPE="STUDY">Coillard 2012</LINK> reported the rate of success (correction or stabilization, i.e. 5° or less curve progression) as 21/26 in the brace group and 9/21 in the control group(RR 1.88, 95% CI 1.11 to 3.20; <LINK REF="CMP-001.03" TYPE="ANALYSIS">Analysis 1.3</LINK>). The results were in favour of brace.</P>
<P>
<B>Five years' follow-up:</B> <LINK REF="STD-Coillard-2012" TYPE="STUDY">Coillard 2012</LINK> found the rate of success was 19/26 in the brace group and 12/21 in the control group (RR 1.28, 95% CI 0.83 to 1.98; <LINK REF="CMP-001.04" TYPE="ANALYSIS">Analysis 1.4</LINK>). There was no significant difference between groups.</P>
<P>
<B>Participants with curves exceeding 45º at maturity:</B> <LINK REF="STD-Coillard-2012" TYPE="STUDY">Coillard 2012</LINK> found that 3/21 (14.3%) participants in the control group and 3/26 (11.5%) participants in the treated group had Cobb angles that exceeded 45° at the end of study. <LINK REF="STD-Weinstein-2013b" TYPE="STUDY">Weinstein 2013b</LINK> found that 13/51 participants in the brace group and 38/65 in the observation group reached 50° or more at the end of growth.</P>
<P>
<B>Participants who had undergone surgery or received a recommendation for surgery: </B>
<LINK REF="STD-Coillard-2012" TYPE="STUDY">Coillard 2012</LINK> reported that 3/21 (14.3%) immature participants required surgical fusion while in the trial. The mean curve magnitude at the beginning of the treatment in this particular group was 27° (range 20° to 30º) and they all had a Risser sign of 0. In the treated group, 2/26 (7.7%) immature participants were recommended surgery during the study and 1/26 treated participant was recommended surgery after three years following the end of treatment.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Adverse events</HEADING>
<P>No studies assessed adverse events.</P>
</SUBSECTION>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">2. Brace versus observation or electrical stimulation (prospective cohort studies)</HEADING>
<SUBSECTION>
<HEADING LEVEL="4">Primary outcome measures</HEADING>
<SUBSECTION>
<HEADING LEVEL="5">Pulmonary disorders and disability</HEADING>
<P>No studies assessed pulmonary disorders, and disability.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Quality of life, back pain, and psychological and cosmetic issues</HEADING>
<P>
<B>Two years' follow-up:</B> <LINK REF="STD-Weinstein-2013a" TYPE="STUDY">Weinstein 2013a</LINK> (236 participants) reported that the mean PedsQL for all participants included in the study did not differ significantly between bracing and observation (MD 0.10, 95% CI -3.90 to 4.10; <LINK REF="CMP-002.01" TYPE="ANALYSIS">Analysis 2.1</LINK>).</P>
<P>
<B>Long-term (16 years) follow-up:</B> the Swedish cohort of <LINK REF="STD-Nachemson-1995" TYPE="STUDY">Nachemson 1995</LINK> reported 16 years' follow-up with 40 participants in the observation group and 37 participants in the brace group. Using the SRS22, they found no differences between groups for each of the sub-scales and the total score (mean (SD); pain: 4.3 (0.7) with observation versus 4.4 (0.6) with brace; P value = 0.94; self image/appearance: 3.9 (0.8) with observation versus 3.9 (0.7) with brace; P value = 0.98; function/activity: 4.5 (0.5) with observation versus 4.5 (0.5) with brace; P value = 0.60; mental health: 4.1 (0.7) with observation versus 4.1 (0.7) with brace; P value = 0.93; satisfaction with management: 3.7 (1.0) with observation versus 3.8 (0.9) with brace; P value = 0.45; total score: 4.1 (0.5) with observation versus 4.2 (0.4) with brace; P value = 0.91).</P>
<P>Similarly, there were no differences using the SF-36 (mean observation versus brace; physical functioning 94.5 (95% CI 91.9 to 97.1) versus 94.9 (95% CI 92.1 to 97.1); P value = 0.80; role physical: 93.1 (95% CI 87.3 to 98.9) versus 91.9 (95% CI 84.8 to 97.7); P value = 0.94; bodily pain: 75.0 (95% CI 67.4 to 82.5) versus 68.1 (95% CI 60.2 to 74.5); P value = 0.19; general health: 83.7 (95% CI 74.6 to 88.2) versus 79.8 (95% CI 75.1 to 83.6); P value = 0.15; vitality: 69.9 (95% CI 63.3 to 76.1) versus 68.2 (95% CI 61.6 to 73.7); P value = 0.78; social functioning: 91.9 (95% CI 86.7 to 97.0) versus 89.5 (95% CI 83.3 to 94.6); P value = 0.34; emotional aspects: 90.0 (95% CI 82.5 to 97.5) versus 86.5 (95% CI 76.5 to 94.6); P value = 0.79; mental health: 83.5 (95% CI 78.9 to 88.1) versus 81.3 (95% CI 76.2&#8211;85.4); P value = 0.51).</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Secondary outcome measures</HEADING>
<SUBSECTION>
<HEADING LEVEL="5">Progression of scoliosis</HEADING>
<P>
<B>Two years' follow-up:</B> <LINK REF="STD-Weinstein-2013a" TYPE="STUDY">Weinstein 2013a</LINK> examined rate of success (curves not evolving to 50° or above) among 146 braced and 96 observed participants. The rate of success was in favour of the bracing group (RR 1.50, 95% CI 1.19 to 1.89; <LINK REF="CMP-002.02" TYPE="ANALYSIS">Analysis 2.2</LINK>).</P>
<P>
<B>Three years' follow-up:</B> <LINK REF="STD-Nachemson-1995" TYPE="STUDY">Nachemson 1995</LINK> reported that the success rates (defined as less than 6° increase of the curve) were 80% (95% CI 66% to 88%) for bracing, 46% (95% CI 25% to 56%) for observation, and 39% (95% CI 19% to 59%) for electrical stimulation. When comparing brace with observation, the results favoured the brace group (240 participants; RR 1.75, 95% CI 1.42 to 2.16; <LINK REF="CMP-002.03" TYPE="ANALYSIS">Analysis 2.3</LINK>).</P>
<P>
<B>Four years' follow-up:</B> <LINK REF="STD-Nachemson-1995" TYPE="STUDY">Nachemson 1995</LINK> reported that the success rates were 74% (95% CI 52% to 84%) for bracing, 34% (95% CI 16% to 49%) for observation, and 33% (95% CI 12% to 60%) for electrical stimulation (log-rank test P value &lt; 0.0001). When comparing brace with observation, the results favoured the brace group (240 participants; RR 2.22, 95% CI 1.70 to 2.90; <LINK REF="CMP-002.04" TYPE="ANALYSIS">Analysis 2.4</LINK>). A worst-case analysis for the bracing group in which the 23 participants who dropped out from the brace arm were considered to have had failed treatment, maintained a highly significant success in preventing progression of 6° or more until skeletal maturity (log-rank test P value &lt; 0.0005).</P>
<P>
<B>Long-term (16 years) follow-up:</B> <LINK REF="STD-Nachemson-1995" TYPE="STUDY">Nachemson 1995</LINK> found that participants braced or observed progressed more than 5° (range 5° to 21°). This progression meant that braced participants returned to the pre-treatment levels (31.9° now versus 33.0° at start). Observed participants (excluding 11 who were braced and six who were fused during growth because of failure) showed an overall progression from the start of treatment of 6.4° (range 5° to 14°).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Adverse events</HEADING>
<P>
<B>Two years' follow-up:</B> <LINK REF="STD-Weinstein-2013a" TYPE="STUDY">Weinstein 2013a</LINK> found no difference between groups in the percentage of participants with any adverse event (RR 1.27, 95% CI 0.96 to 1.67; <LINK REF="CMP-002.05" TYPE="ANALYSIS">Analysis 2.5</LINK>) and in the percentage of participants reporting back pain (which was the most common adverse event) (RR 0.72, 95% CI 0.47 to 1.10; <LINK REF="CMP-002.06" TYPE="ANALYSIS">Analysis 2.6</LINK>). One serious adverse event, a hospitalization for anxiety and depression, was reported in one participant who wore a brace. Adverse events involving the skin under the brace were reported in 12/146 (8%) participants who wore a brace.</P>
</SUBSECTION>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">3. Brace and exercise versus observation in high-degree curves (prospective cohort study)</HEADING>
<SUBSECTION>
<HEADING LEVEL="4">Primary outcome measures</HEADING>
<SUBSECTION>
<HEADING LEVEL="5">Pulmonary disorders, disability, back pain, psychological issues, cosmetic issues, and quality of life</HEADING>
<P>The study did not assess pulmonary disorders, disability, back pain, psychological issues, cosmetic issues, and QoL.</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Secondary outcome measures</HEADING>
<SUBSECTION>
<HEADING LEVEL="5">Progression of scoliosis</HEADING>
<P>
<B>Two to nine years' follow up: </B>
<LINK REF="STD-Lusini-2013" TYPE="STUDY">Lusini 2013</LINK> reported that the rate of success (no progression of 5° or more, no fusion, or no waiting list for fusion) was 25/33 in the brace group and 0/10 in observation group in the per-protocol analysis (RR 15.21, 95% CI 1.00 to 230.23; <LINK REF="CMP-003.02" TYPE="ANALYSIS">Analysis 3.2</LINK>) and 31/39 in the brace group and 8/18 in the observation group in the ITT analysis (RR 1.79, 95% CI 1.04 to 3.07; <LINK REF="CMP-003.03" TYPE="ANALYSIS">Analysis 3.3</LINK>). The results were in favour of brace.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Adverse events</HEADING>
<P>The study did not assess adverse events.</P>
</SUBSECTION>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">4. Smart brace versus standard rigid brace (randomized controlled trial)</HEADING>
<SUBSECTION>
<HEADING LEVEL="4">Primary outcome measures</HEADING>
<SUBSECTION>
<HEADING LEVEL="5">Pulmonary disorders, disability, back pain, psychological issues, cosmetic issues, and quality of life</HEADING>
<P>The study did not assess pulmonary disorders, disability, back pain, psychological issues, cosmetic issues, and QoL.</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Secondary outcome measures</HEADING>
<SUBSECTION>
<HEADING LEVEL="5">Progression of scoliosis</HEADING>
<P>
<LINK REF="STD-Lou-2012" TYPE="STUDY">Lou 2012</LINK> (12 participants) found no significant difference between the Smart brace and the standard rigid brace. The Cobb angles (mean ± SD) were: pre-brace 33 ± 6° with Smart brace versus 33 ± 6° with standard rigid brace; in brace: 20 ± 5° with Smart brace versus 21 ± 4° with standard rigid brace; three years after: 35 ± 7° with Smart brace versus 38 ± 9° with standard rigid brace. The in-brace correction (% of initial Cobb angle) was 38 ± 3% with Smart brace versus 36 ± 5% with standard rigid brace.</P>
<P>
<B>Five years' follow-up:</B> risk of progression (mean ± SD): 60.2 ± 27% with Smart versus 63.4 ± 27% with standard rigid brace. At the end of treatment, the Cobb angle progressed by (mean ± SD) 2.2 ± 1.2° with Smartbrace versus 4.8 ± 8° with standard rigid brace.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Adverse events</HEADING>
<P>The study did not assess adverse events.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Compliance</HEADING>
<P>The participants in the Smart brace group were more likely to wear their brace at the prescribed level during day time activity compared with the standard rigid group (67% with Smart brace versus 54% with standard rigid brace).</P>
</SUBSECTION>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">5. Rigid brace versus elastic brace (randomized controlled trial)</HEADING>
<SUBSECTION>
<HEADING LEVEL="4">Primary outcome measures</HEADING>
<SUBSECTION>
<HEADING LEVEL="5">Pulmonary disorders, disability, back pain, psychological issues, and cosmetic issues</HEADING>
<P>The study did not assess pulmonary disorders, disability, back pain, psychological issues, and cosmetic issues.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Quality of life</HEADING>
<P>While the rigid brace caused significantly more problems with heat (85% with rigid brace versus 27% with elastic brace), as well as difficulties with donning and doffing, the participants using the elastic braces had difficulties with toileting (<LINK REF="STD-Wong-2008" TYPE="STUDY">Wong 2008</LINK>).</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Secondary outcome measures</HEADING>
<SUBSECTION>
<HEADING LEVEL="5">Progression of scoliosis</HEADING>
<P>
<B>Four years' follow-up:</B> <LINK REF="STD-Wong-2008" TYPE="STUDY">Wong 2008</LINK> found that, in participants with 20° to 30° Cobb angle before skeletal maturity, a rigid brace showed better results than an elastic brace (SpineCor) (risk of success defined as no progression more than 5°: RR 1.40, 95% CI 1.03 to 1.89; <LINK REF="CMP-004.02" TYPE="ANALYSIS">Analysis 4.2</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Adverse events</HEADING>
<P>
<LINK REF="STD-Wong-2008" TYPE="STUDY">Wong 2008</LINK> did not assess adverse events.</P>
</SUBSECTION>
</SUBSECTION>
</SUBSECTION>
</INTERVENTION_EFFECTS>
</RESULTS>
<DISCUSSION MODIFIED="2015-06-05 13:03:50 -0400" MODIFIED_BY="[Empty name]">
<SUMMARY_OF_RESULTS MODIFIED="2015-06-05 13:01:42 -0400" MODIFIED_BY="[Empty name]">
<P>Despite a comprehensive search of published and unpublished literature, we found only seven studies (one failed), which included 662 participants.</P>
<P>We did not find any results on pulmonary disorders and disability. There was moderate quality evidence from one small RCT (111 participants) that QoL did not differ significantly between rigid bracing and observation (<LINK REF="STD-Weinstein-2013b" TYPE="STUDY">Weinstein 2013b</LINK>); QoL, back pain, and psychological and cosmetic issues did not change in the long term (16 years) (very low quality evidence) (<LINK REF="STD-Nachemson-1995" TYPE="STUDY">Nachemson 1995</LINK>). All included papers were consistent in showing that bracing prevented progression (secondary outcome): rigid bracing in 20° 40° curves (moderate quality evidence) (<LINK REF="STD-Nachemson-1995" TYPE="STUDY">Nachemson 1995</LINK>; <LINK REF="STD-Weinstein-2013a" TYPE="STUDY">Weinstein 2013a</LINK>; <LINK REF="STD-Weinstein-2013b" TYPE="STUDY">Weinstein 2013b</LINK>), elastic bracing in 15° to 30° curves (low quality evidence) (<LINK REF="STD-Coillard-2012" TYPE="STUDY">Coillard 2012</LINK>), very rigid bracing in high degree curves above 45° (very low quality evidence) (<LINK REF="STD-Lusini-2013" TYPE="STUDY">Lusini 2013</LINK>); rigid was more successful than elastic bracing (low quality evidence) (<LINK REF="STD-Wong-2008" TYPE="STUDY">Wong 2008</LINK>), and a pad pressure control system did not increase results (very low quality evidence) (<LINK REF="STD-Lou-2012" TYPE="STUDY">Lou 2012</LINK>). Nevertheless, due to the strength of evidence (from low to very low quality), further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.</P>
<P>No specific harms have been reported. The high rate of failure of RCTs demonstrated the huge difficulties in performing RCTs in a field where parents reject randomization of their children: this questions the possibility of consistently increasing the strength of the actual evidence.</P>
</SUMMARY_OF_RESULTS>
<APPLICABILITY_OF_FINDINGS MODIFIED="2015-06-05 13:03:42 -0400" MODIFIED_BY="[Empty name]">
<P>The current evidence about brace treatment for AIS is of low to very low quality. Until now, four RCTs have been performed, two comparing two types of braces (<LINK REF="STD-Wong-2008" TYPE="STUDY">Wong 2008</LINK>; <LINK REF="STD-Lou-2012" TYPE="STUDY">Lou 2012</LINK>), and two comparing braces versus observation (<LINK REF="STD-Coillard-2012" TYPE="STUDY">Coillard 2012</LINK>; <LINK REF="STD-Weinstein-2013b" TYPE="STUDY">Weinstein 2013b</LINK>). In <LINK REF="STD-Coillard-2012" TYPE="STUDY">Coillard 2012</LINK> and <LINK REF="STD-Wong-2008" TYPE="STUDY">Wong 2008</LINK>, participants had a range of pathology below the most frequent indications for bracing (<LINK REF="REF-Negrini-2012" TYPE="REFERENCE">Negrini 2012</LINK>), 15-30° (<LINK REF="STD-Coillard-2012" TYPE="STUDY">Coillard 2012</LINK>), and 20° to 30º (<LINK REF="STD-Wong-2008" TYPE="STUDY">Wong 2008</LINK>). On the contrary, in the classical range of 25° to 40° curves (<LINK REF="REF-Negrini-2012" TYPE="REFERENCE">Negrini 2012</LINK>; <LINK REF="REF-Richards-2005" TYPE="REFERENCE">Richards 2005</LINK>), the implementation of RCTs is challenging. The members of one of the main scientific societies in the field, the SRS, which consists mainly of orthopaedic surgeons, were found to be in equipoise on bracing (<LINK REF="REF-Dolan-2007b" TYPE="REFERENCE">Dolan 2007b</LINK>), and were able to plan an RCT (<LINK REF="STD-Weinstein-2013b" TYPE="STUDY">Weinstein 2013b</LINK>); conversely, members of the second main society, the conservative experts of SOSORT, rejected the possibility of performing an RCT (<LINK REF="REF-Negrini-2009b" TYPE="REFERENCE">Negrini 2009b</LINK>; <LINK REF="REF-Negrini-2012" TYPE="REFERENCE">Negrini 2012</LINK>; <LINK REF="REF-Negrini-2014" TYPE="REFERENCE">Negrini 2014</LINK>); they found this possibility comparable to an RCT on parachutes (<LINK REF="REF-Smith-2003" TYPE="REFERENCE">Smith 2003</LINK>). Despite these professional positions, the strongest argument against the possibility of performing RCTs comes from the reality that most parents (70% to 80% of cases) will not allow their children to be randomized. This was the main reason for failure of the two best efforts performed in recent years (<LINK REF="REF-Bunge-2008" TYPE="REFERENCE">Bunge 2008</LINK>; <LINK REF="REF-Negrini-2014" TYPE="REFERENCE">Negrini 2014</LINK>; <LINK REF="STD-Weinstein-2013a" TYPE="STUDY">Weinstein 2013a</LINK>). In fact, while the Dutch RCT failed completely (<LINK REF="STD-Bunge-2010" TYPE="STUDY">Bunge 2010</LINK>), the US trial (<LINK REF="STD-Weinstein-2013a" TYPE="STUDY">Weinstein 2013a</LINK>), financed with more than USD 5 million by the US Government through the 'National Institute of Arthritis and Musculoskeletal and Skin Diseases', has finally been changed from an RCT to a CCT (<LINK REF="STD-Weinstein-2013a" TYPE="STUDY">Weinstein 2013a</LINK>). In 2013, the ethical committee requested that the study be stopped due to the evident success of bracing (<LINK REF="STD-Weinstein-2013a" TYPE="STUDY">Weinstein 2013a</LINK>), and for this reason, it was also possible to report the RCT data. Therefore, the probability of new, future RCTs of bracing versus observation is low. Clinicians in this field will rely on the current low quality evidence for many years to come. Bunge, the main Dutch researcher (an epidemiologist) concluded, "it is harder to perform a RCT that abolishes or postpones a treatment than a RCT that adds a new treatment" (<LINK REF="STD-Bunge-2010" TYPE="STUDY">Bunge 2010</LINK>). Nevertheless, RCTs comparing different types or designs of braces (<LINK REF="STD-Lou-2012" TYPE="STUDY">Lou 2012</LINK>; <LINK REF="STD-Wong-2008" TYPE="STUDY">Wong 2008</LINK>), or different approaches have already been done and will presumably be performed in the future.</P>
<P>Apart from the research design used by Alf Nachemson (<LINK REF="STD-Nachemson-1995" TYPE="STUDY">Nachemson 1995</LINK>), the SRS Bracing Committee proposed another possible study design to address the methodological criteria for bracing studies (<LINK REF="REF-Richards-2005" TYPE="REFERENCE">Richards 2005</LINK>). Compliance and the standard of bracing should also be considered (<LINK REF="REF-Grivas-2012" TYPE="REFERENCE">Grivas 2012</LINK>; <LINK REF="REF-Negrini-2009b" TYPE="REFERENCE">Negrini 2009b</LINK>). In fact, the wide range of results in brace studies (<LINK REF="REF-Dolan-2007a" TYPE="REFERENCE">Dolan 2007a</LINK>) usually leads to a discussion on the methodology of the study and the type of brace used, but the quality of bracing and participants' management should also be considered (<LINK REF="REF-Grivas-2012" TYPE="REFERENCE">Grivas 2012</LINK>; <LINK REF="REF-Negrini-2009b" TYPE="REFERENCE">Negrini 2009b</LINK>). These have been addressed by the Society on Scoliosis Orthopaedic and Rehabilitation Treatment (SOSORT) with the Guidelines on "Standards of management of idiopathic scoliosis with corrective braces in daily clinics and in clinical research" (<LINK REF="REF-Negrini-2009b" TYPE="REFERENCE">Negrini 2009b</LINK>). The SRS and SOSORT criteria for bracing should be considered for the methodological and management standards to be followed in future research studies, and will allow meta-analysis to be performed on solid methodological criteria.</P>
<P>Other fields to be explored are the importance of compliance and methods to increase compliance (<LINK REF="REF-Donzelli-2012" TYPE="REFERENCE">Donzelli 2012</LINK>; <LINK REF="REF-Katz-2010" TYPE="REFERENCE">Katz 2010</LINK>); the possible usefulness of physiotherapeutic scoliosis (specific or not) exercises (<LINK REF="REF-Negrini-2012" TYPE="REFERENCE">Negrini 2012</LINK>; <LINK REF="REF-Zaina-2009" TYPE="REFERENCE">Zaina 2009</LINK>); means to reduce the impact of bracing on participants, even if according to our results there is low quality evidence that it is not different from observation alone (<LINK REF="STD-Weinstein-2013a" TYPE="STUDY">Weinstein 2013a</LINK>).</P>
<SUBSECTION>
<HEADING LEVEL="3">Clinical relevance</HEADING>
<P>All included studies strongly mimic the clinical reality (high ecological and external validity). Two studies included only females, which reflects the fact that the majority (80% to 90%) of people with AIS are female (<LINK REF="STD-Nachemson-1995" TYPE="STUDY">Nachemson 1995</LINK>; <LINK REF="STD-Wong-2008" TYPE="STUDY">Wong 2008</LINK>). In fact, the limit of the current evidence comes from the difficulty previously discussed in performing a classical RCT (high internal, but usually low external validity).</P>
<P>Generally in the literature, and specifically in the retrieved studies within this review, outcomes other than Cobb degrees are barely considered. This reflects physicians' attitudes that during growth, their focus is on avoiding or at least curbing curve progression (secondary aim) to prevent future problems of QoL, disability, back pain, etc. (primary aims). This approach comes from the fact that scoliosis is progressive during growth, and if the curves surpass 30° Cobb at the end of growth, the risk of health problems in adulthood increases. Consequently, results reported in this review are clinically relevant, according to the current focus in the literature on Cobb degrees as the primary outcome. Nevertheless, the lack of focus on secondary adverse effects of treatment, as well as the absence of long-term, primary outcome results (QoL, disability, pain) must be stressed and addressed in future studies.</P>
<P>No major risks of the intervention have been reported in the literature, apart from skin problems and anxiety (<LINK REF="STD-Weinstein-2013a" TYPE="STUDY">Weinstein 2013a</LINK>), hot during summer with rigid bracing and difficulties in toileting with the elastic braces, that is, minor adverse effects (<LINK REF="STD-Wong-2008" TYPE="STUDY">Wong 2008</LINK>).</P>
</SUBSECTION>
</APPLICABILITY_OF_FINDINGS>
<QUALITY_OF_EVIDENCE MODIFIED="2015-06-05 13:03:50 -0400" MODIFIED_BY="[Empty name]">
<P>Overall, the quality of evidence in favour of bracing alone or bracing plus exercise compared to observation or electrical stimulation is from low to very low quality. The included studies for these comparisons were two RCTs with only 47 and 116 participants. One RCT was at high risk of attrition bias, the other trial was at unclear risk of selection bias. The other included studies were three prospective cohort studies, two of which had a high attrition rate and no adjustment for potential confounding factors. In addition, the evidence for comparisons of different types of braces is low: only two RCTs with very small sample size and a high or unclear risk of bias across all domains of bias.</P>
<P>Note that since 80% to 90% of people with AIS are female, the inclusion of one study of only females was not considered to be a source of indirectness (<LINK REF="STD-Nachemson-1995" TYPE="STUDY">Nachemson 1995;</LINK> <LINK REF="STD-Wong-2008" TYPE="STUDY">Wong 2008</LINK>).</P>
</QUALITY_OF_EVIDENCE>
<POTENTIAL_BIASES MODIFIED="2015-05-30 16:43:48 -0400" MODIFIED_BY="Anne Lawson">
<P>The strength of the review is the extensive and comprehensive searches conducted, including many different sources in many languages. Another strength is its high ecological validity, due to the real-life situations considered in the studies. The main weakness of the review is the absence of strong studies in this field that do not make it possible to reach firm conclusions. Nevertheless, results among the studies included are fairly coherent. Two authors of this review were also authors of one of the primary studies (<LINK REF="STD-Lusini-2013" TYPE="STUDY">Lusini 2013</LINK>); this paper was evaluated by the other review authors.</P>
</POTENTIAL_BIASES>
<AGREEMENT MODIFIED="2015-05-30 16:43:48 -0400" MODIFIED_BY="Anne Lawson">
<P>The previous Cochrane review was based on two studies only (<LINK REF="REF-Negrini-2010a" TYPE="REFERENCE">Negrini 2010a</LINK>; <LINK REF="REF-Negrini-2010b" TYPE="REFERENCE">Negrini 2010b</LINK>). In recent years, a number of well-designed studies have been conducted, and as a whole, the current evidence is much stronger than that presented in the original review.</P>
<P>One "evidence-based review" looked at entirely different outcomes from those considered here: the "rate of surgery" (failure of treatment) in braced groups ranged between 1.4% and 41% (<LINK REF="REF-Dolan-2007a" TYPE="REFERENCE">Dolan 2007a</LINK>). This paper was based on retrospective comparative studies, and on retrospective and prospective case series results, all of which we excluded from the current review. Furthermore, only papers in English were considered, while those adding exercises to bracing were excluded. It was not possible to obtain a good uniformity of methods and outcomes among papers, even if sub-group analysis was attempted. These problems could be overcome following the SRS criteria for bracing studies (<LINK REF="REF-Richards-2005" TYPE="REFERENCE">Richards 2005</LINK>). Moreover, excluding papers that add exercises to bracing should not be done in the future, because, according to SOSORT criteria (<LINK REF="REF-Negrini-2009b" TYPE="REFERENCE">Negrini 2009b</LINK>), this is a management criterion to increase compliance. In fact, papers including exercises report very low surgery rates (2% to 7% for efficacy analysis, 10% to 14% for worst -case analysis), comparable to the best results in the bracing papers reported above (<LINK REF="REF-Maruyama-2003" TYPE="REFERENCE">Maruyama 2003</LINK>; <LINK REF="REF-Negrini-2008b" TYPE="REFERENCE">Negrini 2008b</LINK>; <LINK REF="REF-Negrini-2009a" TYPE="REFERENCE">Negrini 2009a</LINK>; <LINK REF="STD-Rigo-2003" TYPE="STUDY">Rigo 2003</LINK>; <LINK REF="STD-Weiss-2003" TYPE="STUDY">Weiss 2003</LINK>).</P>
</AGREEMENT>
</DISCUSSION>
<CONCLUSIONS MODIFIED="2015-06-16 09:40:18 -0400" MODIFIED_BY="[Empty name]">
<IMPLICATIONS_PRACTICE MODIFIED="2015-06-16 09:40:18 -0400" MODIFIED_BY="[Empty name]">
<P>Due to the important clinical differences among the studies, it was not possible to perform a meta-analysis. We found no studies reporting pulmonary disorders and disability; one study showed that bracing did not change quality of life (QoL) during treatment (moderate quality evidence); QoL, back pain, and psychological and cosmetic issues did not change in the long term (16 years) (very low quality). All included papers were consistent in showing that bracing avoided progression (secondary outcome). Due to the strength of evidence (from moderate to very low, owing to the methodological quality of the studies), a good estimate of the effect remains uncertain. The high rate of failure of randomized controlled trials (RCTs) demonstrates the huge difficulties in performing RCTs in a field where parents reject randomization of their children: this questions the possibility of consistently increasing the strength of the actual evidence.</P>
</IMPLICATIONS_PRACTICE>
<IMPLICATIONS_RESEARCH MODIFIED="2015-06-09 10:49:35 -0400" MODIFIED_BY="[Empty name]">
<P>Due to the difficulties in performing RCTs in this field, &#8220;expertise-based" trials, where people are randomized to centres acting according to their preferred protocols, are a possible option. Together with controlled prospective trials, another option is studies conducted according to the SRS (<LINK REF="REF-Richards-2005" TYPE="REFERENCE">Richards 2005</LINK>) and SOSORT (<LINK REF="REF-Negrini-2009b" TYPE="REFERENCE">Negrini 2009b</LINK>) criteria for bracing to allow comparability, such as prospective multicentre cohort studies or prospective case series of participants treated and not treated. Other similar criteria for different populations would be important to allow future meta-studies to be performed.</P>
<P>Moreover, any future study should significantly widen their focus on participant outcomes (not just radiographic outcomes of scoliosis progression) as well as adverse effects, so that balanced conclusions may be generated. Other fields to be explored are the importance of compliance and methods to increase compliance; the possible usefulness of physiotherapeutic exercises as well as means to reduce the impact of bracing on participants.</P>
</IMPLICATIONS_RESEARCH>
</CONCLUSIONS>
</BODY>
<ACKNOWLEDGEMENTS MODIFIED="2015-05-30 16:43:48 -0400" MODIFIED_BY="Anne Lawson">
<P>We wish to thank all the Cochrane Back Group Editors, and particularly Vicki Pennick (first edition), Teresa Marin (second edition), and Rachel Couban, for their work and continuous help. Specifically, Rachel Couban who performed all the electronic searches.</P>
</ACKNOWLEDGEMENTS>
<CONFLICT_OF_INTEREST MODIFIED="2015-06-16 09:28:25 -0400" MODIFIED_BY="[Empty name]">
<P>Negrini S and Romano M are stakeholders of ISICO (Italian Scientific Spine Institute), Milan, Italy.</P>
</CONFLICT_OF_INTEREST>
<CONTRIBUTIONS MODIFIED="2015-06-09 10:52:40 -0400" MODIFIED_BY="[Empty name]">
<P>Substantial contributions to conception and design: Negrini S, Minozzi S.</P>
<P>Study search and selection: Bettany-Saltikov J, Chockalingam N, Grivas TB, Kotwicki T, Maruyama T, Negrini S, Romano M, Zaina F.</P>
<P>Methodological assessment: Minozzi S, Negrini S.</P>
<P>Acquisition/abstraction of data: Minozzi S, Zaina F, Bettany-Saltikov J, Chockalingam N.</P>
<P>Data analysis: Negrini S, Minozzi S, Zaina F.</P>
<P>Interpretation of data: Negrini S, Grivas TB, Kotwicki T, Maruyama T, Romano M, Vasiliadis ES.</P>
<P>Drafting the article: Negrini S, Minozzi S.</P>
<P>Revising it critically for important intellectual content: Negrini S, Grivas TB, Kotwicki T, Maruyama T, Romano M.</P>
<P>Final approval of the version to be published: Negrini S, Minozzi S, Bettany-Saltikov J, Zaina F, Chockalingam N, Grivas TB, Kotwicki T, Maruyama T, Romano M.</P>
</CONTRIBUTIONS>
<PRO_REV_DIFF MODIFIED="2015-06-09 10:49:10 -0400" MODIFIED_BY="[Empty name]">
<P>We changed the criteria to assess methodological quality of included studies from that described in the protocol to conform to the recommended methods outlined in the <I>Cochrane Handbook for Systematic Reviews of Interventions </I>(<LINK REF="REF-Higgins-2011" TYPE="REFERENCE">Higgins 2011</LINK>), and to the requirements of Review Manager 5 (<LINK REF="REF-RevMan-2012" TYPE="REFERENCE">RevMan 2012</LINK>).</P>
</PRO_REV_DIFF>
<PUBLIC_NOTES/>
</MAIN_TEXT>
<STUDIES_AND_REFERENCES MODIFIED="2015-06-10 13:20:35 -0400" MODIFIED_BY="[Empty name]">
<STUDIES MODIFIED="2015-06-09 04:43:19 -0400" MODIFIED_BY="[Empty name]">
<INCLUDED_STUDIES MODIFIED="2015-05-30 17:28:02 -0400" MODIFIED_BY="Anne Lawson">
<STUDY DATA_SOURCE="PUB" ID="STD-Bunge-2010" MODIFIED="2015-05-29 07:37:09 -0400" MODIFIED_BY="Anne Lawson" NAME="Bunge 2010" YEAR="2010 May">
<REFERENCE MODIFIED="2015-05-29 07:36:45 -0400" MODIFIED_BY="Anne Lawson" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Bunge EM, Habbema JD, de Koning HJ</AU>
<TI>A randomised controlled trial on the effectiveness of bracing patients with idiopathic scoliosis: failure to include patients and lessons to be learnt</TI>
<SO>European Spine Journal</SO>
<YR>2010</YR>
<VL>19</VL>
<NO>5</NO>
<PG>747-53</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2015-05-29 07:37:09 -0400" MODIFIED_BY="Anne Lawson" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Bunge EM, de Koning HJ</AU>
<TI>Bracing patients with idiopathic scoliosis: design of the Dutch randomized controlled treatment trial</TI>
<SO>BMC Musculoskeletal Disorders</SO>
<YR>2008</YR>
<VL>9</VL>
<PG>57</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Coillard-2012" MODIFIED="2015-05-29 07:37:35 -0400" MODIFIED_BY="Anne Lawson" NAME="Coillard 2012" YEAR="2012">
<REFERENCE MODIFIED="2015-05-29 07:37:35 -0400" MODIFIED_BY="Anne Lawson" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Coillard C, Circo A, Rivard C</AU>
<TI>A prospective randomized study of the natural history of idiopathic scoliosis versus treatment with the SpineCor brace</TI>
<SO>Scoliosis</SO>
<YR>2012</YR>
<VL>7</VL>
<NO>Suppl 1</NO>
<PG>O24</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Lou-2012" MODIFIED="2015-05-29 07:37:53 -0400" MODIFIED_BY="Anne Lawson" NAME="Lou 2012" YEAR="2012">
<REFERENCE MODIFIED="2015-05-29 07:37:53 -0400" MODIFIED_BY="Anne Lawson" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Lou E, Hill D, Raso J, Donauer A, Moreau M, Mahood J, et al</AU>
<TI>Smart brace versus standard rigid brace for the treatment of scoliosis: a pilot study</TI>
<SO>Research into Spinal Deformities</SO>
<YR>2012</YR>
<VL>8</VL>
<PG>338-41</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Lusini-2013" MODIFIED="2015-05-29 07:38:59 -0400" MODIFIED_BY="Anne Lawson" NAME="Lusini 2013" YEAR="2013">
<REFERENCE MODIFIED="2015-05-29 07:38:59 -0400" MODIFIED_BY="Anne Lawson" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Lusini M, Donzelli S, Minnella S, Zaina F, Negrini S</AU>
<TI>Brace treatment is effective in idiopathic scoliosis over 45°: an observational prospective cohort controlled study</TI>
<SO>Spine Journal</SO>
<YR>2014</YR>
<VL>14</VL>
<NO>9</NO>
<PG>1935-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2014-04-27 08:14:32 -0400" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Lusini M, Donzelli S, Zaina F Negrini S</AU>
<TI>Brace treatment is effective in idiopathic scoliosis over 45°: a prospective controlled study</TI>
<SO>Scoliosis</SO>
<YR>2013</YR>
<VL>8</VL>
<NO>suppl 1</NO>
<PG>O35</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Nachemson-1995" MODIFIED="2014-04-27 08:14:49 -0400" MODIFIED_BY="VEP  " NAME="Nachemson 1995" YEAR="1995">
<REFERENCE MODIFIED="2009-11-10 17:13:03 -0500" MODIFIED_BY="VEP  " PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Danielsson AJ, Hasserius R, Ohlin A, Nachemson AL</AU>
<TI>A prospective study of brace treatment versus observation alone in adolescent idiopathic scoliosis. A follow-up of 16 years after maturity</TI>
<SO>Spine</SO>
<YR>2007</YR>
<VL>32</VL>
<NO>20</NO>
<PG>2198-207</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2014-04-27 08:14:49 -0400" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Danielsson AJ, Hasserius R, Ohlin A, Nachemson AL</AU>
<TI>Body appearance and quality of life in adult patients with adolescent idiopathic scoliosis treated with a brace or under observation alone during adolescence</TI>
<SO>Spine</SO>
<YR>2012</YR>
<VL>37</VL>
<NO>9</NO>
<PG>755-62</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2014-04-27 08:14:42 -0400" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Danielsson AJ, Hasserius R, Ohlin A, Nachemson AL</AU>
<TI>Health-related quality of life in untreated versus brace-treated patients with adolescent idiopathic scoliosis: a long-term follow-up</TI>
<SO>Spine</SO>
<YR>2010</YR>
<VL>35</VL>
<NO>2</NO>
<PG>199-205</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2009-11-11 16:44:50 -0500" MODIFIED_BY="VEP  " PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Nachemson AL, Peterson LE</AU>
<TI>Effectiveness of treatment with a brace in girls who have adolescent idiopathic scoliosis. A prospective, controlled study based on data from the Brace Study of the Scoliosis Research Society</TI>
<SO>Journal of Bone &amp; Joint Surgery. American Version</SO>
<YR>1995</YR>
<VL>77</VL>
<NO>6</NO>
<PG>815-22</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Weinstein-2013a" MODIFIED="2015-05-30 17:28:02 -0400" MODIFIED_BY="Anne Lawson" NAME="Weinstein 2013a" YEAR="2013">
<REFERENCE MODIFIED="2015-05-29 07:40:14 -0400" MODIFIED_BY="Anne Lawson" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Weinstein SL, Dolan LA, Wright JG , Dobbs MB</AU>
<TI>Effects of bracing in adolescents with idiopathic scoliosis</TI>
<SO>New England Journal of Medicine</SO>
<YR>2013</YR>
<VL>369</VL>
<NO>16</NO>
<PG>1512-21</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2015-05-30 17:28:02 -0400" MODIFIED_BY="Anne Lawson" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Weinstein SL, Dolan LA, Wright JG, Dobbs MB</AU>
<TI>Design of the Bracing in Adolescent Idiopathic Scoliosis Trial (BrAIST)</TI>
<SO>SPINE</SO>
<YR>2013</YR>
<VL>38</VL>
<NO>21</NO>
<PG>1382-41</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Weinstein-2013b" MODIFIED="2015-05-29 07:40:40 -0400" MODIFIED_BY="Anne Lawson" NAME="Weinstein 2013b" YEAR="2013">
<REFERENCE MODIFIED="2015-05-29 07:40:40 -0400" MODIFIED_BY="Anne Lawson" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Weinstein SL, Dolan LA, Wright JG, Dobbs MB</AU>
<TI>Effects of bracing in adolescents with idiopathic scoliosis</TI>
<SO>New England Journal of Medicine</SO>
<YR>2013</YR>
<VL>369</VL>
<NO>16</NO>
<PG>1512-21</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Wong-2008" MODIFIED="2009-11-11 16:44:50 -0500" MODIFIED_BY="VEP  " NAME="Wong 2008" YEAR="2008">
<REFERENCE MODIFIED="2009-11-11 16:44:50 -0500" MODIFIED_BY="VEP  " PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Wong MS, Cheng JC, Lam TP, Ng BK, Sin SW, Lee-Shum SL, et al</AU>
<TI>The effect of rigid versus flexible spinal orthosis on the clinical efficacy and acceptance of the patients with adolescent idiopathic scoliosis</TI>
<SO>Spine</SO>
<YR>2008</YR>
<VL>33</VL>
<NO>12</NO>
<PG>1360-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS MODIFIED="2009-04-20 17:59:51 -0400" MODIFIED_BY="[Empty name]"/>
</STUDY>
</INCLUDED_STUDIES>
<EXCLUDED_STUDIES MODIFIED="2015-06-09 04:43:19 -0400" MODIFIED_BY="[Empty name]">
<STUDY DATA_SOURCE="PUB" ID="STD-Allington-1996" MODIFIED="2015-05-29 07:40:56 -0400" MODIFIED_BY="Anne Lawson" NAME="Allington 1996" YEAR="1996">
<REFERENCE MODIFIED="2015-05-29 07:40:56 -0400" MODIFIED_BY="Anne Lawson" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Allington NJ, Bowen JR</AU>
<TI>Adolescent idiopathic scoliosis: treatment with the Wilmington brace. A comparison of full-time and part-time use</TI>
<SO>Journal of Bone &amp; Joint Surgery - American Volume</SO>
<YR>1996</YR>
<VL>78</VL>
<NO>7</NO>
<PG>1056-62</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS MODIFIED="2009-03-09 06:47:41 -0400" MODIFIED_BY="[Empty name]"/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Andersen-2006" MODIFIED="2009-11-10 17:14:30 -0500" MODIFIED_BY="VEP  " NAME="Andersen 2006" YEAR="2006">
<REFERENCE MODIFIED="2009-11-10 17:14:30 -0500" MODIFIED_BY="VEP  " PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Andersen MO, Christensen SB, Thomsen K</AU>
<TI>Outcome at 10 years after treatment for adolescent idiopathic scoliosis</TI>
<SO>Spine</SO>
<YR>2006</YR>
<VL>31</VL>
<NO>3</NO>
<PG>350-4</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Avellanet-2006" MODIFIED="2009-11-10 17:14:17 -0500" MODIFIED_BY="VEP  " NAME="Avellanet 2006" YEAR="2006">
<REFERENCE MODIFIED="2009-11-10 17:14:17 -0500" MODIFIED_BY="VEP  " PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Avellanet M, Gonzalez VMA, Saenz A, Hijos M-E</AU>
<TI>Is it too late start orthopedic treatment for idiopathic scoliosis with Risser scores of 4?</TI>
<SO>Annales de Readaptation et de Medecine Physique</SO>
<YR>2006</YR>
<VL>49</VL>
<NO>9</NO>
<PG>659-62</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Bassett-1986" MODIFIED="2015-05-30 15:36:26 -0400" MODIFIED_BY="Anne Lawson" NAME="Bassett 1986" YEAR="1986">
<REFERENCE MODIFIED="2009-11-11 16:44:50 -0500" MODIFIED_BY="VEP  " PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Bassett GS, Bunnell WP, MacEwen GD</AU>
<TI>Treatment of idiopathic scoliosis with the Wilmington brace. Results in patients with a twenty to thirty-nine-degree curve</TI>
<SO>Journal of Bone and Joint Surgery</SO>
<YR>1986</YR>
<VL>68</VL>
<NO>4</NO>
<PG>602-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Bassett-1987" MODIFIED="2015-05-30 15:36:39 -0400" MODIFIED_BY="Anne Lawson" NAME="Bassett 1987" YEAR="1987">
<REFERENCE MODIFIED="2009-11-11 16:44:50 -0500" MODIFIED_BY="VEP  " PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Bassett GS, Bunnell WP</AU>
<TI>Influence of the Wilmington brace on spinal decompensation in adolescent idiopathic scoliosis</TI>
<SO>Clinical Orthopaedics and Related Research</SO>
<YR>1987</YR>
<VL>223</VL>
<PG>164-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Becchetti-1990" MODIFIED="2009-03-09 11:03:39 -0400" MODIFIED_BY="[Empty name]" NAME="Becchetti 1990" YEAR="1990">
<REFERENCE MODIFIED="2009-03-09 11:03:39 -0400" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Becchetti S, Senes FM, Pinelli G</AU>
<TI>Maguelone plaster braces for the reduction of scoliotic curves: methods and results</TI>
<SO>Italian Journal of Orthopaedics &amp; Traumatology</SO>
<YR>1990</YR>
<VL>16</VL>
<NO>1</NO>
<PG>53-60</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Bernard-2005" MODIFIED="2009-11-10 17:15:21 -0500" MODIFIED_BY="VEP  " NAME="Bernard 2005" YEAR="2005">
<REFERENCE MODIFIED="2009-11-10 17:15:21 -0500" MODIFIED_BY="VEP  " PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Bernard JC, Jemni S, Schneider M, Boussard D, Saillard V, Bard R, et al</AU>
<TI>Evaluation of the efficacy of a carbon brace ("Corset monocoque carbone respectant la respiration" [CMCR]) preserving lung capacity to treat idiopathic scoliosis in children and adolescents: a retrospective study of 115 patients</TI>
<SO>Annales de Readaptation et de Medecine Physique</SO>
<YR>2005</YR>
<VL>48</VL>
<NO>9</NO>
<PG>637-49</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Bowen-2001" MODIFIED="2009-11-10 17:15:41 -0500" MODIFIED_BY="VEP  " NAME="Bowen 2001" YEAR="2001">
<REFERENCE MODIFIED="2009-11-10 17:15:41 -0500" MODIFIED_BY="VEP  " PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Bowen JR, Keeler KA, Pelegie S</AU>
<TI>Adolescent idiopathic scoliosis managed by a nighttime bending brace</TI>
<SO>Orthopedics</SO>
<YR>2001</YR>
<VL>24</VL>
<NO>10</NO>
<PG>967-70</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Brox-2012" MODIFIED="2015-05-29 07:41:50 -0400" MODIFIED_BY="Anne Lawson" NAME="Brox 2012" YEAR="2012">
<REFERENCE MODIFIED="2015-05-29 07:41:50 -0400" MODIFIED_BY="Anne Lawson" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Brox JI, Lange JE, Gunderson RB, Steen H</AU>
<TI>Good brace compliance reduced curve progression and surgical rates in patients with idiopathic scoliosis</TI>
<SO>European Spine Journal</SO>
<YR>2012</YR>
<VL>21</VL>
<NO>10</NO>
<PG>1957-63</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Bullmann-2004" MODIFIED="2009-11-10 17:15:47 -0500" MODIFIED_BY="VEP  " NAME="Bullmann 2004" YEAR="2004">
<REFERENCE MODIFIED="2009-11-10 17:15:47 -0500" MODIFIED_BY="VEP  " PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Bullmann V, Halm HF, Lerner T, Lepsien U, Hackenberg L, Liljenqvist U</AU>
<TI>Prospective evaluation of braces as treatment in idiopathic scoliosis</TI>
<SO>Zeitschrift fur Orthopadie und Ihre Grenzgebiete</SO>
<YR>2004</YR>
<VL>142</VL>
<NO>4</NO>
<PG>403-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Bunge-2007" MODIFIED="2009-11-10 17:15:56 -0500" MODIFIED_BY="VEP  " NAME="Bunge 2007" YEAR="2007">
<REFERENCE MODIFIED="2009-11-10 17:15:56 -0500" MODIFIED_BY="VEP  " PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Bunge EM, Juttmann RE, De Kleuver M, Van Biezen FC, de Koning HJ, NESCIO group</AU>
<TI>Health-related quality of life in patients with adolescent idiopathic scoliosis after treatment: short-term effects after brace or surgical treatment</TI>
<SO>European Spine Journal</SO>
<YR>2007</YR>
<VL>16</VL>
<NO>1</NO>
<PG>83-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Bunnell-1980" MODIFIED="2009-11-10 17:16:07 -0500" MODIFIED_BY="VEP  " NAME="Bunnell 1980" YEAR="1980">
<REFERENCE MODIFIED="2009-11-10 17:16:07 -0500" MODIFIED_BY="VEP  " PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Bunnell WP, MacEwen GD, Jayakumar S</AU>
<TI>The use of plastic jackets in the non-operative treatment of idiopathic scoliosis. Preliminary report</TI>
<SO>Journal of Bone &amp; Joint Surgery</SO>
<YR>1980</YR>
<VL>62</VL>
<NO>1</NO>
<PG>31-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Carman-1985" MODIFIED="2009-11-10 17:16:33 -0500" MODIFIED_BY="VEP  " NAME="Carman 1985" YEAR="1985">
<REFERENCE MODIFIED="2009-11-10 17:16:33 -0500" MODIFIED_BY="VEP  " PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Carman D, Roach JW, Speck G, Wenger DR, Herring JA</AU>
<TI>Role of exercises in the Milwaukee brace treatment of scoliosis</TI>
<SO>Journal of Pediatric Orthopedics</SO>
<YR>1985</YR>
<VL>5</VL>
<NO>1</NO>
<PG>65-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Carr-1980" MODIFIED="2009-03-09 11:17:01 -0400" MODIFIED_BY="[Empty name]" NAME="Carr 1980" YEAR="1980">
<REFERENCE MODIFIED="2009-03-09 11:17:01 -0400" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Carr WA, Moe JH, Winter RB, Lonstein JE</AU>
<TI>Treatment of idiopathic scoliosis in the Milwaukee brace</TI>
<SO>Journal of Bone &amp; Joint Surgery</SO>
<YR>1980</YR>
<VL>62</VL>
<NO>4</NO>
<PG>599-612</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Cassella-1991" MODIFIED="2009-03-09 11:18:20 -0400" MODIFIED_BY="[Empty name]" NAME="Cassella 1991" YEAR="1991">
<REFERENCE MODIFIED="2009-03-09 11:18:20 -0400" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Cassella MC, Hall JE</AU>
<TI>Current treatment approaches in the nonoperative and operative management of adolescent idiopathic scoliosis</TI>
<SO>Physical Therapy</SO>
<YR>1991</YR>
<VL>71</VL>
<NO>12</NO>
<PG>897-909</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Castro-2003" MODIFIED="2009-11-10 17:16:16 -0500" MODIFIED_BY="VEP  " NAME="Castro 2003" YEAR="2003">
<REFERENCE MODIFIED="2009-11-10 17:16:16 -0500" MODIFIED_BY="VEP  " PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Castro FP, Jr</AU>
<TI>Adolescent idiopathic scoliosis, bracing, and the Hueter-Volkmann principle</TI>
<SO>Spine Journal</SO>
<YR>2003</YR>
<VL>3</VL>
<NO>3</NO>
<PG>180-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Charlopain-1998" MODIFIED="2015-05-29 07:42:41 -0400" MODIFIED_BY="Anne Lawson" NAME="Charlopain 1998" YEAR="1998">
<REFERENCE MODIFIED="2015-05-29 07:42:41 -0400" MODIFIED_BY="Anne Lawson" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Charlopain P, Biot B, Fauchet R</AU>
<TI>Lyonnais orthopedic treatment: long-term results (237 patients)</TI>
<SO>Annales de Readaptation et de Medecine Physique</SO>
<YR>1998</YR>
<VL>41</VL>
<NO>3</NO>
<PG>147-53</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Cheung-2007" MODIFIED="2009-11-10 17:16:41 -0500" MODIFIED_BY="VEP  " NAME="Cheung 2007" YEAR="2007">
<REFERENCE MODIFIED="2009-11-10 17:16:41 -0500" MODIFIED_BY="VEP  " PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Cheung KMC, Cheng EYL, Chan SCW, Yeung KWK, Luk KDK</AU>
<TI>Outcome assessment of bracing in adolescent idiopathic scoliosis by the use of the SRS-22 questionnaire</TI>
<SO>International Orthopaedics</SO>
<YR>2007</YR>
<VL>31</VL>
<NO>4</NO>
<PG>507-11</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Coillard-1999" MODIFIED="2009-11-10 17:16:47 -0500" MODIFIED_BY="VEP  " NAME="Coillard 1999" YEAR="1999">
<REFERENCE MODIFIED="2009-11-10 17:16:47 -0500" MODIFIED_BY="VEP  " PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Coillard C, Leroux MA, Zabjek KF, Rivard CH</AU>
<TI>The reducibility of idiopathic scoliosis during non-operative treatment</TI>
<SO>Annales de Chirurgie</SO>
<YR>1999</YR>
<VL>53</VL>
<NO>8</NO>
<PG>781-91</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Coillard-2003" MODIFIED="2015-05-29 07:54:20 -0400" MODIFIED_BY="Anne Lawson" NAME="Coillard 2003" YEAR="2003">
<REFERENCE MODIFIED="2015-05-29 07:54:20 -0400" MODIFIED_BY="Anne Lawson" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Coillard C, Leroux MA, Zabjek KF, Rivard CH</AU>
<TI>SpineCor - a non-rigid brace for the treatment of idiopathic scoliosis: post-treatment results</TI>
<SO>European Spine Journal</SO>
<YR>2003</YR>
<VL>12</VL>
<NO>2</NO>
<PG>141-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Coillard-2007" MODIFIED="2009-11-10 17:17:04 -0500" MODIFIED_BY="VEP  " NAME="Coillard 2007" YEAR="2007">
<REFERENCE MODIFIED="2009-11-10 17:17:04 -0500" MODIFIED_BY="VEP  " PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Coillard C, Vachon V, Circo AB, Beausejour M, Rivard CH</AU>
<TI>Effectiveness of the SpineCor brace based on the new standardized criteria proposed by the scoliosis research society for adolescent idiopathic scoliosis</TI>
<SO>Journal of Pediatric Orthopaedics</SO>
<YR>2007</YR>
<VL>27</VL>
<NO>4</NO>
<PG>375-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Cottalorda-2005" MODIFIED="2015-05-29 07:54:46 -0400" MODIFIED_BY="Anne Lawson" NAME="Cottalorda 2005" YEAR="2005">
<REFERENCE MODIFIED="2015-05-29 07:54:46 -0400" MODIFIED_BY="Anne Lawson" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Cottalorda J, Kohler R, Garin C, Genevois P, Lecante C, Berge B</AU>
<TI>Orthoses for mild scoliosis: a prospective study comparing traditional plaster mold manufacturing with fast, non-contact, 3-dimensional acquisition</TI>
<SO>Spine</SO>
<YR>2005</YR>
<VL>30</VL>
<NO>4</NO>
<PG>399-405</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-D_x0027_Amato-2001" MODIFIED="2015-05-29 07:55:00 -0400" MODIFIED_BY="Anne Lawson" NAME="D'Amato 2001" YEAR="2001">
<REFERENCE MODIFIED="2015-05-29 07:55:00 -0400" MODIFIED_BY="Anne Lawson" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>D'Amato CR, Griggs S, McCoy B</AU>
<TI>Nighttime bracing with the Providence brace in adolescent girls with idiopathic scoliosis</TI>
<SO>Spine</SO>
<YR>2001</YR>
<VL>26</VL>
<NO>18</NO>
<PG>2006-12</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Danielsson-2001a" MODIFIED="2009-11-10 17:18:00 -0500" MODIFIED_BY="VEP  " NAME="Danielsson 2001a" YEAR="2001">
<REFERENCE MODIFIED="2009-11-10 17:18:00 -0500" MODIFIED_BY="VEP  " PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Danielsson AJ, Nachemson AL</AU>
<TI>Radiologic findings and curve progression 22 years after treatment for adolescent idiopathic scoliosis: comparison of brace and surgical treatment with matching control group of straight individuals</TI>
<SO>Spine</SO>
<YR>2001</YR>
<VL>26</VL>
<NO>5</NO>
<PG>516-25</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Danielsson-2001b" MODIFIED="2015-05-30 15:39:59 -0400" MODIFIED_BY="Anne Lawson" NAME="Danielsson 2001b" YEAR="2001">
<REFERENCE MODIFIED="2009-11-10 17:17:48 -0500" MODIFIED_BY="VEP  " PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Danielsson AJ, Wiklund I, Pehrsson K, Nachemson AL</AU>
<TI>Health-related quality of life in patients with adolescent idiopathic scoliosis: a matched follow-up at least 20 years after treatment with brace or surgery</TI>
<SO>European Spine Journal</SO>
<YR>2001</YR>
<VL>10</VL>
<NO>4</NO>
<PG>278-88</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Danielsson-2006" MODIFIED="2009-11-10 17:18:07 -0500" MODIFIED_BY="VEP  " NAME="Danielsson 2006" YEAR="2006">
<REFERENCE MODIFIED="2009-11-10 17:18:07 -0500" MODIFIED_BY="VEP  " PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Danielsson AJ, Romberg K, Nachemson AL</AU>
<TI>Spinal range of motion, muscle endurance, and back pain and function at least 20 years after fusion or brace treatment for adolescent idiopathic scoliosis: a case-control study</TI>
<SO>Spine</SO>
<YR>2006</YR>
<VL>31</VL>
<NO>3</NO>
<PG>275-83</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Den-Boer-1999" MODIFIED="2009-11-10 17:18:13 -0500" MODIFIED_BY="VEP  " NAME="Den Boer 1999" YEAR="1999">
<REFERENCE MODIFIED="2009-11-10 17:18:13 -0500" MODIFIED_BY="VEP  " PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Den Boer WA, Anderson PG, Limbeek J, Kooijman MA</AU>
<TI>Treatment of idiopathic scoliosis with side-shift therapy: an initial comparison with a brace treatment historical cohort</TI>
<SO>European Spine Journal</SO>
<YR>1999</YR>
<VL>8</VL>
<NO>5</NO>
<PG>406-10</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Dickson-1999a" MODIFIED="2015-05-30 16:08:57 -0400" MODIFIED_BY="Anne Lawson" NAME="Dickson 1999a" YEAR="1999">
<REFERENCE MODIFIED="2015-05-29 07:56:45 -0400" MODIFIED_BY="Anne Lawson" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Dickson RA</AU>
<TI>Spinal deformity - adolescent idiopathic scoliosis: nonoperative treatment</TI>
<SO>Spine</SO>
<YR>1999</YR>
<VL>24</VL>
<NO>24</NO>
<PG>2601-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Dobosiewicz-2006" MODIFIED="2009-03-09 11:46:58 -0400" MODIFIED_BY="[Empty name]" NAME="Dobosiewicz 2006" YEAR="2006">
<REFERENCE MODIFIED="2009-03-09 11:46:58 -0400" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Dobosiewicz K, Durmala J, Czernicki K, Piotrowski J</AU>
<TI>Radiological results of Dobosiewicz method of three-dimensional treatment of progressive idiopathic scoliosis</TI>
<SO>Studies in Health Technology &amp; Informatics</SO>
<YR>2006</YR>
<VL>123</VL>
<PG>267-72</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Durham-1990" MODIFIED="2009-11-10 17:18:47 -0500" MODIFIED_BY="VEP  " NAME="Durham 1990" YEAR="1990">
<REFERENCE MODIFIED="2009-11-10 17:18:47 -0500" MODIFIED_BY="VEP  " PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Durham JW, Moskowitz A, Whitney J</AU>
<TI>Surface electrical stimulation versus brace in treatment of idiopathic scoliosis</TI>
<SO>Spine</SO>
<YR>1990</YR>
<VL>15</VL>
<NO>9</NO>
<PG>888-92</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Dziri-1991" MODIFIED="2009-11-10 17:18:52 -0500" MODIFIED_BY="VEP  " NAME="Dziri 1991" YEAR="1991">
<REFERENCE MODIFIED="2009-11-10 17:18:52 -0500" MODIFIED_BY="VEP  " PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Dziri C, Delarque A, Conil JL, Kraenzler R, Costes O, Bardot P</AU>
<TI>Results of short-term treatment with CTM braces in a series of 25 patients with idiopathic scoliosis</TI>
<SO>Annales de Readaptation et de Medecine Physique</SO>
<YR>1991</YR>
<VL>34</VL>
<NO>1</NO>
<PG>41-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Ebenbichler-1994" MODIFIED="2009-03-09 11:56:39 -0400" MODIFIED_BY="[Empty name]" NAME="Ebenbichler 1994" YEAR="1994">
<REFERENCE MODIFIED="2009-03-09 11:56:39 -0400" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Ebenbichler G, Liederer A, Lack W</AU>
<TI>Idiopathic scoliosis and non-operative scoliosis therapy</TI>
<SO>Wiener Medizinische Wochenschrift</SO>
<YR>1994</YR>
<VL>144</VL>
<NO>24</NO>
<PG>593-604</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Edmonsson-1977" MODIFIED="2015-05-29 07:59:17 -0400" MODIFIED_BY="Anne Lawson" NAME="Edmonsson 1977" YEAR="1977">
<REFERENCE MODIFIED="2009-03-09 11:57:36 -0400" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Edmonsson AS, Morris JT</AU>
<TI>Follow-up study of Milwaukee brace treatment in patients with idiopathic scoliosis</TI>
<SO>Clinical Orthopaedics &amp; Related Research</SO>
<YR>1977</YR>
<VL>126</VL>
<PG>58-61</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-El-Sayyad-1994" MODIFIED="2009-11-10 17:19:04 -0500" MODIFIED_BY="VEP  " NAME="El Sayyad 1994" YEAR="1994">
<REFERENCE MODIFIED="2009-11-10 17:19:04 -0500" MODIFIED_BY="VEP  " PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>El Sayyad M, Conine TA</AU>
<TI>Effect of exercise, bracing and electrical surface stimulation on idiopathic scoliosis: a preliminary study</TI>
<SO>International Journal of Rehabilitation Research</SO>
<YR>1994</YR>
<VL>17</VL>
<NO>1</NO>
<PG>70-4</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Emans-1986" MODIFIED="2009-03-09 12:03:43 -0400" MODIFIED_BY="[Empty name]" NAME="Emans 1986" YEAR="1986">
<REFERENCE MODIFIED="2009-03-09 12:03:43 -0400" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Emans JB, Kaelin A, Bancel P, Hall JE, Miller ME</AU>
<TI>The Boston bracing system for idiopathic scoliosis. Follow-up results in 295 patients</TI>
<SO>Spine</SO>
<YR>1986</YR>
<VL>11</VL>
<NO>8</NO>
<PG>792-801</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-F_x00e4_llstr_x00f6_m-1986" MODIFIED="2009-11-10 17:19:43 -0500" MODIFIED_BY="VEP  " NAME="Fällström 1986" YEAR="1986">
<REFERENCE MODIFIED="2009-11-10 17:19:43 -0500" MODIFIED_BY="VEP  " PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Fällström K, Cochran T, Nachemson A</AU>
<TI>Long-term effects on personality development in patients with adolescent idiopathic scoliosis. Influence of type of treatment</TI>
<SO>Spine</SO>
<YR>1986</YR>
<VL>11</VL>
<NO>7</NO>
<PG>756-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Feise-2005" MODIFIED="2009-11-10 17:19:14 -0500" MODIFIED_BY="VEP  " NAME="Feise 2005" YEAR="2005">
<REFERENCE MODIFIED="2009-11-10 17:19:14 -0500" MODIFIED_BY="VEP  " PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Feise RJ, Donaldson S, Crowther ER, Menke JM, Wright JG</AU>
<TI>Construction and validation of the scoliosis quality of life index in adolescent idiopathic scoliosis</TI>
<SO>Spine</SO>
<YR>2005</YR>
<VL>30</VL>
<NO>11</NO>
<PG>1310-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Fernandez_x002d_Feliberti-1995" MODIFIED="2009-11-10 17:19:20 -0500" MODIFIED_BY="VEP  " NAME="Fernandez-Feliberti 1995" YEAR="1995">
<REFERENCE MODIFIED="2009-11-10 17:19:20 -0500" MODIFIED_BY="VEP  " PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Fernandez-Feliberti R, Flynn J, Ramirez N, Trautmann M, Alegria M</AU>
<TI>Effectiveness of TLSO bracing in the conservative treatment of idiopathic scoliosis</TI>
<SO>Journal of Pediatric Orthopedics</SO>
<YR>1995</YR>
<VL>15</VL>
<NO>2</NO>
<PG>176-81</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Fisher-1987" MODIFIED="2009-11-10 17:19:27 -0500" MODIFIED_BY="VEP  " NAME="Fisher 1987" YEAR="1987">
<REFERENCE MODIFIED="2009-11-10 17:19:27 -0500" MODIFIED_BY="VEP  " PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Fisher DA, Rapp GF, Emkes M</AU>
<TI>Idiopathic scoliosis: transcutaneous muscle stimulation versus the Milwaukee brace</TI>
<SO>Spine</SO>
<YR>1987</YR>
<VL>12</VL>
<NO>10</NO>
<PG>987-91</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Gabos-2004" MODIFIED="2009-11-11 16:44:50 -0500" MODIFIED_BY="VEP  " NAME="Gabos 2004" YEAR="2004">
<REFERENCE MODIFIED="2009-11-11 16:44:50 -0500" MODIFIED_BY="VEP  " PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Gabos PG, Bojescul JA, Bowen JR, Keeler K, Rich L</AU>
<TI>Long-term follow-up of female patients with idiopathic scoliosis treated with the Wilmington orthosis</TI>
<SO>Journal of Bone &amp; Joint Surgery</SO>
<YR>2004</YR>
<VL>86</VL>
<NO>9</NO>
<PG>1891-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Gammon-2010" MODIFIED="2015-05-29 08:01:46 -0400" MODIFIED_BY="Anne Lawson" NAME="Gammon 2010" YEAR="2010">
<REFERENCE MODIFIED="2015-05-29 08:01:46 -0400" MODIFIED_BY="Anne Lawson" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Gammon SR, Mehlman CT, Chan W, Heifetz J, Durrett G, Wall EJ</AU>
<TI>A comparison of thoracolumbosacral orthoses and SpineCor treatment of adolescent idiopathic scoliosis patients using the Scoliosis Research Society standardized criteria</TI>
<SO>Journal of Pediatric Orthopedics</SO>
<YR>2010</YR>
<VL>30</VL>
<NO>6</NO>
<PG>531-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Geissele-1991" MODIFIED="2009-11-10 17:20:02 -0500" MODIFIED_BY="VEP  " NAME="Geissele 1991" YEAR="1991">
<REFERENCE MODIFIED="2009-11-10 17:20:02 -0500" MODIFIED_BY="VEP  " PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Geissele AE, Kransdorf MJ, Geyer CA, Jelinek JS, Van Dam BE</AU>
<TI>Magnetic resonance imaging of the brain stem in adolescent idiopathic scoliosis</TI>
<SO>Spine</SO>
<YR>1991</YR>
<VL>16</VL>
<NO>7</NO>
<PG>761-3</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Gepstein-2002" MODIFIED="2009-11-10 17:20:18 -0500" MODIFIED_BY="VEP  " NAME="Gepstein 2002" YEAR="2002">
<REFERENCE MODIFIED="2009-11-10 17:20:18 -0500" MODIFIED_BY="VEP  " PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Gepstein R, Leitner Y, Zohar E, Angel I, Shabat S, Pekarsky I, et al</AU>
<TI>Effectiveness of the Charleston bending brace in the treatment of single-curve idiopathic scoliosis</TI>
<SO>Journal of Pediatric Orthopedics</SO>
<YR>2002</YR>
<VL>22</VL>
<NO>1</NO>
<PG>84-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Goldberg-1981" MODIFIED="2009-11-10 17:20:27 -0500" MODIFIED_BY="VEP  " NAME="Goldberg 1981" YEAR="1981">
<REFERENCE MODIFIED="2009-11-10 17:20:27 -0500" MODIFIED_BY="VEP  " PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Goldberg C, Dowling F, Blake NS, Regan BF</AU>
<TI>A retrospective study of Cotrel dynamic spinal traction in the conservative management of scoliosis</TI>
<SO>Irish Medical Journal</SO>
<YR>1981</YR>
<VL>74</VL>
<NO>12</NO>
<PG>363-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Gore-1981" MODIFIED="2015-05-29 08:02:20 -0400" MODIFIED_BY="Anne Lawson" NAME="Gore 1981" YEAR="1981">
<REFERENCE MODIFIED="2015-05-29 08:02:20 -0400" MODIFIED_BY="Anne Lawson" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Gore DR, Passehl R, Sepic S, Dalton A</AU>
<TI>Scoliosis screening: results of a community project</TI>
<SO>Pediatrics</SO>
<YR>1981</YR>
<VL>67</VL>
<NO>2</NO>
<PG>196-200</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Green-1986" MODIFIED="2009-11-10 17:20:37 -0500" MODIFIED_BY="VEP  " NAME="Green 1986" YEAR="1986">
<REFERENCE MODIFIED="2009-11-10 17:20:37 -0500" MODIFIED_BY="VEP  " PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Green NE</AU>
<TI>Part-time bracing of adolescent idiopathic scoliosis</TI>
<SO>Journal of Bone &amp; Joint Surgery</SO>
<YR>1986</YR>
<VL>68</VL>
<NO>5</NO>
<PG>738-42</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Griffet-1996" MODIFIED="2009-11-10 17:20:45 -0500" MODIFIED_BY="VEP  " NAME="Griffet 1996" YEAR="1996">
<REFERENCE MODIFIED="2009-11-10 17:20:45 -0500" MODIFIED_BY="VEP  " PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Griffet J, Thevenot J, Barral F</AU>
<TI>GTB orthoses in the treatment by lumbar hyperlordosis of idiopathic scoliosis</TI>
<SO>Annales de Readaptation et de Medecine Physique</SO>
<YR>1996</YR>
<VL>39</VL>
<NO>2</NO>
<PG>117-22</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Griffet-2000" MODIFIED="2009-11-10 17:20:50 -0500" MODIFIED_BY="VEP  " NAME="Griffet 2000" YEAR="2000">
<REFERENCE MODIFIED="2009-11-10 17:20:50 -0500" MODIFIED_BY="VEP  " PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Griffet J, Leroux MA, Badeaux J, Coillard C, Zabjek KF, Rivard CH</AU>
<TI>Relationship between gibbosity and Cobb angle during treatment of idiopathic scoliosis with the SpineCor brace</TI>
<SO>European Spine Journal</SO>
<YR>2000</YR>
<VL>9</VL>
<NO>6</NO>
<PG>516-22</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Grivas-2003" MODIFIED="2009-11-10 17:20:58 -0500" MODIFIED_BY="VEP  " NAME="Grivas 2003" YEAR="1996">
<REFERENCE MODIFIED="2009-11-10 17:20:58 -0500" MODIFIED_BY="VEP  " PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Grivas TB, Vasiliadis E, Chatziargiropoulos T, Polyzois VD, Gatos K</AU>
<TI>The effect of a modified Boston brace with anti-rotatory blades on the progression of curves in idiopathic scoliosis: aetiologic implications</TI>
<SO>Pediatric Rehabilitation</SO>
<YR>2003</YR>
<VL>6</VL>
<NO>3-4</NO>
<PG>237-42</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Haefeli-2006" MODIFIED="2009-11-10 17:21:03 -0500" MODIFIED_BY="VEP  " NAME="Haefeli 2006" YEAR="2006">
<REFERENCE MODIFIED="2009-11-10 17:21:03 -0500" MODIFIED_BY="VEP  " PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Haefeli M, Elfering A, Kilian R, Min K, Boos N</AU>
<TI>Nonoperative treatment for adolescent idiopathic scoliosis: a 10- to 60-year follow-up with special reference to health-related quality of life</TI>
<SO>Spine</SO>
<YR>2006</YR>
<VL>31</VL>
<NO>3</NO>
<PG>355-66</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Hanks-1998" MODIFIED="2009-11-10 17:21:08 -0500" MODIFIED_BY="VEP  " NAME="Hanks 1998" YEAR="1998">
<REFERENCE MODIFIED="2009-11-10 17:21:08 -0500" MODIFIED_BY="VEP  " PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Hanks GA, Zimmer B, Nogi J</AU>
<TI>TLSO treatment of idiopathic scoliosis. An analysis of the Wilmington jacket</TI>
<SO>Spine</SO>
<YR>1988</YR>
<VL>13</VL>
<NO>6</NO>
<PG>626-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Hassan-1983" MODIFIED="2009-03-15 17:55:50 -0400" MODIFIED_BY="[Empty name]" NAME="Hassan 1983" YEAR="1983">
<REFERENCE MODIFIED="2009-03-15 17:55:50 -0400" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Hassan I, Bjerkreim I</AU>
<TI>Progression in idiopathic scoliosis after conservative treatment</TI>
<SO>Acta Orthopaedica Scandinavica</SO>
<YR>1983</YR>
<VL>54</VL>
<NO>1</NO>
<PG>88-90</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Hensinger-2007" MODIFIED="2009-11-10 17:21:17 -0500" MODIFIED_BY="VEP  " NAME="Hensinger 2007" YEAR="2007">
<REFERENCE MODIFIED="2009-11-10 17:21:17 -0500" MODIFIED_BY="VEP  " PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Hensinger RN, Thompson GH</AU>
<TI>Orthotic management in adolescent idiopathic scoliosis: leveling the playing field</TI>
<SO>Journal of Pediatric Orthopedics</SO>
<YR>2007</YR>
<VL>27</VL>
<NO>4</NO>
<PG>367-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Hopf-1985" MODIFIED="2009-11-10 17:21:22 -0500" MODIFIED_BY="VEP  " NAME="Hopf 1985" YEAR="1985">
<REFERENCE MODIFIED="2009-11-10 17:21:22 -0500" MODIFIED_BY="VEP  " PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Hopf C, Heine J</AU>
<TI>Long-term results of conservative treatment of scoliosis with the Cheneau brace</TI>
<SO>Zeitschrift fur Orthopadie und Ihre Grenzgebiete</SO>
<YR>1985</YR>
<VL>123</VL>
<NO>3</NO>
<PG>312-22</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Howard-1998" MODIFIED="2009-11-10 17:21:28 -0500" MODIFIED_BY="VEP  " NAME="Howard 1998" YEAR="1998">
<REFERENCE MODIFIED="2009-11-10 17:21:28 -0500" MODIFIED_BY="VEP  " PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Howard A, Wright JG, Hedden D</AU>
<TI>A comparative study of TLSO, Charleston, and Milwaukee braces for idiopathic scoliosis</TI>
<SO>Spine</SO>
<YR>1998</YR>
<VL>23</VL>
<NO>22</NO>
<PG>2404-11</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Janicki-2007" MODIFIED="2009-11-10 17:21:33 -0500" MODIFIED_BY="VEP  " NAME="Janicki 2007" YEAR="2007">
<REFERENCE MODIFIED="2009-11-10 17:21:33 -0500" MODIFIED_BY="VEP  " PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Janicki JA, Poe-Kochert C, Armstrong DG, Thompson GH</AU>
<TI>A comparison of the thoracolumbosacral orthoses and providence orthosis in the treatment of adolescent idiopathic scoliosis: results using the new SRS inclusion and assessment criteria for bracing studies</TI>
<SO>Journal of Pediatric Orthopedics</SO>
<YR>2007</YR>
<VL>27</VL>
<NO>4</NO>
<PG>369-74</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Kahanovitz-1982" MODIFIED="2009-11-10 17:21:42 -0500" MODIFIED_BY="VEP  " NAME="Kahanovitz 1982" YEAR="1982">
<REFERENCE MODIFIED="2009-11-10 17:21:42 -0500" MODIFIED_BY="VEP  " PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Kahanovitz N, Levine DB, Lardone J</AU>
<TI>The part-time Milwaukee brace treatment of juvenile idiopathic scoliosis. Long-term follow-up</TI>
<SO>Clinical Orthopaedics &amp; Related Research</SO>
<YR>1982</YR>
<VL>167</VL>
<PG>145-51</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Karol-2001" MODIFIED="2009-11-10 17:21:51 -0500" MODIFIED_BY="VEP  " NAME="Karol 2001" YEAR="2001">
<REFERENCE MODIFIED="2009-11-10 17:21:51 -0500" MODIFIED_BY="VEP  " PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Karol LA</AU>
<TI>Effectiveness of bracing in male patients with idiopathic scoliosis</TI>
<SO>Spine</SO>
<YR>2001</YR>
<VL>26</VL>
<NO>18</NO>
<PG>2001-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Katz-1997" MODIFIED="2009-11-10 17:21:58 -0500" MODIFIED_BY="VEP  " NAME="Katz 1997" YEAR="1997">
<REFERENCE MODIFIED="2009-11-10 17:21:58 -0500" MODIFIED_BY="VEP  " PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Katz DE, Richards BS, Browne RH, Herring JA</AU>
<TI>A comparison between the Boston brace and the Charleston bending brace in adolescent idiopathic scoliosis</TI>
<SO>Spine</SO>
<YR>1997</YR>
<VL>22</VL>
<NO>12</NO>
<PG>1302-12</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Keiser-1976" MODIFIED="2009-03-15 18:07:13 -0400" MODIFIED_BY="[Empty name]" NAME="Keiser 1976" YEAR="1976">
<REFERENCE MODIFIED="2009-03-15 18:07:06 -0400" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Keiser RP, Shufflebarger HL</AU>
<TI>The Milwaukee brace in idiopathic scoliosis: evaluation of 123 completed cases</TI>
<SO>Clinical Orthopaedics &amp; Related Research</SO>
<YR>1976</YR>
<VL>118</VL>
<PG>19-24</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Kohashi-1996" MODIFIED="2009-11-10 17:22:31 -0500" MODIFIED_BY="VEP  " NAME="Kohashi 1996" YEAR="1996">
<REFERENCE MODIFIED="2009-11-10 17:22:31 -0500" MODIFIED_BY="VEP  " PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Kohashi Y, Oga M, Sugioka Y</AU>
<TI>A new method using top views of the spine to predict the progression of curves in idiopathic scoliosis during growth</TI>
<SO>Spine</SO>
<YR>1996</YR>
<VL>21</VL>
<NO>2</NO>
<PG>212-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Korovessis-2000" MODIFIED="2009-11-10 17:22:48 -0500" MODIFIED_BY="VEP  " NAME="Korovessis 2000" YEAR="2000">
<REFERENCE MODIFIED="2009-11-10 17:22:48 -0500" MODIFIED_BY="VEP  " PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Korovessis P, Kyrkos C, Piperos G, Soucacos PN</AU>
<TI>Effects of thoracolumbosacral orthosis on spinal deformities, trunk asymmetry, and frontal lower rib cage in adolescent idiopathic scoliosis</TI>
<SO>Spine</SO>
<YR>2000</YR>
<VL>25</VL>
<NO>16</NO>
<PG>2064-71</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Kotwicki-2002" MODIFIED="2009-04-01 05:04:10 -0400" MODIFIED_BY="[Empty name]" NAME="Kotwicki 2002" YEAR="2002">
<REFERENCE MODIFIED="2009-04-01 05:04:10 -0400" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Kotwicki T, Pietrzak S, Szulc A</AU>
<TI>Three-dimensional action of Chêneau brace on thoracolumbar scoliosis</TI>
<SO>Studies in Health Technology &amp; Informatics</SO>
<YR>2002</YR>
<VL>88</VL>
<PG>226-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Kumano-1992" MODIFIED="2009-11-10 17:23:00 -0500" MODIFIED_BY="VEP  " NAME="Kumano 1992" YEAR="1992">
<REFERENCE MODIFIED="2009-11-10 17:23:00 -0500" MODIFIED_BY="VEP  " PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Kumano K, Maruyama T, Kojima T, Kondoh Y, Shimode M</AU>
<TI>Results of wearing Milwaukee brace at night for adolescent idiopathic scoliosis</TI>
<SO>Journal of the Western Pacific Orthopaedic Association</SO>
<YR>1992</YR>
<VL>29</VL>
<NO>2</NO>
<PG>53-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Little-2000" MODIFIED="2009-11-10 17:23:07 -0500" MODIFIED_BY="VEP  " NAME="Little 2000" YEAR="2000">
<REFERENCE MODIFIED="2009-11-10 17:23:07 -0500" MODIFIED_BY="VEP  " PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Little DG, Song KM, Katz D, Herring JA</AU>
<TI>Relationship of peak height velocity to other maturity indicators in idiopathic scoliosis in girls</TI>
<SO>Journal of Bone &amp; Joint Surgery</SO>
<YR>2000</YR>
<VL>82</VL>
<NO>5</NO>
<PG>685-93</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Lonstein-1994" MODIFIED="2009-11-10 17:23:14 -0500" MODIFIED_BY="VEP  " NAME="Lonstein 1994" YEAR="1994">
<REFERENCE MODIFIED="2009-11-10 17:23:14 -0500" MODIFIED_BY="VEP  " PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Lonstein JE, Winter RB</AU>
<TI>The Milwaukee brace for the treatment of adolescent idiopathic scoliosis. A review of one thousand and twenty patients</TI>
<SO>Journal of Bone &amp; Joint Surgery</SO>
<YR>1994</YR>
<VL>76</VL>
<NO>8</NO>
<PG>1207-21</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Lou-2004" MODIFIED="2009-03-15 18:16:30 -0400" MODIFIED_BY="[Empty name]" NAME="Lou 2004" YEAR="2004">
<REFERENCE MODIFIED="2009-03-15 18:16:30 -0400" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Lou E, Raso JV, Hill DL, Mahood JK, Moreau MJ</AU>
<TI>Correlation between quantity and quality of orthosis wear and treatment outcomes in adolescent idiopathic scoliosis</TI>
<SO>Prosthetics and Orthotics International</SO>
<YR>2004</YR>
<VL>28</VL>
<NO>1</NO>
<PG>49-54</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Lou-2005" MODIFIED="2009-11-10 17:23:24 -0500" MODIFIED_BY="VEP  " NAME="Lou 2005" YEAR="2005">
<REFERENCE MODIFIED="2009-11-10 17:23:24 -0500" MODIFIED_BY="VEP  " PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Lou E, Hill DL, Raso JV, Moreau MJ, Mahood JK</AU>
<TI>Smart orthosis for the treatment of adolescent idiopathic scoliosis</TI>
<SO>Medical &amp; Biological Engineering &amp; Computing</SO>
<YR>2005</YR>
<VL>43</VL>
<NO>6</NO>
<PG>746-50</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Mellencamp-1977" MODIFIED="2009-03-15 18:18:55 -0400" MODIFIED_BY="[Empty name]" NAME="Mellencamp 1977" YEAR="1977">
<REFERENCE MODIFIED="2009-03-15 18:18:55 -0400" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Mellencamp DD, Blount WP, Anderson AJ</AU>
<TI>Milwaukee brace treatment of idiopathic scoliosis: late results</TI>
<SO>Clinical Orthopaedics &amp; Related Research</SO>
<YR>1977</YR>
<VL>126</VL>
<PG>47-57</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Miller-1984" MODIFIED="2009-11-10 17:23:34 -0500" MODIFIED_BY="VEP  " NAME="Miller 1984" YEAR="1984">
<REFERENCE MODIFIED="2009-11-10 17:23:34 -0500" MODIFIED_BY="VEP  " PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Miller JA, Nachemson AL, Schultz AB</AU>
<TI>Effectiveness of braces in mild idiopathic scoliosis</TI>
<SO>Spine</SO>
<YR>1984</YR>
<VL>9</VL>
<NO>6</NO>
<PG>632-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Minami-1982" MODIFIED="2015-05-29 08:06:04 -0400" MODIFIED_BY="Anne Lawson" NAME="Minami 1982" YEAR="1982">
<REFERENCE MODIFIED="2015-05-29 08:06:04 -0400" MODIFIED_BY="Anne Lawson" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Minami S</AU>
<TI>Results of brace treatment in idiopathic scoliosis - evaluation of the patients treated for over 2 years or those who completed the treatment</TI>
<SO>Journal of the Japanese Orthopaedic Association</SO>
<YR>1982</YR>
<VL>56</VL>
<NO>6</NO>
<PG>471-85</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Miyasaki-1980" MODIFIED="2009-11-10 17:23:45 -0500" MODIFIED_BY="VEP  " NAME="Miyasaki 1980" YEAR="1980">
<REFERENCE MODIFIED="2009-11-10 17:23:45 -0500" MODIFIED_BY="VEP  " PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Miyasaki RA</AU>
<TI>Immediate influence of the thoracic flexion exercise on vertebral position in Milwaukee brace wearers</TI>
<SO>Physical Therapy</SO>
<YR>1980</YR>
<VL>68</VL>
<NO>8</NO>
<PG>1005-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Moe-1970" MODIFIED="2009-11-10 17:23:51 -0500" MODIFIED_BY="VEP  " NAME="Moe 1970" YEAR="1970">
<REFERENCE MODIFIED="2009-11-10 17:23:51 -0500" MODIFIED_BY="VEP  " PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Moe JH, Kettleson DN</AU>
<TI>Idiopathic scoliosis. Analysis of curve patterns and the preliminary results of Milwaukee-brace treatment in one hundred sixty-nine patients</TI>
<SO>Journal of Bone &amp; Joint Surgery</SO>
<YR>1970</YR>
<VL>52</VL>
<NO>8</NO>
<PG>1509-33</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Mollon-1984" MODIFIED="2015-05-29 08:06:25 -0400" MODIFIED_BY="Anne Lawson" NAME="Mollon 1984" YEAR="1984">
<REFERENCE MODIFIED="2015-05-29 08:06:25 -0400" MODIFIED_BY="Anne Lawson" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Mollon G, Ollier M</AU>
<TI>Orthopedic treatment from Lyon: ortheses and kinesitherapy</TI>
<SO>Cahiers de Kinesitherapie</SO>
<YR>1984</YR>
<VL>106</VL>
<PG>45-58</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Montgomery-1989" MODIFIED="2009-11-10 17:24:02 -0500" MODIFIED_BY="VEP  " NAME="Montgomery 1989" YEAR="1989">
<REFERENCE MODIFIED="2009-11-10 17:24:02 -0500" MODIFIED_BY="VEP  " PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Montgomery F, Willner S</AU>
<TI>Prognosis of brace-treated scoliosis. Comparison of the Boston and Milwaukee methods in 244 girls</TI>
<SO>Acta Orthopaedica Scandinavica</SO>
<YR>1989</YR>
<VL>60</VL>
<NO>4</NO>
<PG>383-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Montgomery-1990" MODIFIED="2009-03-15 18:30:16 -0400" MODIFIED_BY="[Empty name]" NAME="Montgomery 1990" YEAR="1990">
<REFERENCE MODIFIED="2009-03-15 18:30:16 -0400" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Montgomery F, Willner S, Appelgren G</AU>
<TI>Long-term follow-up of patients with adolescent idiopathic scoliosis treated conservatively: an analysis of the clinical value of progression</TI>
<SO>Journal of Pediatric Orthopedics</SO>
<YR>1990</YR>
<VL>10</VL>
<NO>1</NO>
<PG>48-52</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Mouilleseaux-1984" MODIFIED="2009-11-10 17:24:57 -0500" MODIFIED_BY="VEP  " NAME="Mouilleseaux 1984" YEAR="1984">
<REFERENCE MODIFIED="2009-11-10 17:24:57 -0500" MODIFIED_BY="VEP  " PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Mouilleseaux B, Pallandre B, Picault C</AU>
<TI>A gauze corset from Saint-Etienne for the early treatment of lumbar scoliosis</TI>
<SO>Cahiers de Kinesitherapie</SO>
<YR>1984</YR>
<VL>106</VL>
<PG>31-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Mounier-1984" MODIFIED="2009-03-15 18:32:11 -0400" MODIFIED_BY="[Empty name]" NAME="Mounier 1984" YEAR="1984">
<REFERENCE MODIFIED="2009-03-15 18:32:11 -0400" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Mounier C</AU>
<TI>The Milwaukee brace</TI>
<SO>Cahiers de Kinesitherapie</SO>
<YR>1984</YR>
<VL>105</VL>
<PG>65-74</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Negrini-2007" MODIFIED="2009-11-10 15:15:37 -0500" MODIFIED_BY="VEP  " NAME="Negrini 2007" YEAR="2007">
<REFERENCE MODIFIED="2009-11-10 15:15:37 -0500" MODIFIED_BY="VEP  " PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Negrini S, Marchini G</AU>
<TI>Efficacy of the symmetric, patient-oriented, rigid, three-dimensional, active (SPoRT) concept of bracing for scoliosis: a prospective study of the Sforzesco versus Lyon brace</TI>
<SO>Europa Medicophysica</SO>
<YR>2007</YR>
<VL>43</VL>
<NO>2</NO>
<PG>171-81</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Noonan-1996" MODIFIED="2009-11-10 17:25:04 -0500" MODIFIED_BY="VEP  " NAME="Noonan 1996" YEAR="1996">
<REFERENCE MODIFIED="2009-11-10 17:25:04 -0500" MODIFIED_BY="VEP  " PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Noonan KJ, Weinstein SL, Jacobson WC, Dolan LA</AU>
<TI>Use of the Milwaukee brace for progressive idiopathic scoliosis</TI>
<SO>Journal of Bone &amp; Joint Surgery</SO>
<YR>1996</YR>
<VL>78</VL>
<NO>4</NO>
<PG>557-67</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-O_x0027_Donnell-1988" MODIFIED="2015-05-30 15:44:34 -0400" MODIFIED_BY="Anne Lawson" NAME="O'Donnell 1988" YEAR="1988">
<REFERENCE MODIFIED="2009-11-10 17:25:12 -0500" MODIFIED_BY="VEP  " PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>O'Donnell CS, Bunnell WP, Betz RR, Bowen JR, Tipping CR</AU>
<TI>Electrical stimulation in the treatment of idiopathic scoliosis</TI>
<SO>Clinical Orthopaedics &amp; Related Research</SO>
<YR>1988</YR>
<VL>229</VL>
<PG>107-13</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-O_x0027_Neill-2005" MODIFIED="2015-05-29 08:07:22 -0400" MODIFIED_BY="Anne Lawson" NAME="O'Neill 2005" YEAR="2005">
<REFERENCE MODIFIED="2015-05-29 08:07:22 -0400" MODIFIED_BY="Anne Lawson" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>O'Neill PJ, Karol LA, Shindle MK, Elerson EE, BrintzenhofeSzoc KM, Katz DE, et al</AU>
<TI>Decreased orthotic effectiveness in overweight patients with adolescent idiopathic scoliosis</TI>
<SO>Journal of Bone and Joint Surgery</SO>
<YR>2005</YR>
<VL>87</VL>
<NO>5</NO>
<PG>1069-74</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Park-1977" MODIFIED="2009-03-15 18:47:16 -0400" MODIFIED_BY="[Empty name]" NAME="Park 1977" YEAR="1977">
<REFERENCE MODIFIED="2009-03-15 18:47:16 -0400" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Park J, Houtkin S, Grossman J, Levine DB</AU>
<TI>A modified brace (Prenyl) for scoliosis</TI>
<SO>Clinical Orthopaedics &amp; Related Research</SO>
<YR>1977</YR>
<VL>126</VL>
<PG>67-73</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Peltonen-1988" MODIFIED="2009-11-10 17:25:30 -0500" MODIFIED_BY="VEP  " NAME="Peltonen 1988" YEAR="1988">
<REFERENCE MODIFIED="2009-11-10 17:25:30 -0500" MODIFIED_BY="VEP  " PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Peltonen J, Poussa M, Ylikoski M</AU>
<TI>Three-year results of bracing in scoliosis</TI>
<SO>Acta Orthopaedica Scandinavica</SO>
<YR>1988</YR>
<VL>59</VL>
<NO>5</NO>
<PG>487-90</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Peterson-1995" MODIFIED="2015-05-29 08:07:46 -0400" MODIFIED_BY="Anne Lawson" NAME="Peterson 1995" YEAR="1995">
<REFERENCE MODIFIED="2015-05-29 08:07:46 -0400" MODIFIED_BY="Anne Lawson" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Peterson LE, Nachemson AL</AU>
<TI>Prediction of progression of the curve in girls who have adolescent idiopathic scoliosis of moderate severity. Logistic regression analysis based on data from The Brace Study of the Scoliosis Research Society</TI>
<SO>Journal of Bone and Joint Surgery</SO>
<YR>1995</YR>
<VL>77</VL>
<NO>6</NO>
<PG>823-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Pham-2007" MODIFIED="2009-11-10 17:26:00 -0500" MODIFIED_BY="VEP  " NAME="Pham 2007" YEAR="2007">
<REFERENCE MODIFIED="2009-11-10 17:26:00 -0500" MODIFIED_BY="VEP  " PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Pham VM, Herbaux B, Schill A, Thevenon A</AU>
<TI>Evaluation of the Cheneau brace in adolescent idiopathic scoliosis</TI>
<SO>Annales de Readaptation et de Medecine Physique</SO>
<YR>2007</YR>
<VL>50</VL>
<NO>3</NO>
<PG>125-33</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Piazza-1990" MODIFIED="2009-03-15 18:52:40 -0400" MODIFIED_BY="[Empty name]" NAME="Piazza 1990" YEAR="1990">
<REFERENCE MODIFIED="2009-03-15 18:52:40 -0400" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Piazza MR, Bassett GS</AU>
<TI>Curve progression after treatment with the Wilmington brace for idiopathic scoliosis</TI>
<SO>Journal of Pediatric Orthopedics</SO>
<YR>1990</YR>
<VL>10</VL>
<NO>1</NO>
<PG>39-43</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Price-1990" MODIFIED="2015-05-29 08:08:15 -0400" MODIFIED_BY="Anne Lawson" NAME="Price 1990" YEAR="1990">
<REFERENCE MODIFIED="2015-05-29 08:08:15 -0400" MODIFIED_BY="Anne Lawson" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Price CT, Scott DS, Reed FE Jr, Riddick MF</AU>
<TI>Nighttime bracing for adolescent idiopathic scoliosis with the Charleston bending brace. Preliminary report</TI>
<SO>Spine</SO>
<YR>1990</YR>
<VL>15</VL>
<NO>12</NO>
<PG>1294-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Price-1997" MODIFIED="2015-05-29 08:08:24 -0400" MODIFIED_BY="Anne Lawson" NAME="Price 1997" YEAR="1997">
<REFERENCE MODIFIED="2015-05-29 08:08:24 -0400" MODIFIED_BY="Anne Lawson" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Price CT, Scott DS, Reed FR Jr, Sproul JT, Riddick MF</AU>
<TI>Nighttime bracing for adolescent idiopathic scoliosis with the Charleston Bending Brace: long-term follow-up</TI>
<SO>Journal of Pediatric Orthopedics</SO>
<YR>1997</YR>
<VL>17</VL>
<NO>6</NO>
<PG>703-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Rahman-2005" MODIFIED="2009-11-10 17:26:21 -0500" MODIFIED_BY="VEP  " NAME="Rahman 2005" YEAR="2005">
<REFERENCE MODIFIED="2009-11-10 17:26:21 -0500" MODIFIED_BY="VEP  " PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Rahman T, Bowen JR, Takemitsu M, Scott C</AU>
<TI>The association between brace compliance and outcome for patients with idiopathic scoliosis</TI>
<SO>Journal of Pediatric Orthopaedics</SO>
<YR>2005</YR>
<VL>25</VL>
<NO>4</NO>
<PG>420-2</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Rigo-2003" MODIFIED="2009-11-10 17:26:27 -0500" MODIFIED_BY="VEP  " NAME="Rigo 2003" YEAR="2003">
<REFERENCE MODIFIED="2009-11-10 17:26:27 -0500" MODIFIED_BY="VEP  " PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Rigo M, Reiter C, Weiss HR</AU>
<TI>Effect of conservative management on the prevalence of surgery in patients with adolescent idiopathic scoliosis</TI>
<SO>Pediatric Rehabilitation</SO>
<YR>2003</YR>
<VL>6</VL>
<NO>3-4</NO>
<PG>209-14</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Roach-1998" MODIFIED="2009-03-15 19:08:12 -0400" MODIFIED_BY="[Empty name]" NAME="Roach 1998" YEAR="1998">
<REFERENCE MODIFIED="2009-03-15 19:08:12 -0400" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Roach CJ, Andrish JT</AU>
<TI>Preliminary results of part-time bracing for the management of idiopathic scoliosis</TI>
<SO>Journal of Prosthetics and Orthotics</SO>
<YR>1998</YR>
<VL>10</VL>
<NO>3</NO>
<PG>71-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Robinson-1996" MODIFIED="2015-06-09 04:43:07 -0400" MODIFIED_BY="[Empty name]" NAME="Robinson 1996" YEAR="1996">
<REFERENCE MODIFIED="2009-11-10 17:26:34 -0500" MODIFIED_BY="VEP  " PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Robinson CM, McMaster MJ</AU>
<TI>Juvenile idiopathic scoliosis. Curve patterns and prognosis in one hundred and nine patients</TI>
<SO>Journal of Bone &amp; Joint Surgery</SO>
<YR>1996</YR>
<VL>78</VL>
<NO>8</NO>
<PG>1140-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Rosso-1998" MODIFIED="2015-05-29 08:09:34 -0400" MODIFIED_BY="Anne Lawson" NAME="Rosso 1998" YEAR="1998">
<REFERENCE MODIFIED="2015-05-29 08:09:34 -0400" MODIFIED_BY="Anne Lawson" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Rosso V, Trucchi F, Collo GL, Marmotti AG</AU>
<TI>Early treatment of a juvenile idiopathic scoliosis. Charleston Bending orthosis and Olympe orthosis: results after 4 years in 117 cases</TI>
<SO>Minerva Ortopedica e Traumatologica</SO>
<YR>1998</YR>
<VL>49</VL>
<NO>9</NO>
<PG>317-23</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Rowe-1997" MODIFIED="2009-11-10 17:26:50 -0500" MODIFIED_BY="VEP  " NAME="Rowe 1997" YEAR="1997">
<REFERENCE MODIFIED="2009-11-10 17:26:50 -0500" MODIFIED_BY="VEP  " PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Rowe DE, Bernstein SM, Riddick MF, Adler F, Emans JB, Gardner-Bonneau D</AU>
<TI>A meta-analysis of the efficacy of non-operative treatments for idiopathic scoliosis</TI>
<SO>Journal of Bone &amp; Joint Surgery</SO>
<YR>1997</YR>
<VL>75</VL>
<NO>9</NO>
<PG>664-74</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Schmitt-1987" MODIFIED="2009-11-10 17:26:56 -0500" MODIFIED_BY="VEP  " NAME="Schmitt 1987" YEAR="1987">
<REFERENCE MODIFIED="2009-11-10 17:26:56 -0500" MODIFIED_BY="VEP  " PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Schmitt O, Jacob S</AU>
<TI>Development of idiopathic scoliosis in electrostimulation treatment with an implantable system</TI>
<SO>Zeitschrift fur Orthopadie und Ihre Grenzgebiete</SO>
<YR>1987</YR>
<VL>125</VL>
<NO>5</NO>
<PG>518-25</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Schraudebach-1974" MODIFIED="2009-11-10 17:27:02 -0500" MODIFIED_BY="VEP  " NAME="Schraudebach 1974" YEAR="1974">
<REFERENCE MODIFIED="2009-11-10 17:27:02 -0500" MODIFIED_BY="VEP  " PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Schraudebach T, Rossler H, Dennert R</AU>
<TI>Experience with the Milwaukee brace in an out-patient department for scoliosis</TI>
<SO>Zeitschrift fur Orthopadie und Ihre Grenzgebiete</SO>
<YR>1974</YR>
<VL>112</VL>
<NO>6</NO>
<PG>1265-74</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Scoloveno-1990" MODIFIED="2009-11-10 17:27:13 -0500" MODIFIED_BY="VEP  " NAME="Scoloveno 1990" YEAR="1990">
<REFERENCE MODIFIED="2009-11-10 17:27:13 -0500" MODIFIED_BY="VEP  " PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Scoloveno MA, Yarcheski A, Mahon NE</AU>
<TI>Scoliosis treatment effects on selected variables among adolescents</TI>
<SO>Western Journal of Nursing Research</SO>
<YR>1990</YR>
<VL>12</VL>
<NO>5</NO>
<PG>601-15</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Shirado-1995" MODIFIED="2009-11-10 17:27:19 -0500" MODIFIED_BY="VEP  " NAME="Shirado 1995" YEAR="1995">
<REFERENCE MODIFIED="2009-11-10 17:27:19 -0500" MODIFIED_BY="VEP  " PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Shirado O, Ito T, Kaneda K, Strax TE</AU>
<TI>Kinesiologic analysis of dynamic side-shift in patients with idiopathic scoliosis</TI>
<SO>Archives of Physical Medicine and Rehabilitation</SO>
<YR>1995</YR>
<VL>76</VL>
<NO>7</NO>
<PG>621-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Skaggs-1996" MODIFIED="2009-03-15 19:16:59 -0400" MODIFIED_BY="[Empty name]" NAME="Skaggs 1996" YEAR="1996">
<REFERENCE MODIFIED="2009-03-15 19:16:03 -0400" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Skaggs DL</AU>
<TI>Effectiveness of treatment with a brace in girl who have adolescent idiopathic scoliosis. A prospective, controlled study based on data from the brace study of the scoliosis research society</TI>
<SO>Journal of Bone &amp; Joint Surgery</SO>
<YR>1996</YR>
<VL>78</VL>
<NO>1</NO>
<PG>151</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Spoonamore-2004" MODIFIED="2009-11-10 17:27:27 -0500" MODIFIED_BY="VEP  " NAME="Spoonamore 2004" YEAR="2004">
<REFERENCE MODIFIED="2009-11-10 17:27:27 -0500" MODIFIED_BY="VEP  " PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Spoonamore MJ, Dolan LA, Weinstein SL</AU>
<TI>Use of the Rosenberger brace in the treatment of progressive adolescent idiopathic scoliosis</TI>
<SO>Spine</SO>
<YR>2004</YR>
<VL>29</VL>
<NO>13</NO>
<PG>1458-64</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Tonseth-2005" MODIFIED="2009-11-10 17:27:45 -0500" MODIFIED_BY="VEP  " NAME="Tonseth 2005" YEAR="2005">
<REFERENCE MODIFIED="2009-11-10 17:27:45 -0500" MODIFIED_BY="VEP  " PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Tonseth KA, Wever DJ</AU>
<TI>Brace treatment of idiopathic scoliosis</TI>
<SO>Tidsskrift for Den Norske Laegeforening</SO>
<YR>2005</YR>
<VL>125</VL>
<NO>2</NO>
<PG>170-2</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Trivedi-2001" MODIFIED="2009-11-10 17:27:38 -0500" MODIFIED_BY="VEP  " NAME="Trivedi 2001" YEAR="2001">
<REFERENCE MODIFIED="2009-11-10 17:27:38 -0500" MODIFIED_BY="VEP  " PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Trivedi JM, Thomson JD</AU>
<TI>Results of Charleston bracing in skeletally immature patients with idiopathic scoliosis</TI>
<SO>Journal of Pediatric Orthopedics</SO>
<YR>2001</YR>
<VL>21</VL>
<NO>3</NO>
<PG>277-80</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Upadhyay-1995" MODIFIED="2009-11-10 17:27:51 -0500" MODIFIED_BY="VEP  " NAME="Upadhyay 1995" YEAR="1995">
<REFERENCE MODIFIED="2009-11-10 17:27:51 -0500" MODIFIED_BY="VEP  " PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Upadhyay SS, Nelson IW, Ho EK, Hsu LC, Leong JC</AU>
<TI>New prognostic factors to predict the final outcome of brace treatment in adolescent idiopathic scoliosis</TI>
<SO>Spine</SO>
<YR>1995</YR>
<VL>20</VL>
<NO>5</NO>
<PG>537-45</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Van-Rhijn-2002" MODIFIED="2009-11-10 17:27:58 -0500" MODIFIED_BY="VEP  " NAME="Van Rhijn 2002" YEAR="2002">
<REFERENCE MODIFIED="2009-11-10 17:27:58 -0500" MODIFIED_BY="VEP  " PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Van Rhijn LW, Plasmans CMT, Veraart BEEM</AU>
<TI>Changes in curve pattern after brace treatment for idiopathic scoliosis</TI>
<SO>Acta Orthopaedica Scandinavica</SO>
<YR>2002</YR>
<VL>73</VL>
<NO>3</NO>
<PG>277-81</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Van-Rhijn-2003" MODIFIED="2009-11-10 17:28:11 -0500" MODIFIED_BY="VEP  " NAME="Van Rhijn 2003" YEAR="2003">
<REFERENCE MODIFIED="2009-11-10 17:28:11 -0500" MODIFIED_BY="VEP  " PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Van Rhijn LW, Veraart BE, Plasmans CM</AU>
<TI>Application of a lumbar brace for thoracic and double thoracic lumbar scoliosis: a comparative study</TI>
<SO>Journal of Pediatric Orthopaedics</SO>
<YR>2003</YR>
<VL>12</VL>
<NO>3</NO>
<PG>178-82</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Veldhuizen-2002" MODIFIED="2015-06-09 04:43:19 -0400" MODIFIED_BY="[Empty name]" NAME="Veldhuizen 2002" YEAR="2002">
<REFERENCE MODIFIED="2009-11-10 17:28:17 -0500" MODIFIED_BY="VEP  " PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Veldhuizen AG, Cheung J, Bulthuis GJ, Nijenbanning G</AU>
<TI>A new orthotic device in the non-operative treatment of idiopathic scoliosis</TI>
<SO>Medical Engineering and Physics</SO>
<YR>2002</YR>
<VL>24</VL>
<NO>3</NO>
<PG>209-18</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Vijvermans-2004" MODIFIED="2015-05-30 15:48:58 -0400" MODIFIED_BY="Anne Lawson" NAME="Vijvermans 2004" YEAR="2004">
<REFERENCE MODIFIED="2009-11-10 17:28:24 -0500" MODIFIED_BY="VEP  " PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Vijvermans V, Fabry G, Nijs J</AU>
<TI>Factors determining the final outcome of treatment of idiopathic scoliosis with the Boston brace: a longitudinal study</TI>
<SO>Journal of Pediatric Orthopaedics</SO>
<YR>2004</YR>
<VL>13</VL>
<NO>3</NO>
<PG>143-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Watanabe-2005" MODIFIED="2009-11-10 17:28:46 -0500" MODIFIED_BY="VEP  " NAME="Watanabe 2005" YEAR="2005">
<REFERENCE MODIFIED="2009-11-10 17:28:46 -0500" MODIFIED_BY="VEP  " PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Watanabe K, Hasegawa K, Hirano T, Uchiyama S, Endo N</AU>
<TI>Use of the scoliosis research society outcomes instrument to evaluate patient outcome in untreated idiopathic scoliosis patients in Japan: Part I: comparison with non-scoliosis group: preliminary/limited review in a Japanese population</TI>
<SO>Spine</SO>
<YR>2005</YR>
<VL>30</VL>
<NO>10</NO>
<PG>1197-201</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Weigert-2006" MODIFIED="2009-11-10 17:28:57 -0500" MODIFIED_BY="VEP  " NAME="Weigert 2006" YEAR="2006">
<REFERENCE MODIFIED="2009-11-10 17:28:57 -0500" MODIFIED_BY="VEP  " PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Weigert KP, Nygaard LM, Christensen FB, Hansen ES, Bunger C</AU>
<TI>Outcome in adolescent idiopathic scoliosis after brace treatment and surgery assessed by means of the Scoliosis Research Society Instrument 24</TI>
<SO>European Spine Journal</SO>
<YR>2006</YR>
<VL>15</VL>
<NO>7</NO>
<PG>1108-17</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Weiss-2003" MODIFIED="2009-11-10 17:29:06 -0500" MODIFIED_BY="VEP  " NAME="Weiss 2003" YEAR="2003">
<REFERENCE MODIFIED="2009-11-10 17:29:06 -0500" MODIFIED_BY="VEP  " PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Weiss HR, Weiss G, Schaar HJ</AU>
<TI>Incidence of surgery in conservatively treated patients with scoliosis</TI>
<SO>Pediatric Rehabilitation</SO>
<YR>2003</YR>
<VL>6</VL>
<NO>2</NO>
<PG>111-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Weiss-2005" MODIFIED="2009-03-15 19:33:23 -0400" MODIFIED_BY="[Empty name]" NAME="Weiss 2005" YEAR="2005">
<REFERENCE MODIFIED="2009-03-15 19:33:23 -0400" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Weiss H, Weiss GM</AU>
<TI>Brace treatment during pubertal growth spurt in girls with idiopathic scoliosis (IS): a prospective trial comparing two different concepts</TI>
<SO>Pediatric Rehabilitation</SO>
<YR>2005</YR>
<VL>8</VL>
<NO>3</NO>
<PG>199-206</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Weiss-2006" MODIFIED="2009-03-15 19:34:14 -0400" MODIFIED_BY="[Empty name]" NAME="Weiss 2006" YEAR="2006">
<REFERENCE MODIFIED="2009-03-15 19:34:14 -0400" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Weiss H, Klein R</AU>
<TI>Improving excellence in scoliosis rehabilitation: a controlled study of matched pairs</TI>
<SO>Pediatric Rehabilitation</SO>
<YR>2006</YR>
<VL>9</VL>
<NO>3</NO>
<PG>190-200</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Wessberg-2011" MODIFIED="2015-05-29 08:37:11 -0400" MODIFIED_BY="Anne Lawson" NAME="Wessberg 2011" YEAR="2011">
<REFERENCE MODIFIED="2015-05-29 08:37:11 -0400" MODIFIED_BY="Anne Lawson" PRIMARY="NO" TYPE="CONFERENCE_PROC">
<AU>Wessberg, P, Rune H, Anders N. Night</AU>
<TI>Time providence bracing compared to fulltime Boston bracing in adolescent idiopathic Scoliosis. A prospective randomized study</TI>
<SO>Spine: Affiliated Society Meeting Abstracts</SO>
<YR>2011</YR>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Wever-2002" MODIFIED="2009-03-15 19:36:17 -0400" MODIFIED_BY="[Empty name]" NAME="Wever 2002" YEAR="2002">
<REFERENCE MODIFIED="2009-03-15 19:36:17 -0400" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Wever DJ, Tonseth KA, Veldhuizen AG</AU>
<TI>Curve progression and spinal growth in brace treated idiopathic scoliosis</TI>
<SO>Studies in Health Technology &amp; Informatics</SO>
<YR>2002</YR>
<VL>91</VL>
<PG>387-92</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Wiley-2000" MODIFIED="2009-11-10 17:29:28 -0500" MODIFIED_BY="VEP  " NAME="Wiley 2000" YEAR="2000">
<REFERENCE MODIFIED="2009-11-10 17:29:28 -0500" MODIFIED_BY="VEP  " PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Wiley JW, Thomson JD, Mitchell TM, Smith BG, Banta JV</AU>
<TI>Effectiveness of the Boston brace in treatment of large curves in adolescent idiopathic scoliosis</TI>
<SO>Spine</SO>
<YR>2000</YR>
<VL>25</VL>
<NO>18</NO>
<PG>2326-32</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Willers-1993" MODIFIED="2009-11-10 17:29:37 -0500" MODIFIED_BY="VEP  " NAME="Willers 1993" YEAR="1993">
<REFERENCE MODIFIED="2009-11-10 17:29:37 -0500" MODIFIED_BY="VEP  " PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Willers U, Normelli H, Aaro S, Svensson O, Hedlund R</AU>
<TI>Long-term results of Boston brace treatment on vertebral rotation in idiopathic scoliosis</TI>
<SO>Spine</SO>
<YR>1993</YR>
<VL>18</VL>
<NO>4</NO>
<PG>432-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Yamauchi-1986" MODIFIED="2015-05-30 15:50:49 -0400" MODIFIED_BY="Anne Lawson" NAME="Yamauchi 1986" YEAR="1986">
<REFERENCE MODIFIED="2009-11-10 17:29:45 -0500" MODIFIED_BY="VEP  " PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Yamauchi Y, Asaka Y, Chen WS, Tsuji T, Yamaguchi T, Tsuruoka H</AU>
<TI>Follow-up results of brace treatment of adolescent idiopathic scoliosis</TI>
<SO>Journal of the Japanese Orthopaedic Association</SO>
<YR>1986</YR>
<VL>60</VL>
<NO>11</NO>
<PG>1079-85</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Ylikoski-1989" MODIFIED="2009-11-10 17:29:59 -0500" MODIFIED_BY="VEP  " NAME="Ylikoski 1989" YEAR="1989">
<REFERENCE MODIFIED="2009-11-10 17:29:59 -0500" MODIFIED_BY="VEP  " PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Ylikoski M, Peltonen J, Poussa M</AU>
<TI>Biological factors and predictability of bracing in adolescent idiopathic scoliosis</TI>
<SO>Journal of Pediatric Orthopaedics</SO>
<YR>1989</YR>
<VL>9</VL>
<NO>6</NO>
<PG>680-3</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Yrjonen-2006" MODIFIED="2015-05-29 10:08:38 -0400" MODIFIED_BY="Anne Lawson" NAME="Yrjonen 2006" YEAR="2006">
<REFERENCE MODIFIED="2015-05-29 10:08:38 -0400" MODIFIED_BY="Anne Lawson" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Yrjonen T, Ylikoski M, Schlenzka D, Kinnunen R, Poussa M</AU>
<TI>Effectiveness of the Providence nighttime bracing in adolescent idiopathic scoliosis: a comparative study of 36 female patients</TI>
<SO>European Spine Journal</SO>
<YR>2006</YR>
<VL>15</VL>
<NO>7</NO>
<PG>1139-43</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
</EXCLUDED_STUDIES>
<AWAITING_STUDIES MODIFIED="2015-05-29 10:09:02 -0400" MODIFIED_BY="Anne Lawson">
<STUDY DATA_SOURCE="PUB" ID="STD-Guo-2014" MODIFIED="2015-05-29 10:09:02 -0400" MODIFIED_BY="Anne Lawson" NAME="Guo 2014" YEAR="2014">
<REFERENCE MODIFIED="2015-05-29 10:09:02 -0400" MODIFIED_BY="Anne Lawson" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Guo J, Lam TP, Wong MS, Ng BK, Lee KM, Liu KL, et al</AU>
<TI>A prospective randomized controlled study on the treatment outcome of SpineCor brace versus rigid brace for adolescent idiopathic scoliosis with follow-up according to the SRS standardized criteria</TI>
<SO>European Spine Journal</SO>
<YR>2014</YR>
<VL>23</VL>
<NO>12</NO>
<PG>2650-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Wiemann-2014" MODIFIED="2015-04-09 15:14:38 -0400" MODIFIED_BY="[Empty name]" NAME="Wiemann 2014" YEAR="2014">
<REFERENCE MODIFIED="2015-04-09 15:14:38 -0400" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Wiemann JM, Shah SA, Price CT</AU>
<TI>Nighttime bracing versus observation for early adolescent idiopathic scoliosis</TI>
<SO>Journal of Pediatric Orthopedics</SO>
<YR>2014</YR>
<VL>34</VL>
<NO>6</NO>
<PG>603-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
</AWAITING_STUDIES>
<ONGOING_STUDIES MODIFIED="2013-10-26 07:26:06 -0400" MODIFIED_BY="VEP  "/>
</STUDIES>
<OTHER_REFERENCES MODIFIED="2015-06-10 13:20:35 -0400" MODIFIED_BY="[Empty name]">
<ADDITIONAL_REFERENCES MODIFIED="2015-06-10 13:20:35 -0400" MODIFIED_BY="[Empty name]">
<REFERENCE ID="REF-Altaf-2013" MODIFIED="2015-05-29 10:09:19 -0400" MODIFIED_BY="Anne Lawson" NAME="Altaf 2013" TYPE="JOURNAL_ARTICLE">
<AU>Altaf F, Gibson A, Dannawi Z, Noordeen H</AU>
<TI>Adolescent idiopathic scoliosis</TI>
<SO>BMJ</SO>
<YR>2013</YR>
<VL>346</VL>
<PG>f2508</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Asher-2003a" MODIFIED="2015-05-30 15:51:48 -0400" MODIFIED_BY="Anne Lawson" NAME="Asher 2003a" TYPE="JOURNAL_ARTICLE">
<AU>Asher M, Min Lai S, Burton D, Manna B</AU>
<TI>Discrimination validity of the Scoliosis Research Society-22 patient questionnaire: relationship to idiopathic scoliosis curve pattern and curve size</TI>
<SO>Spine</SO>
<YR>2003</YR>
<VL>28</VL>
<PG>74-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Asher-2003b" MODIFIED="2015-05-29 10:10:56 -0400" MODIFIED_BY="Anne Lawson" NAME="Asher 2003b" TYPE="JOURNAL_ARTICLE">
<AU>Asher M, Min Lai S, Burton D, Manna B</AU>
<TI>The reliability and concurrent validity of the Scoliosis Research Society-22 patient questionnaire for idiopathic scoliosis</TI>
<SO>Spine</SO>
<YR>2003</YR>
<VL>28</VL>
<PG>63-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Boutron-2005" MODIFIED="2015-06-05 13:14:50 -0400" MODIFIED_BY="[Empty name]" NAME="Boutron 2005" TYPE="JOURNAL_ARTICLE">
<AU>Boutron I, Moher D, Tugwell P, Giraudeau B, Poiraudeau S, Nizard R, et al</AU>
<TI>A checklist to evaluate a report of a non pharmacological trial (CLEAR NPT) was developed using consensus</TI>
<SO>Journal of Clinical Epidemiology</SO>
<YR>2005</YR>
<VL>58</VL>
<NO>12</NO>
<PG>1233-40</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Bunge-2008" MODIFIED="2015-05-29 14:39:06 -0400" MODIFIED_BY="Anne Lawson" NAME="Bunge 2008" TYPE="JOURNAL_ARTICLE">
<AU>Bunge EM, de Koning HJ</AU>
<TI>Bracing patients with idiopathic scoliosis: design of the Dutch randomized controlled treatment trial</TI>
<SO>BMC Musculoskeletal Disorders</SO>
<YR>2008</YR>
<VL>9</VL>
<PG>57</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Climent-1999" NAME="Climent 1999" TYPE="JOURNAL_ARTICLE">
<AU>Climent JM, Sanchez J</AU>
<TI>Impact of the type of brace on the quality of life of adolescents with spine deformities</TI>
<SO>Spine</SO>
<YR>1999</YR>
<VL>24</VL>
<NO>18</NO>
<PG>1903-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Coillard-2002" MODIFIED="2009-11-10 17:32:33 -0500" MODIFIED_BY="VEP  " NAME="Coillard 2002" TYPE="JOURNAL_ARTICLE">
<AU>Coillard C, Leroux MA, Badeaux J, Rivard CH</AU>
<TI>SPINECOR: a new therapeutic approach for idiopathic scoliosis</TI>
<SO>Studies in Health Technology &amp; Informatics</SO>
<YR>2002</YR>
<VL>88</VL>
<PG>215-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Danielsson-2003a" MODIFIED="2015-05-29 10:12:05 -0400" MODIFIED_BY="Anne Lawson" NAME="Danielsson 2003a" TYPE="JOURNAL_ARTICLE">
<AU>Danielsson AJ, Nachemson AL</AU>
<TI>Back pain and function 22 years after brace treatment for adolescent idiopathic scoliosis: a case-control study - Part I</TI>
<SO>Spine</SO>
<YR>2003</YR>
<VL>28</VL>
<NO>18</NO>
<PG>2078-85</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Danielsson-2003b" MODIFIED="2015-05-29 10:12:13 -0400" MODIFIED_BY="Anne Lawson" NAME="Danielsson 2003b" TYPE="JOURNAL_ARTICLE">
<AU>Danielsson AJ, Nachemson AL</AU>
<TI>Back pain and function 23 years after fusion for adolescent idiopathic scoliosis: a case-control study - Part II</TI>
<SO>Spine</SO>
<YR>2003</YR>
<VL>28</VL>
<NO>18</NO>
<PG>E373-83</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Dickson-1999b" MODIFIED="2015-05-29 10:12:21 -0400" MODIFIED_BY="Anne Lawson" NAME="Dickson 1999b" TYPE="JOURNAL_ARTICLE">
<AU>Dickson RA, Weinstein SL</AU>
<TI>Bracing (and screening) - yes or no?</TI>
<SO>Journal of Bone &amp; Joint Surgery</SO>
<YR>1999</YR>
<VL>81</VL>
<NO>2</NO>
<PG>193-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Dolan-2007a" MODIFIED="2015-05-30 16:10:28 -0400" MODIFIED_BY="Anne Lawson" NAME="Dolan 2007a" TYPE="JOURNAL_ARTICLE">
<AU>Dolan LA, Weinstein SL</AU>
<TI>Surgical rates after observation and bracing for adolescent idiopathic scoliosis: an evidence-based review</TI>
<SO>Spine</SO>
<YR>2007</YR>
<VL>32</VL>
<NO>19 Suppl</NO>
<PG>S91-S100</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Dolan-2007b" MODIFIED="2015-05-30 16:10:25 -0400" MODIFIED_BY="Anne Lawson" NAME="Dolan 2007b" TYPE="JOURNAL_ARTICLE">
<AU>Dolan LA, Donnelly MJ, Spratt KF, Weinstein SL</AU>
<TI>Professional opinion concerning the effectiveness of bracing relative to observation in adolescent idiopathic scoliosis</TI>
<SO>Journal of Pediatric Orthopaedics</SO>
<YR>2007</YR>
<VL>27</VL>
<NO>3</NO>
<PG>270-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Donzelli-2012" MODIFIED="2015-05-29 10:12:39 -0400" MODIFIED_BY="Anne Lawson" NAME="Donzelli 2012" TYPE="JOURNAL_ARTICLE">
<AU>Donzelli S, Zaina F, Negrini S</AU>
<TI>In defense of adolescents: they really do use braces for the hours prescribed, if good help is provided. Results from a prospective everyday clinic cohort using thermobrace</TI>
<SO>Scoliosis</SO>
<YR>2012 May 31</YR>
<VL>7 (1)</VL>
<PG>12</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Freidel-2002a" NAME="Freidel 2002a" TYPE="JOURNAL_ARTICLE">
<AU>Freidel K, Petermann F, Reichel D, Steiner A, Warschburger P, Weiss HR</AU>
<TI>Quality of life in women with idiopathic scoliosis</TI>
<SO>Spine</SO>
<YR>2002</YR>
<VL>27</VL>
<NO>4</NO>
<PG>E87-91</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Freidel-2002b" MODIFIED="2009-11-10 17:33:52 -0500" MODIFIED_BY="VEP  " NAME="Freidel 2002b" TYPE="JOURNAL_ARTICLE">
<AU>Freidel K, Reichel D, Steiner A, Warschburger P, Petermann F, Weiss HR</AU>
<TI>Idiopathic scoliosis and quality of life</TI>
<SO>Studies in Health Technology &amp; Informatics</SO>
<YR>2002</YR>
<VL>88</VL>
<PG>24-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Furlan-2009" MODIFIED="2009-09-30 10:47:27 -0400" MODIFIED_BY="VEP  " NAME="Furlan 2009" TYPE="JOURNAL_ARTICLE">
<AU>Furlan AD, Pennick V, Bombardier C, van Tulder M, Cochrane Back Review Group</AU>
<TI>2009 updated method guidelines for systematic reviews in the Cochrane Back Review Group</TI>
<SO>Spine</SO>
<YR>2009</YR>
<VL>34</VL>
<NO>18</NO>
<PG>1929-41</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Fusco-2011" MODIFIED="2015-05-29 10:13:36 -0400" MODIFIED_BY="Anne Lawson" NAME="Fusco 2011" TYPE="JOURNAL_ARTICLE">
<AU>Fusco C, Zaina F, Atanasio S, Romano M, Negrini A, Negrini S</AU>
<TI>Physical exercises in the treatment of adolescent idiopathic scoliosis: an updated systematic review</TI>
<SO>Physiotherapy Theory and Practice</SO>
<YR>2011</YR>
<VL>27</VL>
<NO>1</NO>
<PG>80-114</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Goldberg-1993" NAME="Goldberg 1993" TYPE="JOURNAL_ARTICLE">
<AU>Goldberg CJ, Dowling FE, Hall JE, Emans JB</AU>
<TI>A statistical comparison between natural history of idiopathic scoliosis and brace treatment in skeletally immature adolescent girls</TI>
<SO>Spine</SO>
<YR>1993</YR>
<VL>18</VL>
<NO>7</NO>
<PG>902-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Grivas-2006" MODIFIED="2015-05-29 10:18:13 -0400" MODIFIED_BY="Anne Lawson" NAME="Grivas 2006" TYPE="JOURNAL_ARTICLE">
<AU>Grivas TB, Vasiliadis E, Mouzakis V, Mihas C, Koufopoulos G</AU>
<TI>Association between adolescent idiopathic scoliosis prevalence and age at menarche in different geographic latitudes</TI>
<SO>Scoliosis</SO>
<YR>2006</YR>
<VL>1</VL>
<PG>9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Grivas-2008" MODIFIED="2009-11-10 17:34:08 -0500" MODIFIED_BY="VEP  " NAME="Grivas 2008" TYPE="JOURNAL_ARTICLE">
<AU>Grivas TB, Vasiliadis ES, Rodopoulos G, Bardakos N</AU>
<TI>The role of the intervertebral disc in correction of scoliotic curves. A theoretical model of idiopathic scoliosis pathogenesis</TI>
<SO>Studies in Health Technology &amp; Informatics</SO>
<YR>2008</YR>
<VL>140</VL>
<PG>33-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Grivas-2012" MODIFIED="2015-05-29 10:18:21 -0400" MODIFIED_BY="Anne Lawson" NAME="Grivas 2012" TYPE="OTHER">
<AU>Grivas TB</AU>
<TI>Spine: maintaining mobility of the spine. Steps toward more effective scoliosis brace treatment to prevent the need for fusion</TI>
<SO>www.boneandjoint.org.uk/content/maintaining-mobility-spine%E2%80%A6</SO>
<YR>(accessed 29 May 2015)</YR>
<IDENTIFIERS MODIFIED="2015-05-29 10:18:21 -0400" MODIFIED_BY="Anne Lawson"/>
</REFERENCE>
<REFERENCE ID="REF-Higgins-2011" MODIFIED="2015-06-09 04:46:42 -0400" MODIFIED_BY="[Empty name]" NAME="Higgins 2011" TYPE="OTHER">
<AU>Higgins JPT, Green S (editors)</AU>
<TI>Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]</TI>
<SO>The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org</SO>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Hresko-2013" MODIFIED="2015-05-29 10:20:30 -0400" MODIFIED_BY="Anne Lawson" NAME="Hresko 2013" TYPE="JOURNAL_ARTICLE">
<AU>Hresko MT</AU>
<TI>Clinical practice. Idiopathic scoliosis in adolescents</TI>
<SO>New England Journal of Medicine</SO>
<YR>2013</YR>
<VL>368</VL>
<NO>9</NO>
<PG>834-41</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Katz-2001" NAME="Katz 2001" TYPE="JOURNAL_ARTICLE">
<AU>Katz DE, Durrani AA</AU>
<TI>Factors that influence outcome in bracing large curves in patients with adolescent idiopathic scoliosis</TI>
<SO>Spine</SO>
<YR>2001</YR>
<VL>26</VL>
<NO>21</NO>
<PG>2354-61</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Katz-2010" MODIFIED="2015-05-29 10:21:37 -0400" MODIFIED_BY="Anne Lawson" NAME="Katz 2010" TYPE="JOURNAL_ARTICLE">
<AU>Katz DE, Herring JA, Browne RH, Kelly DM, Birch JG</AU>
<TI>Brace wear control of curve progression in adolescent idiopathic scoliosis</TI>
<SO>Journal of Bone and Joint Surgery American Version</SO>
<YR>2010</YR>
<VL>92</VL>
<NO>6</NO>
<PG>1343-52</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Landauer-2003" MODIFIED="2009-11-10 17:34:22 -0500" MODIFIED_BY="VEP  " NAME="Landauer 2003" TYPE="JOURNAL_ARTICLE">
<AU>Landauer F, Wimmer C, Behensky H</AU>
<TI>Estimating the final outcome of brace treatment for idiopathic thoracic scoliosis at 6-month follow-up</TI>
<SO>Pediatric Rehabilitation</SO>
<YR>2003</YR>
<VL>6</VL>
<NO>3-4</NO>
<PG>201-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Lenssinck-2005" MODIFIED="2015-05-30 15:54:29 -0400" MODIFIED_BY="Anne Lawson" NAME="Lenssinck 2005" TYPE="JOURNAL_ARTICLE">
<AU>Lenssinck ML, Frijlink AC, Berger MY, Bierman-Zeinstra SM, Verkerk K, Verhagen AP</AU>
<TI>Effect of bracing and other conservative interventions in the treatment of idiopathic scoliosis in adolescents: a systematic review of clinical trials</TI>
<SO>Physical Therapy</SO>
<YR>2005</YR>
<VL>85</VL>
<NO>12</NO>
<PG>1329-39</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Lonstein-2006" MODIFIED="2009-11-10 17:35:02 -0500" MODIFIED_BY="VEP  " NAME="Lonstein 2006" TYPE="JOURNAL_ARTICLE">
<AU>Lonstein JE</AU>
<TI>Scoliosis: surgical versus non-surgical treatment</TI>
<SO>Clinical Orthopaedics &amp; Related Research</SO>
<YR>2006</YR>
<VL>443</VL>
<PG>248-59</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Lupparelli-2002" MODIFIED="2009-11-10 17:35:20 -0500" MODIFIED_BY="VEP  " NAME="Lupparelli 2002" TYPE="JOURNAL_ARTICLE">
<AU>Lupparelli S, Pola E, Pitta L, Mazza O, De Santis V, Aulisa L</AU>
<TI>Biomechanical factors affecting progression of structural scoliotic curves of the spine</TI>
<SO>Studies in Health Technology &amp; Informatics</SO>
<YR>2002</YR>
<VL>91</VL>
<PG>81-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-MacLean-1989" MODIFIED="2015-05-29 10:22:36 -0400" MODIFIED_BY="Anne Lawson" NAME="MacLean 1989" TYPE="JOURNAL_ARTICLE">
<AU>MacLean WE Jr, Green NE, Pierre CB, Ray DC</AU>
<TI>Stress and coping with scoliosis: psychological effects on adolescents and their families</TI>
<SO>Journal of Pediatric Orthopaedics</SO>
<YR>1989</YR>
<VL>9</VL>
<NO>3</NO>
<PG>257-61</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Maruyama-2003" MODIFIED="2009-11-10 17:36:02 -0500" MODIFIED_BY="VEP  " NAME="Maruyama 2003" TYPE="JOURNAL_ARTICLE">
<AU>Maruyama T, Kitagawa T, Takeshita K, Mochizuki K, Nakamura K</AU>
<TI>Conservative treatment for adolescent idiopathic scoliosis: can it reduce the incidence of surgical treatment?</TI>
<SO>Pediatric Rehabilitation</SO>
<YR>2003</YR>
<VL>6</VL>
<NO>3-4</NO>
<PG>215-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Mayo-1994" NAME="Mayo 1994" TYPE="JOURNAL_ARTICLE">
<AU>Mayo NE, Goldberg MS, Poitras B, Scott S, Hanley J</AU>
<TI>The Ste. Justine Adolescent Idiopathic Scoliosis Cohort Study. Part III: Back pain</TI>
<SO>Spine</SO>
<YR>1994</YR>
<VL>19</VL>
<NO>14</NO>
<PG>1573-81</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Negrini-2003" MODIFIED="2009-11-10 17:36:21 -0500" MODIFIED_BY="VEP  " NAME="Negrini 2003" TYPE="JOURNAL_ARTICLE">
<AU>Negrini S, Antonini G, Carabalona R, Minozzi S</AU>
<TI>Physical exercises as a treatment for adolescent idiopathic scoliosis. A systematic review</TI>
<SO>Pediatric Rehabilitation</SO>
<YR>2003</YR>
<VL>6</VL>
<NO>3-4</NO>
<PG>227-35</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Negrini-2005" MODIFIED="2009-11-10 17:36:35 -0500" MODIFIED_BY="VEP  " NAME="Negrini 2005" TYPE="JOURNAL_ARTICLE">
<AU>Negrini S, Aulisa L, Ferraro C, Fraschini P, Masiero S, Simonazzi P, et al</AU>
<TI>Italian guidelines on rehabilitation treatment of adolescents with scoliosis or other spinal deformities</TI>
<SO>Europa Medicophysica</SO>
<YR>2005</YR>
<VL>41</VL>
<NO>2</NO>
<PG>183-201</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Negrini-2006a" MODIFIED="2015-05-30 16:11:28 -0400" MODIFIED_BY="Anne Lawson" NAME="Negrini 2006a" TYPE="JOURNAL_ARTICLE">
<AU>Negrini S, Grivas TB, Kotwicki T, Maruyama T, Rigo M, Weiss HR, et al</AU>
<TI>Why do we treat adolescent idiopathic scoliosis? What we want to obtain and to avoid for our patients. SOSORT 2005 Consensus paper</TI>
<SO>Scoliosis</SO>
<YR>2006</YR>
<VL>1</VL>
<PG>4</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Negrini-2006b" MODIFIED="2015-05-30 16:11:25 -0400" MODIFIED_BY="Anne Lawson" NAME="Negrini 2006b" TYPE="JOURNAL_ARTICLE">
<AU>Negrini S, Carabalona R</AU>
<TI>Social acceptability of treatments for adolescent idiopathic scoliosis: a cross-sectional study</TI>
<SO>Scoliosis</SO>
<YR>2006</YR>
<VL>1</VL>
<PG>14</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Negrini-2006c" MODIFIED="2009-11-10 17:36:52 -0500" MODIFIED_BY="VEP  " NAME="Negrini 2006c" TYPE="JOURNAL_ARTICLE">
<AU>Negrini S, Marchini G</AU>
<TI>Efficacy of the Symmetric, Patient-oriented, Rigid, Three-dimensional, active (SPoRT) concept of bracing for scoliosis: a prospective study of the Sforzesco versus Lyon brace</TI>
<SO>Europa Medicophysica</SO>
<YR>2006</YR>
<VL>43</VL>
<NO>2</NO>
<PG>171-81</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Negrini-2008a" MODIFIED="2015-05-30 16:05:27 -0400" MODIFIED_BY="Anne Lawson" NAME="Negrini 2008a" TYPE="JOURNAL_ARTICLE">
<AU>Negrini S, Fusco C, Minozzi S, Atanasio S, Zaina F, Romano M</AU>
<TI>Exercises reduce the progression rate of adolescent idiopathic scoliosis: results of a comprehensive systematic review of the literature</TI>
<SO>Disability Rehabilitation</SO>
<YR>2008</YR>
<VL>30</VL>
<NO>10</NO>
<PG>772-85</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Negrini-2008b" MODIFIED="2015-05-30 16:05:24 -0400" MODIFIED_BY="Anne Lawson" NAME="Negrini 2008b" TYPE="JOURNAL_ARTICLE">
<AU>Negrini S, Atanasio S, Zaina F, Romano M, Parzini S, Negrini A</AU>
<TI>End-growth results of bracing and exercises for adolescent idiopathic scoliosis. Prospective worst-case analysis</TI>
<SO>Studies in Health Technology &amp; Informatics</SO>
<YR>2008</YR>
<VL>135</VL>
<PG>395-408</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Negrini-2009a" MODIFIED="2009-11-10 17:38:29 -0500" MODIFIED_BY="VEP  " NAME="Negrini 2009a" TYPE="JOURNAL_ARTICLE">
<AU>Negrini S, Atanasio S, Fusco C, Zaina F</AU>
<TI>Effectiveness of complete conservative treatment for adolescent idiopathic scoliosis (bracing and exercises) based on SOSORT management criteria: results according to the SRS criteria for bracing studies - 2009 SOSORT Award Winner</TI>
<SO>Scoliosis</SO>
<YR>2009</YR>
<VL>4</VL>
<NO>1</NO>
<PG>19</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Negrini-2009b" MODIFIED="2015-05-30 15:56:06 -0400" MODIFIED_BY="Anne Lawson" NAME="Negrini 2009b" TYPE="JOURNAL_ARTICLE">
<AU>Negrini S, Grivas TB, Kotwicki T, Rigo M, Zaina F, the international Society on Scoliosis Orthopaedic and Rehabilitation Treatment (SOSORT)</AU>
<TI>Guidelines on "Standards of management of idiopathic scoliosis with corrective braces in everyday clinics and in clinical research": SOSORT Consensus 2008</TI>
<SO>Scoliosis</SO>
<YR>2009</YR>
<VL>4</VL>
<NO>1</NO>
<PG>2</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Negrini-2010b" MODIFIED="2015-05-30 16:05:58 -0400" MODIFIED_BY="Anne Lawson" NAME="Negrini 2010b" TYPE="JOURNAL_ARTICLE">
<AU>Negrini S, Minozzi S, Bettany-Saltikov J, Zaina F, Chockalingam N, Grivas TB, et al</AU>
<TI>Braces for idiopathic scoliosis in adolescents</TI>
<SO>Spine</SO>
<YR>2010</YR>
<VL>35</VL>
<NO>13</NO>
<PG>1285-93</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Negrini-2012" MODIFIED="2015-05-29 10:29:00 -0400" MODIFIED_BY="Anne Lawson" NAME="Negrini 2012" TYPE="JOURNAL_ARTICLE">
<AU>Negrini S, Aulisa AG, Aulisa L, Circo AB, de Mauroy JC, Durmala J, et al</AU>
<TI>2011 SOSORT guidelines: Orthopaedic and Rehabilitation treatment of idiopathic scoliosis during growth</TI>
<SO>Scoliosis</SO>
<YR>2012</YR>
<VL>7</VL>
<NO>1</NO>
<PG>3</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Negrini-2014" MODIFIED="2015-05-29 10:30:37 -0400" MODIFIED_BY="Anne Lawson" NAME="Negrini 2014" TYPE="JOURNAL_ARTICLE">
<AU>Negrini S</AU>
<TI>Evidence in adolescent idiopathic scoliosis treatment</TI>
<SO>European Journal of Physical and Rehabilitation Medicine</SO>
<YR>2014</YR>
<VL>50</VL>
<NO>1</NO>
<PG>100</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Noonan-1997" MODIFIED="2009-11-10 17:38:44 -0500" MODIFIED_BY="VEP  " NAME="Noonan 1997" TYPE="JOURNAL_ARTICLE">
<AU>Noonan KJ, Dolan LA, Jacobson WC, Weinstein SL</AU>
<TI>Long-term psychosocial characteristics of patients treated for idiopathic scoliosis</TI>
<SO>Journal of Pediatric Orthopaedics</SO>
<YR>1997</YR>
<VL>17</VL>
<NO>6</NO>
<PG>712-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Odermatt-2003" MODIFIED="2009-11-10 17:38:59 -0500" MODIFIED_BY="VEP  " NAME="Odermatt 2003" TYPE="JOURNAL_ARTICLE">
<AU>Odermatt D, Mathieu PA, Beausejour M, Labelle H, Aubin CE</AU>
<TI>Electromyography of scoliotic patients treated with a brace</TI>
<SO>Journal of Orthopaedic Research</SO>
<YR>2003</YR>
<VL>21</VL>
<NO>5</NO>
<PG>931-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Parent-2005" MODIFIED="2009-11-10 17:39:24 -0500" MODIFIED_BY="VEP  " NAME="Parent 2005" TYPE="JOURNAL_ARTICLE">
<AU>Parent S, Newton PO, Wenger DR</AU>
<TI>Adolescent idiopathic scoliosis: etiology, anatomy, natural history, and bracing</TI>
<SO>Instructional Course Lectures</SO>
<YR>2005</YR>
<VL>54</VL>
<PG>529-36</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Pehrsson-1992" NAME="Pehrsson 1992" TYPE="JOURNAL_ARTICLE">
<AU>Pehrsson K, Larsson S, Oden A, Nachemson A</AU>
<TI>Long-term follow-up of patients with untreated scoliosis. A study of mortality, causes of death, and symptoms</TI>
<SO>Spine</SO>
<YR>1992</YR>
<VL>17</VL>
<NO>9</NO>
<PG>1091-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Pehrsson-2001" NAME="Pehrsson 2001" TYPE="JOURNAL_ARTICLE">
<AU>Pehrsson K, Danielsson A, Nachemson A</AU>
<TI>Pulmonary function in adolescent idiopathic scoliosis: a 25 year follow up after surgery or start of brace treatment</TI>
<SO>Thorax</SO>
<YR>2001</YR>
<VL>56</VL>
<NO>5</NO>
<PG>388-93</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Reichel-2003" MODIFIED="2009-11-10 17:39:40 -0500" MODIFIED_BY="VEP  " NAME="Reichel 2003" TYPE="JOURNAL_ARTICLE">
<AU>Reichel D, Schanz J</AU>
<TI>Developmental psychological aspects of scoliosis treatment</TI>
<SO>Pediatric Rehabilitation</SO>
<YR>2003</YR>
<VL>6</VL>
<NO>3-4</NO>
<PG>221-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-RevMan-2012" MODIFIED="2015-06-10 13:20:35 -0400" MODIFIED_BY="[Empty name]" NAME="RevMan 2012" TYPE="COMPUTER_PROGRAM">
<TI>Review Manager (RevMan)</TI>
<YR>2012</YR>
<EN>5.2</EN>
<PB>The Nordic Cochrane Centre, The Cochrane Collaboration</PB>
<CY>Copenhagen</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Richards-2005" MODIFIED="2009-03-17 11:10:14 -0400" MODIFIED_BY="[Empty name]" NAME="Richards 2005" TYPE="JOURNAL_ARTICLE">
<AU>Richards BS, Bernstein RM, D'Amato CR, Thompson GH</AU>
<TI>Standardization of criteria for adolescent idiopathic scoliosis brace studies: SRS Committee on Bracing and Nonoperative Management</TI>
<SO>Spine</SO>
<YR>2005</YR>
<VL>30</VL>
<NO>18</NO>
<PG>2068-75</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Rigo-2006" MODIFIED="2015-05-30 16:04:37 -0400" MODIFIED_BY="Anne Lawson" NAME="Rigo 2006" TYPE="JOURNAL_ARTICLE">
<AU>Rigo M, Negrini S, Weiss HR, Grivas TB, Maruyama T, Kotwicki T, et al</AU>
<TI>SOSORT consensus paper on brace action: TLSO biomechanics of correction (investigating the rationale for force vector selection)</TI>
<SO>Scoliosis</SO>
<YR>2006</YR>
<VL>1</VL>
<PG>11</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Romano-2008" MODIFIED="2009-11-10 17:39:57 -0500" MODIFIED_BY="VEP  " NAME="Romano 2008" TYPE="JOURNAL_ARTICLE">
<AU>Romano M, Negrini S</AU>
<TI>Manual therapy as a conservative treatment for adolescent idiopathic scoliosis: a systematic review</TI>
<SO>Scoliosis</SO>
<YR>2008</YR>
<VL>3</VL>
<PG>2</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Romano-2012" MODIFIED="2015-05-29 10:34:10 -0400" MODIFIED_BY="Anne Lawson" NAME="Romano 2012" TYPE="COCHRANE_REVIEW">
<AU>Romano M, Minozzi S, Bettany-Saltikov J, Zaina F, Chockalingam N, Kotwicki T, et al</AU>
<TI>Exercises for adolescent idiopathic scoliosis</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2012</YR>
<NO>8</NO>
<IDENTIFIERS MODIFIED="2015-05-29 10:34:10 -0400" MODIFIED_BY="Anne Lawson">
<IDENTIFIER MODIFIED="2015-05-29 10:34:10 -0400" MODIFIED_BY="Anne Lawson" TYPE="DOI" VALUE="10.1002/14651858.CD007837.pub2"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Romano-2013" MODIFIED="2015-05-29 10:34:39 -0400" MODIFIED_BY="Anne Lawson" NAME="Romano 2013" TYPE="JOURNAL_ARTICLE">
<AU>Romano M, Minozzi S, Zaina F, Saltikov JB, Chockalingam N, Kotwicki T, et al</AU>
<TI>Exercises for adolescent idiopathic scoliosis: a Cochrane systematic review</TI>
<SO>Spine</SO>
<YR>2013</YR>
<VL>38</VL>
<NO>14</NO>
<PG>E883-93</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Shekelle-1994" MODIFIED="2008-06-17 10:37:39 -0400" MODIFIED_BY="[Empty name]" NAME="Shekelle 1994" TYPE="JOURNAL_ARTICLE">
<AU>Shekelle PG, Andersson G, Bombardier C, Cherkin D, Deyo R, Keller R</AU>
<TI>A brief introduction to the critical reading of the clinical literature</TI>
<SO>Spine</SO>
<YR>1994</YR>
<VL>19</VL>
<PG>2028S-31S</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Smania-2008" MODIFIED="2009-11-11 16:44:50 -0500" MODIFIED_BY="VEP  " NAME="Smania 2008" TYPE="JOURNAL_ARTICLE">
<AU>Smania N, Picelli A, Romano M, Negrini S</AU>
<TI>Neurophysiological basis of rehabilitation of adolescent idiopathic scoliosis</TI>
<SO>Disability Rehabilitation</SO>
<YR>2008</YR>
<VL>30</VL>
<NO>10</NO>
<PG>763-71</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Smith-2003" MODIFIED="2015-05-29 10:35:11 -0400" MODIFIED_BY="Anne Lawson" NAME="Smith 2003" TYPE="JOURNAL_ARTICLE">
<AU>Smith GC, Pell JP</AU>
<TI>Parachute use to prevent death and major trauma related to gravitational challenge: systematic review of randomised controlled trials</TI>
<SO>BMJ</SO>
<YR>2003</YR>
<VL>327</VL>
<NO>7429</NO>
<PG>1459-61</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-SRS-2006" MODIFIED="2015-05-30 17:47:03 -0400" MODIFIED_BY="Anne Lawson" NAME="SRS 2006" TYPE="OTHER">
<AU>Edgar M; Scoliosis Research Society</AU>
<TI>Brace wear compliance</TI>
<SO>www.srs.org/professionals/bracing_manuals/section3.pdf</SO>
<YR>(accessed 30 June 2007)</YR>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Stokes-2006" MODIFIED="2015-05-29 10:36:19 -0400" MODIFIED_BY="Anne Lawson" NAME="Stokes 2006" TYPE="JOURNAL_ARTICLE">
<AU>Stokes IA, Burwell RG, Dangerfield PH</AU>
<TI>Biomechanical spinal growth modulation and progressive adolescent scoliosis - a test of the 'vicious cycle' pathogenetic hypothesis: summary of an electronic focus group debate of the IBSE</TI>
<SO>Scoliosis</SO>
<YR>2006</YR>
<VL>1</VL>
<PG>16</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Ugwonali-2004" MODIFIED="2009-11-10 17:40:15 -0500" MODIFIED_BY="VEP  " NAME="Ugwonali 2004" TYPE="JOURNAL_ARTICLE">
<AU>Ugwonali OF, Lomas G, Choe JC, Hyman JE, Lee FY, Vitale MG, et al</AU>
<TI>Effect of bracing on the quality of life of adolescents with idiopathic scoliosis</TI>
<SO>Spine Journal</SO>
<YR>2004</YR>
<VL>4</VL>
<NO>3</NO>
<PG>254-60</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-van-Tulder-2003" MODIFIED="2015-06-05 13:16:01 -0400" MODIFIED_BY="[Empty name]" NAME="van Tulder 2003" TYPE="JOURNAL_ARTICLE">
<AU>van Tulder M, Furlan A, Bombardier C, Bouter L, Editorial Board Cochrane Back Review Group</AU>
<TI>Updated method guidelines for systemic reviews in the Cochrane Collaboration Back Review Group</TI>
<SO>Spine</SO>
<YR>2003</YR>
<VL>28</VL>
<NO>12</NO>
<PG>1290-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Varni-2001" MODIFIED="2015-05-29 10:37:11 -0400" MODIFIED_BY="Anne Lawson" NAME="Varni 2001" TYPE="JOURNAL_ARTICLE">
<AU>Varni JW, Seid M, Kurtin PS</AU>
<TI>PedsQL 4.0: reliability and validity of the Pediatric Quality of Life Inventory version 4.0 generic core scales in healthy and patient populations</TI>
<SO>Medical Care</SO>
<YR>2001</YR>
<VL>39</VL>
<PG>800-12</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Varni-2003" MODIFIED="2015-05-29 10:37:58 -0400" MODIFIED_BY="Anne Lawson" NAME="Varni 2003" TYPE="JOURNAL_ARTICLE">
<AU>Varni JW, Burwinkle TM, Seid M, Skarr D</AU>
<TI>The PedsQL 4.0 as a pediatric population health measure: feasibility, reliability, and validity</TI>
<SO>Ambulatory Pediatrics</SO>
<YR>2003</YR>
<VL>3</VL>
<PG>329-41</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Vasiliadis-2006" MODIFIED="2015-05-30 16:03:16 -0400" MODIFIED_BY="Anne Lawson" NAME="Vasiliadis 2006" TYPE="JOURNAL_ARTICLE">
<AU>Vasiliadis E, Grivas TB, Savvidou O, Triantafyllopoulos G</AU>
<TI>The influence of brace on quality of life of adolescents with idiopathic scoliosis</TI>
<SO>Studies in Health Technology &amp; Informatics</SO>
<YR>2006</YR>
<VL>123</VL>
<PG>352-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Vasiliadis-2008" MODIFIED="2015-05-29 10:39:44 -0400" MODIFIED_BY="Anne Lawson" NAME="Vasiliadis 2008" TYPE="JOURNAL_ARTICLE">
<AU>Vasiliadis ES, Grivas TB</AU>
<TI>Quality of life after conservative treatment of adolescent idiopathic scoliosis</TI>
<SO>Studies in Health Technology and Informatics</SO>
<YR>2008</YR>
<VL>135</VL>
<PG>409-13</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Ware-1992" MODIFIED="2015-05-29 10:40:33 -0400" MODIFIED_BY="Anne Lawson" NAME="Ware 1992" TYPE="JOURNAL_ARTICLE">
<AU>Ware JE Jr, Sherbourne CD</AU>
<TI>The MOS 36-item Short-Form Health Survey (SF-36). I. Conceptual framework and item selection</TI>
<SO>Medical Care</SO>
<YR>1992</YR>
<VL>30</VL>
<PG>473-83</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Weinstein-2003" NAME="Weinstein 2003" TYPE="JOURNAL_ARTICLE">
<AU>Weinstein SL, Dolan LA, Spratt KF, Peterson KK, Spoonamore MJ, Ponseti IV</AU>
<TI>Health and function of patients with untreated idiopathic scoliosis: a 50-year natural history study</TI>
<SO>JAMA</SO>
<YR>2003</YR>
<VL>289</VL>
<NO>5</NO>
<PG>559-67</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Wells-2008" MODIFIED="2015-05-29 10:41:29 -0400" MODIFIED_BY="Anne Lawson" NAME="Wells 2008" TYPE="OTHER">
<AU>Wells GA, Shea B, O'Connell D, Peterson J, Welch V, Losos M, et al</AU>
<TI>The Newcastle-Ottawa Scale (NOS) for assessing the quality of non-randomised studies in meta-analyses</TI>
<SO>www.ohri.ca/programs/clinical_epidemiology/oxford.htm</SO>
<YR>(accessed 29 May 2015)</YR>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Wiklund-1991" MODIFIED="2015-05-29 10:41:56 -0400" MODIFIED_BY="Anne Lawson" NAME="Wiklund 1991" TYPE="JOURNAL_ARTICLE">
<AU>Wiklund I, Karlberg J</AU>
<TI>Evaluation of quality of life in clinical trials. Selecting quality-of-life measures</TI>
<SO>Controlled Clinical Trials</SO>
<YR>1991</YR>
<VL>12</VL>
<NO>20</NO>
<PG>4S-16S</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Zaina-2009" MODIFIED="2015-05-29 10:42:20 -0400" MODIFIED_BY="Anne Lawson" NAME="Zaina 2009" TYPE="JOURNAL_ARTICLE">
<AU>Zaina F, Negrini S, Atanasio S, Fusco C, Romano M, Negrini A</AU>
<TI>Specific exercises performed in the period of brace weaning can avoid loss of correction in Adolescent Idiopathic Scoliosis (AIS) patients: winner of SOSORT's 2008 Award for Best Clinical Paper</TI>
<SO>Scoliosis</SO>
<YR>2009</YR>
<VL>4</VL>
<PG>8</PG>
<IDENTIFIERS/>
</REFERENCE>
</ADDITIONAL_REFERENCES>
<OTHER_VERSIONS_REFERENCES MODIFIED="2015-05-30 16:06:06 -0400" MODIFIED_BY="Anne Lawson">
<REFERENCE ID="REF-Negrini-2010a" MODIFIED="2015-05-30 16:06:06 -0400" MODIFIED_BY="Anne Lawson" NAME="Negrini 2010a" TYPE="COCHRANE_REVIEW">
<AU>Negrini S, Minozzi S, Bettany-Saltikov J, Zaina F, Chockalingam N, Grivas TB, et al</AU>
<TI>Braces for idiopathic scoliosis in adolescents</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2010</YR>
<NO>1</NO>
<IDENTIFIERS MODIFIED="2014-04-11 13:56:42 -0400" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2014-04-11 13:56:34 -0400" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1002/14651858.CD006850.pub2"/>
</IDENTIFIERS>
</REFERENCE>
</OTHER_VERSIONS_REFERENCES>
<PENDING_REFERENCES/>
</OTHER_REFERENCES>
</STUDIES_AND_REFERENCES>
<CHARACTERISTICS_OF_STUDIES MODIFIED="2015-06-10 12:24:36 -0400" MODIFIED_BY="[Empty name]">
<CHARACTERISTICS_OF_INCLUDED_STUDIES MODIFIED="2015-06-10 12:24:36 -0400" MODIFIED_BY="[Empty name]" SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<INCLUDED_CHAR MODIFIED="2015-06-10 12:24:36 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Bunge-2010">
<CHAR_METHODS MODIFIED="2015-05-30 16:43:48 -0400" MODIFIED_BY="Anne Lawson">
<P>Multicentre randomized controlled trial</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2015-05-30 16:43:47 -0400" MODIFIED_BY="Anne Lawson">
<P>Girls and boys aged 8-15 years whose diagnosis of AIS has been established by an orthopaedic surgeon, who have not yet been treated by bracing or surgery, and for whom further growth of physical height is still expected based on medical examination and maturation characteristics (Risser sign) established by X-ray</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2015-06-10 12:24:36 -0400" MODIFIED_BY="[Empty name]">
<P>
<B>Experimental:</B> Boston brace worn every day 12-23 hours. Participants are usually advised to attend physiotherapy for muscle training and to correct body posture. Physiotherapy alone is not expected to prevent further progression of the curvature. Therefore, participants were free to choose whether they would attend physiotherapy. Although some orthopaedic surgeons prefer to keep people in the hospital for a few days to allow them to become used to wearing the brace, others do not. The orthopaedic surgeons were allowed to apply their own protocol concerning this hospital admission</P>
<P>
<B>Control: </B>people in the control group were not initially braced during the 2-year study, unless their curvature shows more than 10° progression compared with the Cobb angle at inclusion. In this case, the orthopaedic surgeon, participants, and their parents could decide to start brace treatment. The participants in the control group were allowed to attend physiotherapy if they want to, because physiotherapy alone would not prevent further progression of the curvature</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2015-05-30 16:43:46 -0400" MODIFIED_BY="Anne Lawson">
<P>Progression in Cobb angle</P>
<P>Health-related quality of life</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2015-05-30 16:43:46 -0400" MODIFIED_BY="Anne Lawson">
<P>Study failed in the recruitment phase</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2015-06-05 13:04:32 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Coillard-2012">
<CHAR_METHODS MODIFIED="2015-05-30 16:43:45 -0400" MODIFIED_BY="Anne Lawson">
<P>Randomized controlled trial</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2015-05-30 16:43:44 -0400" MODIFIED_BY="Anne Lawson">
<P>68 participants diagnosed with AIS and with a Cobb angle 15-30°. Mean age: 12.2 years</P>
<P>Radiological confirmation of absence of significant pathological malformation of the spine. All participants had no prior treatment for scoliosis</P>
<P>All participants had a suspected high risk of progression: 1. family history of scoliosis or other well knows prognostic factors (Risser, age, menstruation status, etc.) or 2) confirmed progression (Cobb angle increase of 5° in the last 6 months), or both</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2015-06-05 13:04:32 -0400" MODIFIED_BY="[Empty name]">
<P>
<B>Experimental:</B> Dynamic SpineCor brace orthosis, which uses a specific Corrective Movement dependant of the type of the curve. The curve specific Corrective Movement is performed and the orthosis is applied according to definitions contained in the SpineCor Assistant Software. All the health providers need to complete a 2-phase training course before fitting the SpineCor orthosis</P>
<P>In order to obtain the neuromuscular integration, the orthosis must maintain and amplify the corrective movement over time. The orthosis must be worn 20 hours a day for a minimum of 18 months to create a neuromuscular integration of the Corrective Movement through active bio-feedback (36 participants)</P>
<P>
<B>Control:</B> no treatment (32 participants)</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2015-06-05 13:04:32 -0400" MODIFIED_BY="[Empty name]">
<P>Percentage of participants who had &#8804; 5° curve progression and the percentage of participants who had &#8805; 6° progression</P>
<P>Percentage of participants who had surgery recommendation/under gone before skeletal maturity</P>
<P>Percentage of participants with curves &gt; 45º at maturity<BR/>
</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2015-05-30 16:43:44 -0400" MODIFIED_BY="Anne Lawson">
<P>Follow-up: 5 years post randomization</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2015-05-30 16:43:42 -0400" MODIFIED_BY="Anne Lawson" STUDY_ID="STD-Lou-2012">
<CHAR_METHODS MODIFIED="2015-05-30 16:43:42 -0400" MODIFIED_BY="Anne Lawson">
<P>Randomized controlled trial</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2015-05-30 16:43:42 -0400" MODIFIED_BY="Anne Lawson">
<P>12 participants, 10 girls, mean age 12.5 ± 1.7 years, no further description</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2015-05-30 16:43:42 -0400" MODIFIED_BY="Anne Lawson">
<P>
<B>Experimental:</B> Smart brace for 12 months and then rigid standard brace for 12 months. Smart brace was a standard brace with a microcomputer system, a force transducer, and an air-bladder control system. The force transducer and air bladder were embedded at the main pressure pad area to control the interface pressure. When the mean pad pressure was less than the target range over a period of 15 minutes the microcomputer system directed air to be pumped into the bladder. Similarly, when the mean pad pressure was greater than the target range over a period of 15 minutes, the microcomputer system caused air to be released from the bladder. The pressure control was to maintain the interface pressure at the prescribed level during daily activities (6 participants)</P>
<P>
<B>Control:</B> standard rigid brace for 24 months (6 participants)</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2015-05-30 16:43:42 -0400" MODIFIED_BY="Anne Lawson">
<P>Cobb angle </P>
<P>Risk of progression</P>
<P>Brace wear time</P>
<P>Quality of brace wear</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2015-05-30 16:43:42 -0400" MODIFIED_BY="Anne Lawson">
<P>Follow-up: 3 years after the brace treatment was finished</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2015-05-30 16:43:41 -0400" MODIFIED_BY="Anne Lawson" STUDY_ID="STD-Lusini-2013">
<CHAR_METHODS MODIFIED="2015-05-30 16:43:41 -0400" MODIFIED_BY="Anne Lawson">
<P>Prospective controlled cohort study</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2015-05-30 16:43:39 -0400" MODIFIED_BY="Anne Lawson">
<P>57 participants with AIS, at least 1 curve of &#8805; 45°, Risser stage 0-4, aged &gt;above 10 years, first evaluation between 1 March 2003 and 31 December 2010, surgical intervention refused</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2015-05-30 16:43:39 -0400" MODIFIED_BY="Anne Lawson">
<P>
<B>Experimental:</B> full-time brace treatment. Participants who arrived in the institute for the first time in 2003 and 2004 were treated with either a Risser cast followed by the Lyon brace, or only the Lyon brace if they refused a cast; from 2005, participants were treated with the Sforzesco brace. Braces had to be worn full-time (24 hours per day for the Risser cast, 23 hours for the Lyon/Sforzesco brace for the first year, followed by a 1-hour reduction for 6 months, and then a weaning of 2 hours every 6 months. Physiotherapy-specific exercises were prescribed systematically to all participants, which were to be performed twice a week. Participants were prescribed Scientific Exercises Approach to Scoliosis exercises to be followed up and updated regularly in the institute (every 3 months - exercised then performed autonomously at home or followed by a trainer) (39 participants)</P>
<P>
<B>Control:</B> treatment not accepted or came for a second opinion only (18 participants)</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2015-05-30 16:43:39 -0400" MODIFIED_BY="Anne Lawson">
<P>Percentage of participants to have radiographically improved above the measurement error (5°). We considered the main curve (if there was &gt; 1 curve, both were considered main curves if their difference was less than 11° Cobb) and the maximum curve. Treatment success (improvement of &#8805; 5°)</P>
<P>Treatment failure (either progression of &#8805; 5°, or fusion)</P>
<P>Clinical and radiographic results: TRACE for aesthetics, Cobb degrees, angle of trunk rotation, and plumb-line distances for the sagittal plane</P>
<P>Compliance</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2015-05-30 16:43:39 -0400" MODIFIED_BY="Anne Lawson">
<P>Both per-protocol (treatment completers) and ITT analysis (all participants enrolled, including drop-outs) performed length of follow-up: 2-9 years</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2015-05-30 16:43:38 -0400" MODIFIED_BY="Anne Lawson" STUDY_ID="STD-Nachemson-1995">
<CHAR_METHODS MODIFIED="2015-05-30 16:43:38 -0400" MODIFIED_BY="Anne Lawson">
<P>Multicentre multinational prospective cohort trial. 8 centres enrolled; included only physicians who firmly believed in effectiveness of bracing or who firmly believed that bracing was ineffective. Each physician consecutively enrolled all participants who met the inclusion criteria and prescribed only 1 treatment</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2015-05-30 16:43:38 -0400" MODIFIED_BY="Anne Lawson">
<P>240 girls with AIS; mean age 12.7 years; Cobb angle 30-35°: 42% in the observation group and 65% in the brace group; Cobb angle 20-29°: 58% in the observation group and 35% in the brace group; menarche at baseline: 57% in the observation group and 41% in the brace group; imbalance: 46% in the observational group and 25% in the brace group</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2015-05-30 16:43:37 -0400" MODIFIED_BY="Anne Lawson">
<P>
<B>Experimental:</B> plastic brace worn for at least 16 hours per day (111 girls)</P>
<P>
<B>Control:</B> observation only (who received the electrical stimulation referred to in the text) (129 girls)</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2015-05-30 16:43:37 -0400" MODIFIED_BY="Anne Lawson">
<P>Failure of treatment as measured by an increase of the curve of &#8805; 6°, noted on 2 consecutive roentgenograms performed every 4 months before menarche and every 6 months after menarche</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2015-05-30 16:43:37 -0400" MODIFIED_BY="Anne Lawson">
<P>Length of follow-up: 16 years after maturity</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2015-06-10 12:24:25 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Weinstein-2013a">
<CHAR_METHODS MODIFIED="2015-05-30 16:43:36 -0400" MODIFIED_BY="Anne Lawson">
<P>Multicentre study with a randomized cohort and a preference cohort</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2015-06-10 12:24:25 -0400" MODIFIED_BY="[Empty name]">
<P>242 adolescents at high risk of AIS progression. 116 adolescents (48%) in the randomized cohort and 126 (52%) adolescents in the preference cohort. The 2 cohorts differed significantly at baseline with respect to sex distribution, the interval between the diagnosis of scoliosis and trial enrolment, the person who first noticed the scoliosis, and the largest degree of apical vertebral rotation</P>
<P>Mean age: 12.7 ± 1 years; girls: 91.3%; Cobb angle: 30.4 ± 6.0°; Risser grade 0: 69.2%, 1: 26.7%, 2: 11.2%, 3: 2.1%, 4-5: 0.8%. Thoracic curve: 24.6%, thoracolumbar 13.2%, lumbar 3.7, double major 28.5%, double thoracic 9.1%, thoracic and thoracolumbar 13.6%, triple 7.5%</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2015-05-30 16:43:36 -0400" MODIFIED_BY="Anne Lawson">
<P>
<B>Experimental:</B> brace: rigid thoracolumbosacral orthosis, prescribed to be worn for a minimum of 18 hours per day. Participating centres prescribed the type of brace used in their normal clinical practice (146 adolescents)</P>
<P>
<B>Control: </B>observation, no specific treatment (96 adolescents)</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2015-05-30 16:43:35 -0400" MODIFIED_BY="Anne Lawson">
<P>Curve progression of &#8805; 50°Treatment failure</P>
<P>Skeletal maturity without this degree </P>
<P>Treatment success (skeletal maturity defined as a Risser grade of 4 for girls or 5 for boys)</P>
<P>Quality of life (Pediatric Quality of Live Inventory: PedsQL)</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2015-05-30 16:43:34 -0400" MODIFIED_BY="Anne Lawson">
<P>Length of follow-up: mean 23 months</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2015-05-30 17:16:25 -0400" MODIFIED_BY="Anne Lawson" STUDY_ID="STD-Weinstein-2013b">
<CHAR_METHODS MODIFIED="2015-05-30 16:43:33 -0400" MODIFIED_BY="Anne Lawson">
<P>Randomized cohort of a multicentre study including also a preference cohort</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2015-05-30 16:43:33 -0400" MODIFIED_BY="Anne Lawson">
<P>116 adolescents at high risk of AIS progression; mean age: 12.7 ± 1; girls: 87%; Cobb angle: 30.5 ± 6.0°; Risser grade 0: 61%, 1: 22%, 2: 15%, 3: 2%, 4: 1%. Thoracic curve 22%, thoracolumbar 15%, lumbar 3%, double major 33%, double thoracic 5%, thoracic and thoracolumbar 17%, triple 6%</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2015-05-30 16:43:33 -0400" MODIFIED_BY="Anne Lawson">
<P>
<B>Experimental:</B> brace: rigid thoracolumbosacral orthosis, prescribed to be worn for a minimum of 18 hours per day. Participating centres prescribed the type of brace used in their normal clinical practice (51 participants)</P>
<P>
<B>Control:</B> observation: no specific treatment (65 participants)</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2015-05-30 17:16:25 -0400" MODIFIED_BY="Anne Lawson">
<P>Curve progression of &#8805; 50°</P>
<P>Treatment failure</P>
<P>Skeletal maturity without this degree</P>
<P>Treatment success (skeletal maturity defined as a Risser grade of 4 for girls or 5 for boys)</P>
<P>Quality of life (Pediatric Quality of Live Inventory: PedsQL)</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2015-05-30 16:43:31 -0400" MODIFIED_BY="Anne Lawson">
<P>Length of follow-up: mean 23 months</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2015-05-30 17:17:19 -0400" MODIFIED_BY="Anne Lawson" STUDY_ID="STD-Wong-2008">
<CHAR_METHODS MODIFIED="2015-05-30 16:43:30 -0400" MODIFIED_BY="Anne Lawson">
<P>Randomized controlled trial</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2015-05-30 16:43:30 -0400" MODIFIED_BY="Anne Lawson">
<P>43 female adolescents diagnosed with progressive scoliosis. Mean age 12.5 years; mean menarche at 12.7 years. Mean Risser's sign 0.4; mean AP Cobb angle: 24.3°</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2015-05-30 16:43:29 -0400" MODIFIED_BY="Anne Lawson">
<P>
<B>Experimental:</B> dynamic orthosis named 'SpineCor' worn for 23 hours per day (22 adolescents)</P>
<P>
<B>Control:</B> conventional rigid spinal orthosis worn 23 hours per day (21 adolescents)</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2015-05-30 17:17:19 -0400" MODIFIED_BY="Anne Lawson">
<P>Adolescents acceptance assessed by feedback questionnaire with 16 questions in visual analogue scale</P>
<P>Progression of scoliosis as measured by percentage of participants without documented progression and still managed with the original treatment</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2015-05-30 16:43:28 -0400" MODIFIED_BY="Anne Lawson">
<P>Length of follow-up: 18 months</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<FOOTNOTES>
<P>AIS: adolescent idiopathic scoliosis; ITT: intention to treat.</P>
</FOOTNOTES>
</CHARACTERISTICS_OF_INCLUDED_STUDIES>
<CHARACTERISTICS_OF_EXCLUDED_STUDIES MODIFIED="2015-05-31 05:59:23 -0400" MODIFIED_BY="Anne Lawson" SORT_BY="STUDY">
<EXCLUDED_CHAR MODIFIED="2015-05-30 16:43:27 -0400" MODIFIED_BY="Anne Lawson" STUDY_ID="STD-Allington-1996">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-05-30 16:43:27 -0400" MODIFIED_BY="Anne Lawson">
<P>Retrospective</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-05-30 16:43:27 -0400" MODIFIED_BY="Anne Lawson" STUDY_ID="STD-Andersen-2006">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-05-30 16:43:27 -0400" MODIFIED_BY="Anne Lawson">
<P>Follow-up retrospective non-controlled study</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-05-30 16:43:27 -0400" MODIFIED_BY="Anne Lawson" STUDY_ID="STD-Avellanet-2006">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-05-30 16:43:27 -0400" MODIFIED_BY="Anne Lawson">
<P>Case report</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-05-30 16:43:27 -0400" MODIFIED_BY="Anne Lawson" STUDY_ID="STD-Bassett-1986">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-05-30 16:43:27 -0400" MODIFIED_BY="Anne Lawson">
<P>Retrospective</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-05-30 16:43:27 -0400" MODIFIED_BY="Anne Lawson" STUDY_ID="STD-Bassett-1987">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-05-30 16:43:27 -0400" MODIFIED_BY="Anne Lawson">
<P>Retrospective</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-05-30 16:43:27 -0400" MODIFIED_BY="Anne Lawson" STUDY_ID="STD-Becchetti-1990">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-05-30 16:43:27 -0400" MODIFIED_BY="Anne Lawson">
<P>Not controlled</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-05-30 16:43:27 -0400" MODIFIED_BY="Anne Lawson" STUDY_ID="STD-Bernard-2005">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-05-30 16:43:27 -0400" MODIFIED_BY="Anne Lawson">
<P>Retrospective</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-05-30 16:43:27 -0400" MODIFIED_BY="Anne Lawson" STUDY_ID="STD-Bowen-2001">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-05-30 16:43:27 -0400" MODIFIED_BY="Anne Lawson">
<P>Prospective with retrospective control group</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-05-30 16:43:27 -0400" MODIFIED_BY="Anne Lawson" STUDY_ID="STD-Brox-2012">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-05-30 16:43:27 -0400" MODIFIED_BY="Anne Lawson">
<P>Prospective uncontrolled study</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-05-30 16:43:27 -0400" MODIFIED_BY="Anne Lawson" STUDY_ID="STD-Bullmann-2004">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-05-30 16:43:27 -0400" MODIFIED_BY="Anne Lawson">
<P>Prospective no control group</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-05-30 16:43:27 -0400" MODIFIED_BY="Anne Lawson" STUDY_ID="STD-Bunge-2007">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-05-30 16:43:27 -0400" MODIFIED_BY="Anne Lawson">
<P>Retrospective</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-05-30 16:43:27 -0400" MODIFIED_BY="Anne Lawson" STUDY_ID="STD-Bunnell-1980">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-05-30 16:43:27 -0400" MODIFIED_BY="Anne Lawson">
<P>Prospective without control group</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-05-30 16:43:27 -0400" MODIFIED_BY="Anne Lawson" STUDY_ID="STD-Carman-1985">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-05-30 16:43:27 -0400" MODIFIED_BY="Anne Lawson">
<P>Retrospective</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-05-30 16:43:27 -0400" MODIFIED_BY="Anne Lawson" STUDY_ID="STD-Carr-1980">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-05-30 16:43:27 -0400" MODIFIED_BY="Anne Lawson">
<P>Follow-up retrospective not controlled study</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-05-30 16:43:26 -0400" MODIFIED_BY="Anne Lawson" STUDY_ID="STD-Cassella-1991">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-05-30 16:43:26 -0400" MODIFIED_BY="Anne Lawson">
<P>Review</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-05-30 16:43:26 -0400" MODIFIED_BY="Anne Lawson" STUDY_ID="STD-Castro-2003">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-05-30 16:43:26 -0400" MODIFIED_BY="Anne Lawson">
<P>Not controlled</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-05-30 16:43:26 -0400" MODIFIED_BY="Anne Lawson" STUDY_ID="STD-Charlopain-1998">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-05-30 16:43:26 -0400" MODIFIED_BY="Anne Lawson">
<P>Retrospective</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-05-30 16:43:26 -0400" MODIFIED_BY="Anne Lawson" STUDY_ID="STD-Cheung-2007">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-05-30 16:43:26 -0400" MODIFIED_BY="Anne Lawson">
<P>Retrospective</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-05-30 16:43:26 -0400" MODIFIED_BY="Anne Lawson" STUDY_ID="STD-Coillard-1999">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-05-30 16:43:26 -0400" MODIFIED_BY="Anne Lawson">
<P>Not controlled</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-05-30 16:43:26 -0400" MODIFIED_BY="Anne Lawson" STUDY_ID="STD-Coillard-2003">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-05-30 16:43:26 -0400" MODIFIED_BY="Anne Lawson">
<P>Not controlled</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-05-30 16:43:26 -0400" MODIFIED_BY="Anne Lawson" STUDY_ID="STD-Coillard-2007">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-05-30 16:43:26 -0400" MODIFIED_BY="Anne Lawson">
<P>Not controlled</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-05-30 16:43:26 -0400" MODIFIED_BY="Anne Lawson" STUDY_ID="STD-Cottalorda-2005">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-05-30 16:43:26 -0400" MODIFIED_BY="Anne Lawson">
<P>No end growth results</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-05-30 16:43:26 -0400" MODIFIED_BY="Anne Lawson" STUDY_ID="STD-D_x0027_Amato-2001">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-05-30 16:43:26 -0400" MODIFIED_BY="Anne Lawson">
<P>Prospective with literature control group</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-05-30 16:43:26 -0400" MODIFIED_BY="Anne Lawson" STUDY_ID="STD-Danielsson-2001a">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-05-30 16:43:26 -0400" MODIFIED_BY="Anne Lawson">
<P>Follow-up with healthy control group</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-05-30 16:43:26 -0400" MODIFIED_BY="Anne Lawson" STUDY_ID="STD-Danielsson-2001b">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-05-30 16:43:26 -0400" MODIFIED_BY="Anne Lawson">
<P>Follow-up of retrospective study</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-05-30 16:43:26 -0400" MODIFIED_BY="Anne Lawson" STUDY_ID="STD-Danielsson-2006">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-05-30 16:43:26 -0400" MODIFIED_BY="Anne Lawson">
<P>Follow-up with no relevant data</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-05-30 16:43:26 -0400" MODIFIED_BY="Anne Lawson" STUDY_ID="STD-Den-Boer-1999">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-05-30 16:43:26 -0400" MODIFIED_BY="Anne Lawson">
<P>Prospective controlled with historical cohort</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-05-30 16:43:26 -0400" MODIFIED_BY="Anne Lawson" STUDY_ID="STD-Dickson-1999a">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-05-30 16:43:26 -0400" MODIFIED_BY="Anne Lawson">
<P>Review</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-05-30 16:43:26 -0400" MODIFIED_BY="Anne Lawson" STUDY_ID="STD-Dobosiewicz-2006">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-05-30 16:43:26 -0400" MODIFIED_BY="Anne Lawson">
<P>Not controlled</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-05-30 16:43:26 -0400" MODIFIED_BY="Anne Lawson" STUDY_ID="STD-Durham-1990">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-05-30 16:43:26 -0400" MODIFIED_BY="Anne Lawson">
<P>Retrospective not controlled</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-05-30 16:43:26 -0400" MODIFIED_BY="Anne Lawson" STUDY_ID="STD-Dziri-1991">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-05-30 16:43:26 -0400" MODIFIED_BY="Anne Lawson">
<P>Retrospective not controlled</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-05-30 16:43:26 -0400" MODIFIED_BY="Anne Lawson" STUDY_ID="STD-Ebenbichler-1994">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-05-30 16:43:26 -0400" MODIFIED_BY="Anne Lawson">
<P>Review</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-05-30 16:43:26 -0400" MODIFIED_BY="Anne Lawson" STUDY_ID="STD-Edmonsson-1977">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-05-30 16:43:26 -0400" MODIFIED_BY="Anne Lawson">
<P>Follow-up not controlled</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-05-30 16:43:25 -0400" MODIFIED_BY="Anne Lawson" STUDY_ID="STD-El-Sayyad-1994">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-05-30 16:43:25 -0400" MODIFIED_BY="Anne Lawson">
<P>Randomized controlled trial including juvenile and adolescent idiopathic scoliosis (6-16 years)</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-05-30 16:43:25 -0400" MODIFIED_BY="Anne Lawson" STUDY_ID="STD-Emans-1986">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-05-30 16:43:25 -0400" MODIFIED_BY="Anne Lawson">
<P>Retrospective not controlled</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-05-30 16:43:25 -0400" MODIFIED_BY="Anne Lawson" STUDY_ID="STD-Feise-2005">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-05-30 16:43:25 -0400" MODIFIED_BY="Anne Lawson">
<P>Not relevant topic</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-05-30 16:43:25 -0400" MODIFIED_BY="Anne Lawson" STUDY_ID="STD-Fernandez_x002d_Feliberti-1995">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-05-30 16:43:25 -0400" MODIFIED_BY="Anne Lawson">
<P>Prospective controlled including both juvenile and adolescent idiopathic scoliosis (8-15 years old)</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-05-31 05:59:23 -0400" MODIFIED_BY="Anne Lawson" STUDY_ID="STD-Fisher-1987">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-05-31 05:59:23 -0400" MODIFIED_BY="Anne Lawson">
<P>Prospective with retrospective control group. Controls were matched to pa
rticipants</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-05-30 16:43:25 -0400" MODIFIED_BY="Anne Lawson" STUDY_ID="STD-F_x00e4_llstr_x00f6_m-1986">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-05-30 16:43:25 -0400" MODIFIED_BY="Anne Lawson">
<P>Follow-up with no relevant data</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-05-30 16:43:25 -0400" MODIFIED_BY="Anne Lawson" STUDY_ID="STD-Gabos-2004">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-05-30 16:43:25 -0400" MODIFIED_BY="Anne Lawson">
<P>Retrospective</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-05-30 16:43:25 -0400" MODIFIED_BY="Anne Lawson" STUDY_ID="STD-Gammon-2010">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-05-30 16:43:25 -0400" MODIFIED_BY="Anne Lawson">
<P>Retrospective study</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-05-30 16:43:25 -0400" MODIFIED_BY="Anne Lawson" STUDY_ID="STD-Geissele-1991">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-05-30 16:43:25 -0400" MODIFIED_BY="Anne Lawson">
<P>Not relevant topic</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-05-30 16:43:25 -0400" MODIFIED_BY="Anne Lawson" STUDY_ID="STD-Gepstein-2002">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-05-30 16:43:25 -0400" MODIFIED_BY="Anne Lawson">
<P>Retrospective controlled study</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-05-30 16:43:25 -0400" MODIFIED_BY="Anne Lawson" STUDY_ID="STD-Goldberg-1981">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-05-30 16:43:25 -0400" MODIFIED_BY="Anne Lawson">
<P>Retrospective</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-05-30 16:43:25 -0400" MODIFIED_BY="Anne Lawson" STUDY_ID="STD-Gore-1981">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-05-30 16:43:25 -0400" MODIFIED_BY="Anne Lawson">
<P>Screening, not controlled</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-05-30 16:43:25 -0400" MODIFIED_BY="Anne Lawson" STUDY_ID="STD-Green-1986">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-05-30 16:43:25 -0400" MODIFIED_BY="Anne Lawson">
<P>Retrospective, not controlled</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-05-30 16:43:25 -0400" MODIFIED_BY="Anne Lawson" STUDY_ID="STD-Griffet-1996">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-05-30 16:43:25 -0400" MODIFIED_BY="Anne Lawson">
<P>Not controlled</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-05-30 16:43:25 -0400" MODIFIED_BY="Anne Lawson" STUDY_ID="STD-Griffet-2000">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-05-30 16:43:25 -0400" MODIFIED_BY="Anne Lawson">
<P>Not relevant topic</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-05-30 16:43:25 -0400" MODIFIED_BY="Anne Lawson" STUDY_ID="STD-Grivas-2003">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-05-30 16:43:25 -0400" MODIFIED_BY="Anne Lawson">
<P>Retrospective with literature control group. Included also 2 participants &lt; 10 years</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-05-30 16:43:25 -0400" MODIFIED_BY="Anne Lawson" STUDY_ID="STD-Haefeli-2006">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-05-30 16:43:25 -0400" MODIFIED_BY="Anne Lawson">
<P>Retrospective follow up</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-05-30 16:43:25 -0400" MODIFIED_BY="Anne Lawson" STUDY_ID="STD-Hanks-1998">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-05-30 16:43:25 -0400" MODIFIED_BY="Anne Lawson">
<P>Retrospective</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-05-30 16:43:25 -0400" MODIFIED_BY="Anne Lawson" STUDY_ID="STD-Hassan-1983">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-05-30 16:43:25 -0400" MODIFIED_BY="Anne Lawson">
<P>Not controlled</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-05-30 16:43:25 -0400" MODIFIED_BY="Anne Lawson" STUDY_ID="STD-Hensinger-2007">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-05-30 16:43:25 -0400" MODIFIED_BY="Anne Lawson">
<P>Editorial</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-05-30 16:43:24 -0400" MODIFIED_BY="Anne Lawson" STUDY_ID="STD-Hopf-1985">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-05-30 16:43:24 -0400" MODIFIED_BY="Anne Lawson">
<P>Case series</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-05-30 16:43:24 -0400" MODIFIED_BY="Anne Lawson" STUDY_ID="STD-Howard-1998">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-05-30 16:43:24 -0400" MODIFIED_BY="Anne Lawson">
<P>Retrospective</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-05-30 16:43:24 -0400" MODIFIED_BY="Anne Lawson" STUDY_ID="STD-Janicki-2007">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-05-30 16:43:24 -0400" MODIFIED_BY="Anne Lawson">
<P>Retrospective</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-05-30 16:43:24 -0400" MODIFIED_BY="Anne Lawson" STUDY_ID="STD-Kahanovitz-1982">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-05-30 16:43:24 -0400" MODIFIED_BY="Anne Lawson">
<P>Not controlled</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-05-30 16:43:24 -0400" MODIFIED_BY="Anne Lawson" STUDY_ID="STD-Karol-2001">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-05-30 16:43:24 -0400" MODIFIED_BY="Anne Lawson">
<P>Not controlled</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-05-30 16:43:24 -0400" MODIFIED_BY="Anne Lawson" STUDY_ID="STD-Katz-1997">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-05-30 16:43:24 -0400" MODIFIED_BY="Anne Lawson">
<P>Retrospective</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-05-30 16:43:24 -0400" MODIFIED_BY="Anne Lawson" STUDY_ID="STD-Keiser-1976">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-05-30 16:43:24 -0400" MODIFIED_BY="Anne Lawson">
<P>Retrospective</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-05-30 16:43:24 -0400" MODIFIED_BY="Anne Lawson" STUDY_ID="STD-Kohashi-1996">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-05-30 16:43:24 -0400" MODIFIED_BY="Anne Lawson">
<P>Not relevant topic</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-05-30 16:43:24 -0400" MODIFIED_BY="Anne Lawson" STUDY_ID="STD-Korovessis-2000">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-05-30 16:43:24 -0400" MODIFIED_BY="Anne Lawson">
<P>Prospective not controlled</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-05-30 16:43:24 -0400" MODIFIED_BY="Anne Lawson" STUDY_ID="STD-Kotwicki-2002">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-05-30 16:43:24 -0400" MODIFIED_BY="Anne Lawson">
<P>Retrospective not controlled</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-05-30 16:43:23 -0400" MODIFIED_BY="Anne Lawson" STUDY_ID="STD-Kumano-1992">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-05-30 16:43:23 -0400" MODIFIED_BY="Anne Lawson">
<P>Not controlled</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-05-30 16:43:23 -0400" MODIFIED_BY="Anne Lawson" STUDY_ID="STD-Little-2000">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-05-30 16:43:23 -0400" MODIFIED_BY="Anne Lawson">
<P>Retrospective</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-05-30 16:43:23 -0400" MODIFIED_BY="Anne Lawson" STUDY_ID="STD-Lonstein-1994">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-05-30 16:43:23 -0400" MODIFIED_BY="Anne Lawson">
<P>Retrospective</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-05-30 16:43:23 -0400" MODIFIED_BY="Anne Lawson" STUDY_ID="STD-Lou-2004">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-05-30 16:43:23 -0400" MODIFIED_BY="Anne Lawson">
<P>Not controlled</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-05-30 16:43:23 -0400" MODIFIED_BY="Anne Lawson" STUDY_ID="STD-Lou-2005">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-05-30 16:43:23 -0400" MODIFIED_BY="Anne Lawson">
<P>Not controlled</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-05-30 16:43:23 -0400" MODIFIED_BY="Anne Lawson" STUDY_ID="STD-Mellencamp-1977">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-05-30 16:43:23 -0400" MODIFIED_BY="Anne Lawson">
<P>Retrospective</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-05-30 16:43:23 -0400" MODIFIED_BY="Anne Lawson" STUDY_ID="STD-Miller-1984">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-05-30 16:43:23 -0400" MODIFIED_BY="Anne Lawson">
<P>Retrospective</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-05-30 16:43:23 -0400" MODIFIED_BY="Anne Lawson" STUDY_ID="STD-Minami-1982">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-05-30 16:43:23 -0400" MODIFIED_BY="Anne Lawson">
<P>Not controlled</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-05-30 16:43:23 -0400" MODIFIED_BY="Anne Lawson" STUDY_ID="STD-Miyasaki-1980">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-05-30 16:43:23 -0400" MODIFIED_BY="Anne Lawson">
<P>Not controlled</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-05-30 16:43:23 -0400" MODIFIED_BY="Anne Lawson" STUDY_ID="STD-Moe-1970">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-05-30 16:43:23 -0400" MODIFIED_BY="Anne Lawson">
<P>Retrospective</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-05-30 16:43:23 -0400" MODIFIED_BY="Anne Lawson" STUDY_ID="STD-Mollon-1984">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-05-30 16:43:23 -0400" MODIFIED_BY="Anne Lawson">
<P>No primary research paper</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-05-30 16:43:23 -0400" MODIFIED_BY="Anne Lawson" STUDY_ID="STD-Montgomery-1989">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-05-30 16:43:23 -0400" MODIFIED_BY="Anne Lawson">
<P>Retrospective controlled</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-05-30 16:43:23 -0400" MODIFIED_BY="Anne Lawson" STUDY_ID="STD-Montgomery-1990">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-05-30 16:43:23 -0400" MODIFIED_BY="Anne Lawson">
<P>Retrospective</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-05-30 16:43:23 -0400" MODIFIED_BY="Anne Lawson" STUDY_ID="STD-Mouilleseaux-1984">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-05-30 16:43:23 -0400" MODIFIED_BY="Anne Lawson">
<P>No primary research paper</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-05-30 16:43:23 -0400" MODIFIED_BY="Anne Lawson" STUDY_ID="STD-Mounier-1984">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-05-30 16:43:23 -0400" MODIFIED_BY="Anne Lawson">
<P>No primary research paper</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-05-30 16:43:23 -0400" MODIFIED_BY="Anne Lawson" STUDY_ID="STD-Negrini-2007">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-05-30 16:43:23 -0400" MODIFIED_BY="Anne Lawson">
<P>Prospective with retrospective control group</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-05-30 16:43:22 -0400" MODIFIED_BY="Anne Lawson" STUDY_ID="STD-Noonan-1996">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-05-30 16:43:22 -0400" MODIFIED_BY="Anne Lawson">
<P>Juvenile participants</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-05-30 16:43:22 -0400" MODIFIED_BY="Anne Lawson" STUDY_ID="STD-O_x0027_Donnell-1988">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-05-30 16:43:22 -0400" MODIFIED_BY="Anne Lawson">
<P>Retrospective</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-05-30 16:43:22 -0400" MODIFIED_BY="Anne Lawson" STUDY_ID="STD-O_x0027_Neill-2005">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-05-30 16:43:22 -0400" MODIFIED_BY="Anne Lawson">
<P>Retrospective</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-05-30 16:43:22 -0400" MODIFIED_BY="Anne Lawson" STUDY_ID="STD-Park-1977">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-05-30 16:43:22 -0400" MODIFIED_BY="Anne Lawson">
<P>Retrospective</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-05-30 16:43:22 -0400" MODIFIED_BY="Anne Lawson" STUDY_ID="STD-Peltonen-1988">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-05-30 16:43:22 -0400" MODIFIED_BY="Anne Lawson">
<P>Not controlled</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-05-30 16:43:22 -0400" MODIFIED_BY="Anne Lawson" STUDY_ID="STD-Peterson-1995">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-05-30 16:43:22 -0400" MODIFIED_BY="Anne Lawson">
<P>Prospective not relevant</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-05-30 16:43:22 -0400" MODIFIED_BY="Anne Lawson" STUDY_ID="STD-Pham-2007">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-05-30 16:43:22 -0400" MODIFIED_BY="Anne Lawson">
<P>Retrospective</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-05-30 16:43:22 -0400" MODIFIED_BY="Anne Lawson" STUDY_ID="STD-Piazza-1990">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-05-30 16:43:22 -0400" MODIFIED_BY="Anne Lawson">
<P>Retrospective</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-05-30 16:43:22 -0400" MODIFIED_BY="Anne Lawson" STUDY_ID="STD-Price-1990">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-05-30 16:43:22 -0400" MODIFIED_BY="Anne Lawson">
<P>Prospective not controlled</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-05-30 16:43:22 -0400" MODIFIED_BY="Anne Lawson" STUDY_ID="STD-Price-1997">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-05-30 16:43:22 -0400" MODIFIED_BY="Anne Lawson">
<P>Not controlled</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-05-30 16:43:22 -0400" MODIFIED_BY="Anne Lawson" STUDY_ID="STD-Rahman-2005">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-05-30 16:43:22 -0400" MODIFIED_BY="Anne Lawson">
<P>Prospective not controlled</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-05-30 16:43:22 -0400" MODIFIED_BY="Anne Lawson" STUDY_ID="STD-Rigo-2003">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-05-30 16:43:22 -0400" MODIFIED_BY="Anne Lawson">
<P>Literature control group</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-05-30 16:43:22 -0400" MODIFIED_BY="Anne Lawson" STUDY_ID="STD-Roach-1998">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-05-30 16:43:22 -0400" MODIFIED_BY="Anne Lawson">
<P>Retrospective</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-05-30 16:43:22 -0400" MODIFIED_BY="Anne Lawson" STUDY_ID="STD-Robinson-1996">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-05-30 16:43:22 -0400" MODIFIED_BY="Anne Lawson">
<P>Juvenile scoliosis</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-05-30 16:43:22 -0400" MODIFIED_BY="Anne Lawson" STUDY_ID="STD-Rosso-1998">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-05-30 16:43:22 -0400" MODIFIED_BY="Anne Lawson">
<P>Not controlled</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-05-30 16:43:22 -0400" MODIFIED_BY="Anne Lawson" STUDY_ID="STD-Rowe-1997">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-05-30 16:43:22 -0400" MODIFIED_BY="Anne Lawson">
<P>Meta-analysis</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-05-30 16:43:21 -0400" MODIFIED_BY="Anne Lawson" STUDY_ID="STD-Schmitt-1987">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-05-30 16:43:21 -0400" MODIFIED_BY="Anne Lawson">
<P>Juvenile and adolescent idiopathic scoliosis (7-16 years old)</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-05-30 16:43:21 -0400" MODIFIED_BY="Anne Lawson" STUDY_ID="STD-Schraudebach-1974">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-05-30 16:43:21 -0400" MODIFIED_BY="Anne Lawson">
<P>Juvenile and adolescent idiopathic scoliosis</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-05-30 16:43:21 -0400" MODIFIED_BY="Anne Lawson" STUDY_ID="STD-Scoloveno-1990">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-05-30 16:43:21 -0400" MODIFIED_BY="Anne Lawson">
<P>Retrospective</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-05-30 16:43:21 -0400" MODIFIED_BY="Anne Lawson" STUDY_ID="STD-Shirado-1995">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-05-30 16:43:21 -0400" MODIFIED_BY="Anne Lawson">
<P>Not relevant topic</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-05-30 16:43:21 -0400" MODIFIED_BY="Anne Lawson" STUDY_ID="STD-Skaggs-1996">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-05-30 16:43:21 -0400" MODIFIED_BY="Anne Lawson">
<P>Letter to the editor</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-05-30 16:43:21 -0400" MODIFIED_BY="Anne Lawson" STUDY_ID="STD-Spoonamore-2004">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-05-30 16:43:21 -0400" MODIFIED_BY="Anne Lawson">
<P>Retrospective</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-05-30 16:43:21 -0400" MODIFIED_BY="Anne Lawson" STUDY_ID="STD-Tonseth-2005">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-05-30 16:43:21 -0400" MODIFIED_BY="Anne Lawson">
<P>Retrospective</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-05-30 16:43:21 -0400" MODIFIED_BY="Anne Lawson" STUDY_ID="STD-Trivedi-2001">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-05-30 16:43:21 -0400" MODIFIED_BY="Anne Lawson">
<P>Retrospective not controlled</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-05-30 16:43:21 -0400" MODIFIED_BY="Anne Lawson" STUDY_ID="STD-Upadhyay-1995">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-05-30 16:43:21 -0400" MODIFIED_BY="Anne Lawson">
<P>Not controlled</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-05-30 16:43:21 -0400" MODIFIED_BY="Anne Lawson" STUDY_ID="STD-Van-Rhijn-2002">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-05-30 16:43:21 -0400" MODIFIED_BY="Anne Lawson">
<P>Not controlled</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-05-30 16:43:21 -0400" MODIFIED_BY="Anne Lawson" STUDY_ID="STD-Van-Rhijn-2003">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-05-30 16:43:21 -0400" MODIFIED_BY="Anne Lawson">
<P>Retrospective</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-05-30 16:43:21 -0400" MODIFIED_BY="Anne Lawson" STUDY_ID="STD-Veldhuizen-2002">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-05-30 16:43:21 -0400" MODIFIED_BY="Anne Lawson">
<P>Not controlled</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-05-30 16:43:21 -0400" MODIFIED_BY="Anne Lawson" STUDY_ID="STD-Vijvermans-2004">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-05-30 16:43:21 -0400" MODIFIED_BY="Anne Lawson">
<P>Retrospective</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-05-30 16:43:21 -0400" MODIFIED_BY="Anne Lawson" STUDY_ID="STD-Watanabe-2005">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-05-30 16:43:21 -0400" MODIFIED_BY="Anne Lawson">
<P>Not relevant topic</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-05-30 16:43:21 -0400" MODIFIED_BY="Anne Lawson" STUDY_ID="STD-Weigert-2006">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-05-30 16:43:21 -0400" MODIFIED_BY="Anne Lawson">
<P>Retrospective</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-05-30 16:43:21 -0400" MODIFIED_BY="Anne Lawson" STUDY_ID="STD-Weiss-2003">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-05-30 16:43:21 -0400" MODIFIED_BY="Anne Lawson">
<P>Retrospective</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-05-30 16:43:20 -0400" MODIFIED_BY="Anne Lawson" STUDY_ID="STD-Weiss-2005">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-05-30 16:43:20 -0400" MODIFIED_BY="Anne Lawson">
<P>Case series</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-05-30 16:43:20 -0400" MODIFIED_BY="Anne Lawson" STUDY_ID="STD-Weiss-2006">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-05-30 16:43:20 -0400" MODIFIED_BY="Anne Lawson">
<P>No brace treatment</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-05-30 16:43:20 -0400" MODIFIED_BY="Anne Lawson" STUDY_ID="STD-Wessberg-2011">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-05-30 16:43:20 -0400" MODIFIED_BY="Anne Lawson">
<P>Incomplete data, only congress abstract</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-05-30 16:43:20 -0400" MODIFIED_BY="Anne Lawson" STUDY_ID="STD-Wever-2002">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-05-30 16:43:20 -0400" MODIFIED_BY="Anne Lawson">
<P>Not controlled</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-05-30 16:43:20 -0400" MODIFIED_BY="Anne Lawson" STUDY_ID="STD-Wiley-2000">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-05-30 16:43:20 -0400" MODIFIED_BY="Anne Lawson">
<P>Retrospective</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-05-30 16:43:20 -0400" MODIFIED_BY="Anne Lawson" STUDY_ID="STD-Willers-1993">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-05-30 16:43:20 -0400" MODIFIED_BY="Anne Lawson">
<P>Follow-up not controlled</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-05-30 16:43:20 -0400" MODIFIED_BY="Anne Lawson" STUDY_ID="STD-Yamauchi-1986">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-05-30 16:43:20 -0400" MODIFIED_BY="Anne Lawson">
<P>Retrospective follow-up</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-05-30 16:43:20 -0400" MODIFIED_BY="Anne Lawson" STUDY_ID="STD-Ylikoski-1989">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-05-30 16:43:20 -0400" MODIFIED_BY="Anne Lawson">
<P>Not controlled</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-05-30 16:43:20 -0400" MODIFIED_BY="Anne Lawson" STUDY_ID="STD-Yrjonen-2006">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-05-30 16:43:20 -0400" MODIFIED_BY="Anne Lawson">
<P>Prospective with retrospective control group</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<FOOTNOTES/>
</CHARACTERISTICS_OF_EXCLUDED_STUDIES>
<CHARACTERISTICS_OF_AWAITING_STUDIES MODIFIED="2015-06-09 05:05:18 -0400" MODIFIED_BY="[Empty name]" SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<AWAITING_CHAR MODIFIED="2015-06-09 05:02:04 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Guo-2014">
<CHAR_METHODS MODIFIED="2015-06-09 04:58:19 -0400" MODIFIED_BY="[Empty name]">
<P>Randomized Controlled Trial according to SRS standardized criteria</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2015-06-09 04:57:23 -0400" MODIFIED_BY="[Empty name]">
<P>34 females, 10-14 years of age</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2015-06-09 04:56:58 -0400" MODIFIED_BY="[Empty name]">
<P>SpineCor elastic brace versus rigid brace</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2015-06-09 05:02:04 -0400" MODIFIED_BY="[Empty name]">
<P>35.0% progressed in SpineCor versus 5.6% in Rigid brace (P = 0.026).</P>
<P>At the 4 years follow-up after skeletally maturity, 29.4% of successfully treated by rigid brace showed progression, versus 38.5% in SpineCor (P &gt; 0.05).</P>
<P>For both groups, the primary curves were slightly improved at the time of brace weaning, but additionally increased at the latest follow-up</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</AWAITING_CHAR>
<AWAITING_CHAR MODIFIED="2015-06-09 05:05:18 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Wiemann-2014">
<CHAR_METHODS MODIFIED="2015-06-09 05:03:55 -0400" MODIFIED_BY="[Empty name]">
<P>Randomized (by location) Controlled Trial</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2015-06-09 05:03:51 -0400" MODIFIED_BY="[Empty name]">
<P>37 females, Risser 0, Codd degrees 15-25</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2015-06-09 05:05:18 -0400" MODIFIED_BY="[Empty name]">
<P>nighttime Charleston bending brace versus observation</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2015-06-09 05:04:37 -0400" MODIFIED_BY="[Empty name]">
<P>All patients in the observation group progressed to fulltime bracing threshold. In the nighttime bracing group, 29% of the patients did not progress to 25 degrees primary curve magnitude. Rate of progression to surgical magnitude was similar in the 2 groups.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</AWAITING_CHAR>
<FOOTNOTES/>
</CHARACTERISTICS_OF_AWAITING_STUDIES>
<CHARACTERISTICS_OF_ONGOING_STUDIES MODIFIED="2013-10-26 07:26:06 -0400" MODIFIED_BY="VEP  " SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<FOOTNOTES/>
</CHARACTERISTICS_OF_ONGOING_STUDIES>
</CHARACTERISTICS_OF_STUDIES>
<QUALITY_ITEMS MODIFIED="2015-05-30 17:18:52 -0400" MODIFIED_BY="Anne Lawson">
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-01" LEVEL="STUDY" MODIFIED="2015-05-30 16:43:46 -0400" MODIFIED_BY="Anne Lawson" NO="1">
<NAME>Random sequence generation (selection bias)</NAME>
<DESCRIPTION>
<P>Selection bias (biased allocation to interventions) due to inadequate generation of a randomised sequence</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-05-30 16:43:46 -0400" MODIFIED_BY="Anne Lawson" RESULT="YES" STUDY_ID="STD-Bunge-2010">
<DESCRIPTION>
<P>Computer-generated random numbers</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-05-30 16:43:44 -0400" MODIFIED_BY="Anne Lawson" RESULT="YES" STUDY_ID="STD-Coillard-2012">
<DESCRIPTION>
<P>Quote: "an independent controller based in Sainte-Justine Hospital in Montreal assigned the patients to the control and treated group based on a random computer generated number table"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-05-30 16:43:42 -0400" MODIFIED_BY="Anne Lawson" RESULT="UNKNOWN" STUDY_ID="STD-Lou-2012">
<DESCRIPTION>
<P>No information reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-05-30 16:43:39 -0400" MODIFIED_BY="Anne Lawson" RESULT="NO" STUDY_ID="STD-Lusini-2013">
<DESCRIPTION>
<P>Prospective cohort study</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-05-30 16:43:37 -0400" MODIFIED_BY="Anne Lawson" RESULT="NO" STUDY_ID="STD-Nachemson-1995">
<DESCRIPTION>
<P>Prospective cohort study</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-05-30 16:43:34 -0400" MODIFIED_BY="Anne Lawson" RESULT="NO" STUDY_ID="STD-Weinstein-2013a">
<DESCRIPTION>
<P>Observational study: participants chose the preferred treatment</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-05-30 16:43:31 -0400" MODIFIED_BY="Anne Lawson" RESULT="YES" STUDY_ID="STD-Weinstein-2013b">
<DESCRIPTION>
<P>Computer-generated assignment stratified according to curve type ( thoracic vs. all others)</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-05-30 16:43:28 -0400" MODIFIED_BY="Anne Lawson" RESULT="UNKNOWN" STUDY_ID="STD-Wong-2008">
<DESCRIPTION>
<P>Sequence generation not reported</P>
<P>Quote: "Forty-three subjects were recruited and randomly assigned to two groups"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-02" LEVEL="STUDY" MODIFIED="2015-05-30 16:43:46 -0400" MODIFIED_BY="Anne Lawson" NO="2">
<NAME>Allocation concealment (selection bias)</NAME>
<DESCRIPTION>
<P>Selection bias (biased allocation to interventions) due to inadequate concealment of allocations prior to assignment</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-05-30 16:43:46 -0400" MODIFIED_BY="Anne Lawson" RESULT="UNKNOWN" STUDY_ID="STD-Bunge-2010">
<DESCRIPTION>
<P>Information not reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-05-30 16:43:44 -0400" MODIFIED_BY="Anne Lawson" RESULT="YES" STUDY_ID="STD-Coillard-2012">
<DESCRIPTION>
<P>Quote: "an independent controller based in Sainte-Justine Hospital in Montreal assigned the patients to the control and treated group based on a random computer generated number table"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-05-30 16:43:42 -0400" MODIFIED_BY="Anne Lawson" RESULT="UNKNOWN" STUDY_ID="STD-Lou-2012">
<DESCRIPTION>
<P>No information reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-05-30 16:43:39 -0400" MODIFIED_BY="Anne Lawson" RESULT="NO" STUDY_ID="STD-Lusini-2013">
<DESCRIPTION>
<P>Prospective cohort study</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-05-30 16:43:37 -0400" MODIFIED_BY="Anne Lawson" RESULT="NO" STUDY_ID="STD-Nachemson-1995">
<DESCRIPTION>
<P>Prospective cohort study</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-05-30 16:43:34 -0400" MODIFIED_BY="Anne Lawson" RESULT="NO" STUDY_ID="STD-Weinstein-2013a">
<DESCRIPTION>
<P>Observational study: participants chose the preferred treatment</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-05-30 16:43:31 -0400" MODIFIED_BY="Anne Lawson" RESULT="UNKNOWN" STUDY_ID="STD-Weinstein-2013b">
<DESCRIPTION>
<P>No information reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-05-30 16:43:28 -0400" MODIFIED_BY="Anne Lawson" RESULT="UNKNOWN" STUDY_ID="STD-Wong-2008">
<DESCRIPTION>
<P>Not stated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-03" LEVEL="GROUP" MODIFIED="2013-07-15 02:35:28 -0400" MODIFIED_BY="[Empty name]" NO="3">
<NAME>Blinding (performance bias and detection bias)</NAME>
<DESCRIPTION>
<P>Performance bias or detection bias due to knowledge of the allocated interventions after assignment</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-03.03" NO="3">
<NAME>All outcomes- outcome assessors?</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-03.02" NO="2">
<NAME>All outcomes- providers?</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-03.01" NO="1">
<NAME>All outcomes- patients?</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-14" LEVEL="GROUP" MODIFIED="2015-05-30 17:18:35 -0400" MODIFIED_BY="Anne Lawson" NO="14">
<NAME>Blinding of participants and personnel (performance bias)</NAME>
<DESCRIPTION>
<P>Performance bias due to knowledge of the allocated interventions by participants and personnel during the study</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-14.02" NO="2">
<NAME>objective outcomes</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-14.01" NO="1">
<NAME>subjective outcomes</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-14.01" MODIFIED="2015-05-30 16:43:46 -0400" MODIFIED_BY="Anne Lawson" RESULT="NO" STUDY_ID="STD-Bunge-2010">
<DESCRIPTION>
<P>Blinding of participants and orthopaedic surgeons for treatment was not possible for the type of intervention</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-14.02" MODIFIED="2015-05-30 16:43:46 -0400" MODIFIED_BY="Anne Lawson" RESULT="YES" STUDY_ID="STD-Bunge-2010">
<DESCRIPTION>
<P>Blinding of participants and orthopaedic surgeons for treatment was not possible for the type of intervention but outcome were unlikely to be biased by lack of blinding</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-14.01" MODIFIED="2015-05-30 16:43:44 -0400" MODIFIED_BY="Anne Lawson" RESULT="NO" STUDY_ID="STD-Coillard-2012">
<DESCRIPTION>
<P>Blinding of participants not possible for the type of interventions compared (brace vs. no treatment)</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-14.02" MODIFIED="2015-05-30 16:43:44 -0400" MODIFIED_BY="Anne Lawson" RESULT="YES" STUDY_ID="STD-Coillard-2012">
<DESCRIPTION>
<P>Blinding of participants not possible for the type of interventions compared (brace vs. no treatment), but outcomes unlikely to be influenced by lack of blinding</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-14.01" MODIFIED="2015-05-30 16:43:41 -0400" MODIFIED_BY="Anne Lawson" RESULT="UNKNOWN" STUDY_ID="STD-Lou-2012">
<DESCRIPTION>
<P>No information reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-14.02" MODIFIED="2015-05-30 16:43:41 -0400" MODIFIED_BY="Anne Lawson" RESULT="UNKNOWN" STUDY_ID="STD-Lou-2012">
<DESCRIPTION>
<P>No information reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-14.01" MODIFIED="2015-05-30 16:43:39 -0400" MODIFIED_BY="Anne Lawson" RESULT="NO" STUDY_ID="STD-Lusini-2013">
<DESCRIPTION>
<P>Blinding of participants not possible for the type of interventions compared (brace vs. no treatment)</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-14.02" MODIFIED="2015-05-30 16:43:39 -0400" MODIFIED_BY="Anne Lawson" RESULT="YES" STUDY_ID="STD-Lusini-2013">
<DESCRIPTION>
<P>Blinding of participants not possible for the type of interventions compared (brace vs. no treatment) but outcomes unlikely to be influenced by lack of blinding</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-14.01" MODIFIED="2015-05-30 16:43:36 -0400" MODIFIED_BY="Anne Lawson" RESULT="NO" STUDY_ID="STD-Nachemson-1995">
<DESCRIPTION>
<P>Blinding of participants not possible for the type of interventions compared (brace vs. no treatment)</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-14.02" MODIFIED="2015-05-30 16:43:36 -0400" MODIFIED_BY="Anne Lawson" RESULT="YES" STUDY_ID="STD-Nachemson-1995">
<DESCRIPTION>
<P>Blinding of participants not possible for the type of interventions compared (brace vs. no treatment) but outcomes unlikely to be influenced by lack of blinding</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-14.01" MODIFIED="2015-05-30 16:43:34 -0400" MODIFIED_BY="Anne Lawson" RESULT="NO" STUDY_ID="STD-Weinstein-2013a">
<DESCRIPTION>
<P>Blinding of participants and providers not possible for the type of the interventions compared (brace vs. no intervention)</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-14.02" MODIFIED="2015-05-30 16:43:33 -0400" MODIFIED_BY="Anne Lawson" RESULT="YES" STUDY_ID="STD-Weinstein-2013a">
<DESCRIPTION>
<P>Blinding of participants and providers not possible for the type of the interventions compared (brace vs. no intervention) but outcomes unlikely to be influenced by lack of blinding</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-14.01" MODIFIED="2015-05-30 16:43:31 -0400" MODIFIED_BY="Anne Lawson" RESULT="NO" STUDY_ID="STD-Weinstein-2013b">
<DESCRIPTION>
<P>Blinding of participants and providers not possible for the type of the interventions compared (brace vs. no intervention)</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-14.02" MODIFIED="2015-05-30 16:43:31 -0400" MODIFIED_BY="Anne Lawson" RESULT="YES" STUDY_ID="STD-Weinstein-2013b">
<DESCRIPTION>
<P>Blinding of participants and providers not possible for the type of the interventions compared (brace vs. no intervention) but outcomes unlikely to be influenced by lack of blinding</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-14.01" MODIFIED="2015-05-30 16:43:28 -0400" MODIFIED_BY="Anne Lawson" RESULT="NO" STUDY_ID="STD-Wong-2008">
<DESCRIPTION>
<P>Blinding of providers not possible for the type of interventions compared (rigid brace vs. dynamic SpineCor brace)</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-14.02" MODIFIED="2015-05-30 17:18:35 -0400" MODIFIED_BY="Anne Lawson" RESULT="NO" STUDY_ID="STD-Wong-2008">
<DESCRIPTION>
<P>Blinding of providers not possible for the type of interventions compared (rigid brace vs. dynamic SpineCor brace)</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-15" LEVEL="GROUP" MODIFIED="2015-05-30 16:43:46 -0400" MODIFIED_BY="Anne Lawson" NO="15">
<NAME>Blinding of outcome assessment (detection bias)</NAME>
<DESCRIPTION>
<P>Detection bias due to knowledge of the allocated interventions by outcome assessors</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-15.02" NO="2">
<NAME>objective outcomes</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-15.01" NO="1">
<NAME>subjective outcomes</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-15.01" MODIFIED="2015-05-30 16:43:46 -0400" MODIFIED_BY="Anne Lawson" RESULT="YES" STUDY_ID="STD-Bunge-2010">
<DESCRIPTION>
<P>Quote: "to ensure blinding of the primary outcome, the randomization status of the participants will not be disclosed to these two orthopedic surgeons, who judge the patient's Xrays"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-15.02" MODIFIED="2015-05-30 16:43:46 -0400" MODIFIED_BY="Anne Lawson" RESULT="YES" STUDY_ID="STD-Bunge-2010">
<DESCRIPTION>
<P>Quote: "To ensure blinding of the primary outcome, the randomization status of the participants will not be disclosed to these two orthopedic surgeons, who judge the patient's Xrays"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-15.01" MODIFIED="2015-05-30 16:43:44 -0400" MODIFIED_BY="Anne Lawson" RESULT="NO" STUDY_ID="STD-Coillard-2012">
<DESCRIPTION>
<P>Quote: "the measurements were done without being blinded to the treatment or control group status"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-15.02" MODIFIED="2015-05-30 16:43:44 -0400" MODIFIED_BY="Anne Lawson" RESULT="YES" STUDY_ID="STD-Coillard-2012">
<DESCRIPTION>
<P>Outcomes unlikely to be influenced by lack of blinding</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-15.01" MODIFIED="2015-05-30 16:43:41 -0400" MODIFIED_BY="Anne Lawson" RESULT="UNKNOWN" STUDY_ID="STD-Lou-2012">
<DESCRIPTION>
<P>No information reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-15.02" MODIFIED="2015-05-30 16:43:41 -0400" MODIFIED_BY="Anne Lawson" RESULT="YES" STUDY_ID="STD-Lou-2012">
<DESCRIPTION>
<P>No information reported; outcomes unlikely to be influenced by lack of blinding</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-15.01" MODIFIED="2015-05-30 16:43:39 -0400" MODIFIED_BY="Anne Lawson" RESULT="NO" STUDY_ID="STD-Lusini-2013">
<DESCRIPTION>
<P>Information about blinding of outcome assessor not reported but he was probably not blinded</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-15.02" MODIFIED="2015-05-30 16:43:39 -0400" MODIFIED_BY="Anne Lawson" RESULT="YES" STUDY_ID="STD-Lusini-2013">
<DESCRIPTION>
<P>Information about blinding of outcome assessor not reported but he was probably not blinded; but outcomes unlikely to be influenced by lack of blinding</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-15.01" MODIFIED="2015-05-30 16:43:36 -0400" MODIFIED_BY="Anne Lawson" RESULT="UNKNOWN" STUDY_ID="STD-Nachemson-1995">
<DESCRIPTION>
<P>No subjective outcomes measured</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-15.02" MODIFIED="2015-05-30 16:43:36 -0400" MODIFIED_BY="Anne Lawson" RESULT="YES" STUDY_ID="STD-Nachemson-1995">
<DESCRIPTION>
<P>Roentgenograms read by providers, but objective outcomes unlikely to be influenced by lack of blinding</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-15.01" MODIFIED="2015-05-30 16:43:33 -0400" MODIFIED_BY="Anne Lawson" RESULT="YES" STUDY_ID="STD-Weinstein-2013a">
<DESCRIPTION>
<P>Quote: "all radiographic evaluations and outcome determinations were made at the central coordinating centre by two readers who were unaware of the treatment assignment and the treatment received"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-15.02" MODIFIED="2015-05-30 16:43:33 -0400" MODIFIED_BY="Anne Lawson" RESULT="YES" STUDY_ID="STD-Weinstein-2013a">
<DESCRIPTION>
<P>Quote: "all radiographic evaluations and outcome determinations were made at the central coordinating centre by two readers who were unaware of the treatment assignment and the treatment received"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-15.01" MODIFIED="2015-05-30 16:43:31 -0400" MODIFIED_BY="Anne Lawson" RESULT="YES" STUDY_ID="STD-Weinstein-2013b">
<DESCRIPTION>
<P>Quote: "all radiographic evaluations and outcome determinations were made at the central coordinating centre by two readers who were unaware of the treatment assignment and the treatment received"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-15.02" MODIFIED="2015-05-30 16:43:31 -0400" MODIFIED_BY="Anne Lawson" RESULT="YES" STUDY_ID="STD-Weinstein-2013b">
<DESCRIPTION>
<P>Quote: "all radiographic evaluations and outcome determinations were made at the central coordinating centre by two readers who were unaware of the treatment assignment and the treatment received"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-15.01" MODIFIED="2015-05-30 16:43:28 -0400" MODIFIED_BY="Anne Lawson" RESULT="NO" STUDY_ID="STD-Wong-2008">
<DESCRIPTION>
<P>No blinding</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-15.02" MODIFIED="2015-05-30 16:43:28 -0400" MODIFIED_BY="Anne Lawson" RESULT="YES" STUDY_ID="STD-Wong-2008">
<DESCRIPTION>
<P>Information not reported; probably not blinded; outcomes unlikely to be influenced by lack of blinding</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-04" LEVEL="GROUP" MODIFIED="2015-05-30 16:43:46 -0400" MODIFIED_BY="Anne Lawson" NO="4">
<NAME>Incomplete outcome data (attrition bias)</NAME>
<DESCRIPTION>
<P>Attrition bias due to amount, nature or handling of incomplete outcome data</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-04.02" NO="2">
<NAME>were all randomized participants analyzed in the group to which they were allocated?</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-04.01" NO="1">
<NAME>were drop-out reported and equal between groups?</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2015-05-30 16:43:46 -0400" MODIFIED_BY="Anne Lawson" RESULT="UNKNOWN" STUDY_ID="STD-Bunge-2010">
<DESCRIPTION>
<P>Not applicable. Study failed in the recruitment phase</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.02" MODIFIED="2015-05-30 16:43:46 -0400" MODIFIED_BY="Anne Lawson" RESULT="UNKNOWN" STUDY_ID="STD-Bunge-2010">
<DESCRIPTION>
<P>Not applicable. Study failed in the recruitment phase</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2015-05-30 16:43:43 -0400" MODIFIED_BY="Anne Lawson" RESULT="NO" STUDY_ID="STD-Coillard-2012">
<DESCRIPTION>
<P>21 (15 (47%) from the control group and 6 (17%) from the brace group) participants were lost due to withdrawal from the study</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.02" MODIFIED="2015-05-30 16:43:43 -0400" MODIFIED_BY="Anne Lawson" RESULT="NO" STUDY_ID="STD-Coillard-2012">
<DESCRIPTION>
<P>Only per-protocol analysis performed</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2015-05-30 16:43:41 -0400" MODIFIED_BY="Anne Lawson" RESULT="YES" STUDY_ID="STD-Lou-2012">
<DESCRIPTION>
<P>No lost at follow-up</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.02" MODIFIED="2015-05-30 16:43:41 -0400" MODIFIED_BY="Anne Lawson" RESULT="YES" STUDY_ID="STD-Lou-2012">
<DESCRIPTION>
<P>No information reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2015-05-30 16:43:39 -0400" MODIFIED_BY="Anne Lawson" RESULT="NO" STUDY_ID="STD-Lusini-2013">
<DESCRIPTION>
<P>11 participants lost at follow-up (19.3%), unbalanced between groups: 7.7% in the experimental group, 44.4% in the control group</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.02" MODIFIED="2015-05-30 16:43:39 -0400" MODIFIED_BY="Anne Lawson" RESULT="YES" STUDY_ID="STD-Lusini-2013">
<DESCRIPTION>
<P>ITT analysis with worst-case analysis considering lost at follow-up as failure when the outcome "improvement" was addressed and as success when the outcome "scoliosis progression/fusion" was addressed</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2015-05-30 16:43:36 -0400" MODIFIED_BY="Anne Lawson" RESULT="NO" STUDY_ID="STD-Nachemson-1995">
<DESCRIPTION>
<P>7% lost at follow-up in the control group; 21% lost at follow-up in the experimental group</P>
<P>Comment: percentage unbalanced between groups, but worst-case analysis performed</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.02" MODIFIED="2015-05-30 16:43:36 -0400" MODIFIED_BY="Anne Lawson" RESULT="NO" STUDY_ID="STD-Nachemson-1995">
<DESCRIPTION>
<P>Quote: "the patients lost at follow-up were included in the survivorship analysis for the time they were in the study"</P>
<P>Quote: "the 23 patients who dropped out from the brace group were analysed in the worst-case analysis and considered as treatment failure"</P>
<P>Comment: only the participants who dropped out from the experimental group were included in the worst-case analysis</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2015-05-30 16:43:33 -0400" MODIFIED_BY="Anne Lawson" RESULT="YES" STUDY_ID="STD-Weinstein-2013a">
<DESCRIPTION>
<P>No lost at follow-up</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.02" MODIFIED="2015-05-30 16:43:33 -0400" MODIFIED_BY="Anne Lawson" RESULT="YES" STUDY_ID="STD-Weinstein-2013a">
<DESCRIPTION>
<P>No lost at follow-up</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2015-05-30 16:43:31 -0400" MODIFIED_BY="Anne Lawson" RESULT="YES" STUDY_ID="STD-Weinstein-2013b">
<DESCRIPTION>
<P>No lost at follow-up</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.02" MODIFIED="2015-05-30 16:43:31 -0400" MODIFIED_BY="Anne Lawson" RESULT="YES" STUDY_ID="STD-Weinstein-2013b">
<DESCRIPTION>
<P>No lost at follow-up</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2015-05-30 16:43:28 -0400" MODIFIED_BY="Anne Lawson" RESULT="YES" STUDY_ID="STD-Wong-2008">
<DESCRIPTION>
<P>No drop-outs</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.02" MODIFIED="2015-05-30 16:43:28 -0400" MODIFIED_BY="Anne Lawson" RESULT="YES" STUDY_ID="STD-Wong-2008">
<DESCRIPTION>
<P>No drop-outs</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-05" LEVEL="STUDY" MODIFIED="2015-05-30 16:43:46 -0400" MODIFIED_BY="Anne Lawson" NO="5">
<NAME>Selective reporting (reporting bias)</NAME>
<DESCRIPTION>
<P>Reporting bias due to selective outcome reporting</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-05-30 16:43:46 -0400" MODIFIED_BY="Anne Lawson" RESULT="UNKNOWN" STUDY_ID="STD-Bunge-2010">
<DESCRIPTION>
<P>Not applicable. Study failed in the recruitment phase</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-05-30 16:43:43 -0400" MODIFIED_BY="Anne Lawson" RESULT="YES" STUDY_ID="STD-Coillard-2012">
<DESCRIPTION>
<P>Results from all pre-specified outcomes were adequately reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-05-30 16:43:41 -0400" MODIFIED_BY="Anne Lawson" RESULT="YES" STUDY_ID="STD-Lou-2012">
<DESCRIPTION>
<P>Results from all pre-specified outcomes were adequately reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-05-30 16:43:39 -0400" MODIFIED_BY="Anne Lawson" RESULT="YES" STUDY_ID="STD-Lusini-2013">
<DESCRIPTION>
<P>Results from all pre-specified outcomes have been adequately reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-05-30 16:43:36 -0400" MODIFIED_BY="Anne Lawson" RESULT="YES" STUDY_ID="STD-Nachemson-1995">
<DESCRIPTION>
<P>Results from all pre-specified outcomes have been adequately reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-05-30 16:43:33 -0400" MODIFIED_BY="Anne Lawson" RESULT="YES" STUDY_ID="STD-Weinstein-2013a">
<DESCRIPTION>
<P>Results from all pre-specified outcomes have been adequately reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-05-30 16:43:31 -0400" MODIFIED_BY="Anne Lawson" RESULT="YES" STUDY_ID="STD-Weinstein-2013b">
<DESCRIPTION>
<P>Results from all pre-specified outcomes have been adequately reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-05-30 16:43:28 -0400" MODIFIED_BY="Anne Lawson" RESULT="YES" STUDY_ID="STD-Wong-2008">
<DESCRIPTION>
<P>Results from all pre-specified outcomes have been adequately reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-06" LEVEL="STUDY" MODIFIED="2008-11-30 05:39:24 -0500" MODIFIED_BY="[Empty name]" NO="6">
<NAME>Other bias</NAME>
<DESCRIPTION>
<P>Bias due to problems not covered elsewhere in the table</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-07" LEVEL="STUDY" MODIFIED="2015-05-30 17:18:52 -0400" MODIFIED_BY="Anne Lawson" NO="7">
<NAME>Groups similar at baseline</NAME>
<DESCRIPTION>
<P>Were the groups similar at baseline regarding the most important prognostic indicators?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-05-30 16:43:46 -0400" MODIFIED_BY="Anne Lawson" RESULT="UNKNOWN" STUDY_ID="STD-Bunge-2010">
<DESCRIPTION>
<P>Not applicable. Study failed in the recruitment phase</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-05-30 16:43:43 -0400" MODIFIED_BY="Anne Lawson" RESULT="YES" STUDY_ID="STD-Coillard-2012">
<DESCRIPTION>
<P>No significant difference at baseline</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-05-30 16:43:41 -0400" MODIFIED_BY="Anne Lawson" RESULT="UNKNOWN" STUDY_ID="STD-Lou-2012">
<DESCRIPTION>
<P>No information reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-05-30 16:43:39 -0400" MODIFIED_BY="Anne Lawson" RESULT="UNKNOWN" STUDY_ID="STD-Lusini-2013">
<DESCRIPTION>
<P>Data not reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-05-30 16:43:36 -0400" MODIFIED_BY="Anne Lawson" RESULT="NO" STUDY_ID="STD-Nachemson-1995">
<DESCRIPTION>
<P>Comparability of cohorts on the basis of the design or analysis: more participants with severe scoliosis (30-35° in the brace group (65% with brace vs. 42% with observation); fewer participants with imbalance in the brace group (25% with brace vs. 46% with observation); menarche at baseline: 41% with brace vs. 57% with observation</P>
<P>No adjustment for most important confounding factors</P>
<P>Comment: differences at the baseline were in favour of the control group</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-05-30 16:43:33 -0400" MODIFIED_BY="Anne Lawson" RESULT="YES" STUDY_ID="STD-Weinstein-2013a">
<DESCRIPTION>
<P>Quote: "propensity scores will be used to reduce the effect of treatment selection bias (due to nonrandomized treatment assignment and/or crossover) in the estimation of the treatment effect"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-05-30 16:43:31 -0400" MODIFIED_BY="Anne Lawson" RESULT="YES" STUDY_ID="STD-Weinstein-2013b">
<DESCRIPTION>
<P>There were no significant between-group differences at baseline</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-05-30 17:18:52 -0400" MODIFIED_BY="Anne Lawson" RESULT="YES" STUDY_ID="STD-Wong-2008">
<DESCRIPTION>
<P>Groups comparable for mean age, age at menarche, Risser's sign, AP Cobb angle, apical vertebral r
otation degrees, Trunk listing</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-08" LEVEL="STUDY" MODIFIED="2015-05-30 16:43:46 -0400" MODIFIED_BY="Anne Lawson" NO="8">
<NAME>Co-interventions</NAME>
<DESCRIPTION>
<P>Were co-interventions avoided or similar?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-05-30 16:43:46 -0400" MODIFIED_BY="Anne Lawson" RESULT="NO" STUDY_ID="STD-Bunge-2010">
<DESCRIPTION>
<P>The participants in the control group were allowed to attend physiotherapy if they want to</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-05-30 16:43:43 -0400" MODIFIED_BY="Anne Lawson" RESULT="UNKNOWN" STUDY_ID="STD-Coillard-2012">
<DESCRIPTION>
<P>Information not reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-05-30 16:43:41 -0400" MODIFIED_BY="Anne Lawson" RESULT="UNKNOWN" STUDY_ID="STD-Lou-2012">
<DESCRIPTION>
<P>No information reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-05-30 16:43:39 -0400" MODIFIED_BY="Anne Lawson" RESULT="NO" STUDY_ID="STD-Lusini-2013">
<DESCRIPTION>
<P>Physiotherapy prescribed only to the experimental group</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-05-30 16:43:36 -0400" MODIFIED_BY="Anne Lawson" RESULT="UNKNOWN" STUDY_ID="STD-Nachemson-1995">
<DESCRIPTION>
<P>Not reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-05-30 16:43:33 -0400" MODIFIED_BY="Anne Lawson" RESULT="UNKNOWN" STUDY_ID="STD-Weinstein-2013a">
<DESCRIPTION>
<P>Information not reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-05-30 16:43:30 -0400" MODIFIED_BY="Anne Lawson" RESULT="UNKNOWN" STUDY_ID="STD-Weinstein-2013b">
<DESCRIPTION>
<P>Information not reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-05-30 16:43:28 -0400" MODIFIED_BY="Anne Lawson" RESULT="UNKNOWN" STUDY_ID="STD-Wong-2008">
<DESCRIPTION>
<P>Information about co-intervention not reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-09" LEVEL="STUDY" MODIFIED="2015-05-30 16:43:46 -0400" MODIFIED_BY="Anne Lawson" NO="9">
<NAME>Compliance with intervention</NAME>
<DESCRIPTION>
<P>Was compliance acceptable in all groups?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-05-30 16:43:46 -0400" MODIFIED_BY="Anne Lawson" RESULT="UNKNOWN" STUDY_ID="STD-Bunge-2010">
<DESCRIPTION>
<P>Not applicable. Study failed in the recruitment phase</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-05-30 16:43:43 -0400" MODIFIED_BY="Anne Lawson" RESULT="UNKNOWN" STUDY_ID="STD-Coillard-2012">
<DESCRIPTION>
<P>Information not reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-05-30 16:43:41 -0400" MODIFIED_BY="Anne Lawson" RESULT="YES" STUDY_ID="STD-Lou-2012">
<DESCRIPTION>
<P>No significant difference between groups</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-05-30 16:43:38 -0400" MODIFIED_BY="Anne Lawson" RESULT="UNKNOWN" STUDY_ID="STD-Lusini-2013">
<DESCRIPTION>
<P>Information not reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-05-30 16:43:36 -0400" MODIFIED_BY="Anne Lawson" RESULT="UNKNOWN" STUDY_ID="STD-Nachemson-1995">
<DESCRIPTION>
<P>Not reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-05-30 16:43:33 -0400" MODIFIED_BY="Anne Lawson" RESULT="YES" STUDY_ID="STD-Weinstein-2013a">
<DESCRIPTION>
<P>There were no significant between-group differences at baseline, except for the comparisons of sex in the 2 study cohorts (P value = 0.02)</P>
<P>Quote: "patients in the bracing arm completed a 2-week brace wear diary between each follow-up visit. Moreover temperature monitor data (date, time stamps, and temperature) were downloaded at least every 6 months by the research coordinator. Temperatures 82.4° or greater 72 indicated that the brace was being worn"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-05-30 16:43:30 -0400" MODIFIED_BY="Anne Lawson" RESULT="YES" STUDY_ID="STD-Weinstein-2013b">
<DESCRIPTION>
<P>Quote: "patients in the bracing arm completed a 2-week brace wear diary between each follow-up visit. Moreover temperature monitor data (date, time stamps, and temperature) were downloaded at least every 6 months by the research coordinator. Temperatures 82.4 ° or greater 72 indicated that the brace was being worn"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-05-30 16:43:28 -0400" MODIFIED_BY="Anne Lawson" RESULT="UNKNOWN" STUDY_ID="STD-Wong-2008">
<DESCRIPTION>
<P>Information about compliance not reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-10" LEVEL="STUDY" MODIFIED="2015-05-30 16:43:46 -0400" MODIFIED_BY="Anne Lawson" NO="10">
<NAME>Similar outcome timing</NAME>
<DESCRIPTION>
<P>Was the timing of the outcome assessment similar in all groups?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-05-30 16:43:46 -0400" MODIFIED_BY="Anne Lawson" RESULT="YES" STUDY_ID="STD-Bunge-2010">
<DESCRIPTION>
<P>Every 4 months for both groups</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-07-25 16:59:43 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Coillard-2012">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-07-15 15:43:37 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Lou-2012">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-05-30 16:43:38 -0400" MODIFIED_BY="Anne Lawson" RESULT="UNKNOWN" STUDY_ID="STD-Lusini-2013">
<DESCRIPTION>
<P>Information not reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-05-30 16:43:36 -0400" MODIFIED_BY="Anne Lawson" RESULT="YES" STUDY_ID="STD-Nachemson-1995">
<DESCRIPTION>
<P>All participants received a roentgenogram every 4 months before menarche and every 6 months after menarche</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-05-30 16:43:33 -0400" MODIFIED_BY="Anne Lawson" RESULT="YES" STUDY_ID="STD-Weinstein-2013a">
<DESCRIPTION>
<P>Every 6 months</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-05-30 16:43:30 -0400" MODIFIED_BY="Anne Lawson" RESULT="YES" STUDY_ID="STD-Weinstein-2013b">
<DESCRIPTION>
<P>Every six months</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-05-30 16:43:28 -0400" MODIFIED_BY="Anne Lawson" RESULT="YES" STUDY_ID="STD-Wong-2008">
<DESCRIPTION>
<P>All participants received radiographs after the first month and then every 3 months; all participants completed a feedback questionnaire at 3rd, 9th and 18th months of intervention</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-11" LEVEL="STUDY" MODIFIED="2015-05-30 16:43:45 -0400" MODIFIED_BY="Anne Lawson" NO="11">
<NAME>Representativeness of the exposed cohort</NAME>
<DESCRIPTION>
<P>Whether the sample is truly representative of the average adolescents with scoliosis; somewhat representative of the average adolescents with scoliosis; part of a selected group of adolescents with scoliosis; no description of the derivation of the cohort</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-05-30 16:43:45 -0400" MODIFIED_BY="Anne Lawson" RESULT="UNKNOWN" STUDY_ID="STD-Bunge-2010">
<DESCRIPTION>
<P>Not applicable</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-05-30 16:43:43 -0400" MODIFIED_BY="Anne Lawson" RESULT="UNKNOWN" STUDY_ID="STD-Coillard-2012">
<DESCRIPTION>
<P>Not applicable</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-05-30 16:43:41 -0400" MODIFIED_BY="Anne Lawson" RESULT="UNKNOWN" STUDY_ID="STD-Lou-2012">
<DESCRIPTION>
<P>Not applicable</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-05-30 16:43:38 -0400" MODIFIED_BY="Anne Lawson" RESULT="YES" STUDY_ID="STD-Lusini-2013">
<DESCRIPTION>
<P>Sample representative of the mean population with scoliosis</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-05-30 16:43:36 -0400" MODIFIED_BY="Anne Lawson" RESULT="YES" STUDY_ID="STD-Nachemson-1995">
<DESCRIPTION>
<P>Truly representative of the average adolescents with scoliosis</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-05-30 16:43:33 -0400" MODIFIED_BY="Anne Lawson" RESULT="YES" STUDY_ID="STD-Weinstein-2013a">
<DESCRIPTION>
<P>The sample was truly representative of the average adolescents with scoliosis</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-05-30 16:43:30 -0400" MODIFIED_BY="Anne Lawson" RESULT="UNKNOWN" STUDY_ID="STD-Weinstein-2013b">
<DESCRIPTION>
<P>Not applicable</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-05-30 16:43:28 -0400" MODIFIED_BY="Anne Lawson" RESULT="UNKNOWN" STUDY_ID="STD-Wong-2008">
<DESCRIPTION>
<P>Not applicable</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-12" LEVEL="STUDY" MODIFIED="2015-05-30 16:43:45 -0400" MODIFIED_BY="Anne Lawson" NO="12">
<NAME>Selection of the non-exposed cohort</NAME>
<DESCRIPTION>
<P>Whether the sample has been  drawn from the same community and at the same time as the exposed cohort; drawn from a different source or at a different time; no description of the derivation of the non exposed cohort</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-05-30 16:43:45 -0400" MODIFIED_BY="Anne Lawson" RESULT="UNKNOWN" STUDY_ID="STD-Bunge-2010">
<DESCRIPTION>
<P>Not applicable</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-05-30 16:43:43 -0400" MODIFIED_BY="Anne Lawson" RESULT="UNKNOWN" STUDY_ID="STD-Coillard-2012">
<DESCRIPTION>
<P>Not applicable</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-05-30 16:43:41 -0400" MODIFIED_BY="Anne Lawson" RESULT="UNKNOWN" STUDY_ID="STD-Lou-2012">
<DESCRIPTION>
<P>Not applicable</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-05-30 16:43:38 -0400" MODIFIED_BY="Anne Lawson" RESULT="YES" STUDY_ID="STD-Lusini-2013">
<DESCRIPTION>
<P>Drawn from the same cohort</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-05-30 16:43:36 -0400" MODIFIED_BY="Anne Lawson" RESULT="NO" STUDY_ID="STD-Nachemson-1995">
<DESCRIPTION>
<P>Drawn from a different source</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-05-30 16:43:33 -0400" MODIFIED_BY="Anne Lawson" RESULT="YES" STUDY_ID="STD-Weinstein-2013a">
<DESCRIPTION>
<P>The sample has been drawn from the same community as the exposed cohort</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-05-30 16:43:30 -0400" MODIFIED_BY="Anne Lawson" RESULT="UNKNOWN" STUDY_ID="STD-Weinstein-2013b">
<DESCRIPTION>
<P>Not applicable</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-05-30 16:43:28 -0400" MODIFIED_BY="Anne Lawson" RESULT="UNKNOWN" STUDY_ID="STD-Wong-2008">
<DESCRIPTION>
<P>Not applicable</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-13" LEVEL="STUDY" MODIFIED="2015-05-30 16:43:45 -0400" MODIFIED_BY="Anne Lawson" NO="13">
<NAME>Ascertainment of exposure</NAME>
<DESCRIPTION>
<P>Information in the study was obtained from a secure record (eg clinical records); structured interview; written self report; no description</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-05-30 16:43:45 -0400" MODIFIED_BY="Anne Lawson" RESULT="UNKNOWN" STUDY_ID="STD-Bunge-2010">
<DESCRIPTION>
<P>Not applicable</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-05-30 16:43:43 -0400" MODIFIED_BY="Anne Lawson" RESULT="UNKNOWN" STUDY_ID="STD-Coillard-2012">
<DESCRIPTION>
<P>Not applicable</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-05-30 16:43:41 -0400" MODIFIED_BY="Anne Lawson" RESULT="UNKNOWN" STUDY_ID="STD-Lou-2012">
<DESCRIPTION>
<P>Not applicable</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-05-30 16:43:38 -0400" MODIFIED_BY="Anne Lawson" RESULT="YES" STUDY_ID="STD-Lusini-2013">
<DESCRIPTION>
<P>Clinical records</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-05-30 16:43:36 -0400" MODIFIED_BY="Anne Lawson" RESULT="YES" STUDY_ID="STD-Nachemson-1995">
<DESCRIPTION>
<P>Secure record (e.g. clinical records)</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-05-30 16:43:33 -0400" MODIFIED_BY="Anne Lawson" RESULT="NO" STUDY_ID="STD-Weinstein-2013a">
<DESCRIPTION>
<P>Self report data</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-05-30 16:43:30 -0400" MODIFIED_BY="Anne Lawson" RESULT="UNKNOWN" STUDY_ID="STD-Weinstein-2013b">
<DESCRIPTION>
<P>Not applicable</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-05-30 16:43:27 -0400" MODIFIED_BY="Anne Lawson" RESULT="UNKNOWN" STUDY_ID="STD-Wong-2008">
<DESCRIPTION>
<P>Not applicable</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
</QUALITY_ITEMS>
<SOF_TABLES MODIFIED="2015-06-16 09:27:49 -0400" MODIFIED_BY="[Empty name]">
<SOF_TABLE ID="SOF-01" MODIFIED="2015-06-05 13:06:53 -0400" MODIFIED_BY="[Empty name]" NO="1" READONLY="YES">
<TITLE MODIFIED="2015-06-05 13:06:53 -0400" MODIFIED_BY="[Empty name]">Brace compared with observation (randomized controlled trial) for idiopathic scoliosis in adolescents</TITLE>
<TABLE COLS="7" ROWS="17">
<TR>
<TD COLSPAN="7">
<P>
<B>Brace compared with observation (random</B>ize<B>d controlled trial) for idiopathic scoliosis in adolescents</B>
</P>
</TD>
</TR>
<TR>
<TD COLSPAN="7">
<P>
<B>Patient or population:</B> adolescents with idiopathic scoliosis<BR/>
<B>Settings:</B>
<BR/>
<B>Intervention:</B> brace<BR/>
<B>Comparison: </B>observation</P>
</TD>
</TR>
<TR>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>Outcomes</P>
</TH>
<TH ALIGN="LEFT" COLSPAN="2" VALIGN="TOP">
<P>Illustrative comparative risks* (95% CI)</P>
</TH>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>Relative effect<BR/>(95% CI)</P>
</TH>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>No of participants<BR/>(studies)</P>
</TH>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>Quality of the evidence<BR/>(GRADE)</P>
</TH>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>Comments</P>
</TH>
</TR>
<TR>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>Assumed risk</P>
</TH>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>Corresponding risk</P>
</TH>
</TR>
<TR>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>
<B>Observation (RCT)</B>
</P>
</TH>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>
<B>Brace</B>
</P>
</TH>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>
<B>Quality of life </B>
<BR/>PedsQL scores<SUP>1</SUP>
<BR/>Follow-up: 2 years</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>The mean quality of life in the control groups was<BR/>
<B>83.0 ± 13.2 (0-100)</B>
<SUP>2</SUP>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>The mean quality of life in the intervention groups was<BR/>
<B>2.1 lower</B>
<BR/>(7.69 lower to 3.49 higher)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>-</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>111<BR/>(1 study)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>&#8853;&#8861;&#8861;&#8861;<BR/>
<B>very low</B>
<SUP>3,4</SUP>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>Higher scores indicating a better quality of life</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P>
<B>Risk of success </B>
<BR/>Curves remaining below 50°<BR/>Follow-up: 2 years</P>
</TD>
<TD COLSPAN="2" ROWSPAN="1">
<P>
<B>Study population</B>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P>
<B>RR 1.79 </B>
<BR/>(1.29 to 2.5)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P>116<BR/>(1 study)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P>&#8853;&#8853;&#8861;&#8861;<BR/>
<B>low</B>
<SUP>5</SUP>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P>-</P>
</TD>
</TR>
<TR>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>415 per 1000</B>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>744 per 1000</B>
<BR/>(536 to 1000)</P>
</TD>
</TR>
<TR>
<TD COLSPAN="2" ROWSPAN="1">
<P>
<B>Moderate</B>
</P>
</TD>
</TR>
<TR>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>415 per 1000</B>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>743 per 1000</B>
<BR/>(535 to 1000)</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P>
<B>Pulmonary disorders, disability, back pain, psychological issues, and cosmetic issues</B>
<BR/>Subjective</P>
</TD>
<TD COLSPAN="2" ROWSPAN="1">
<P>
<B>Study population</B>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P>Not estimable</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P>0<BR/>(0)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P>See comment</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P>None of the included studies assessed these outcomes</P>
</TD>
</TR>
<TR>
<TD ROWSPAN="1" VALIGN="TOP">
<P>See comment</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>See comment</P>
</TD>
</TR>
<TR>
<TD COLSPAN="2" ROWSPAN="1">
<P>
<B>Moderate</B>
</P>
</TD>
</TR>
<TR>
<TD ROWSPAN="1" VALIGN="TOP">
<P>-</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>-</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>
<B>Any adverse event </B>
<BR/>Number of participants reporting at least 1 adverse event</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>See comment</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>See comment</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>Not estimable</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>0<BR/>(0)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>See comment</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>None of the included studies assessed this outcome</P>
</TD>
</TR>
<TR>
<TD COLSPAN="7">
<P>*The basis for the <B>assumed risk</B> (e.g. the median control group risk across studies) is provided in footnotes. The <B>corresponding risk</B> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <B>relative effect</B> of the intervention (and its 95% CI).<BR/>
<B>CI:</B> confidence interval; <B>PedsQL:</B> Pediatric Quality of Life Inventory; <B>RCT:</B> randomized controlled trial; <B>RR:</B> risk ratio.</P>
</TD>
</TR>
<TR>
<TD COLSPAN="7">
<P>GRADE Working Group grades of evidence<BR/>
<B>High quality:</B> Further research is very unlikely to change our confidence in the estimate of effect.<BR/>
<B>Moderate quality:</B> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<BR/>
<B>Low quality:</B> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<BR/>
<B>Very low quality:</B> We are very uncertain about the estimate.<BR/>
</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES>
<P>
<SUP>1</SUP> PedsQL, a generic quality-of-life instrument used in studies of acute and chronic illness (<LINK REF="REF-Varni-2001" TYPE="REFERENCE">Varni 2001</LINK>; <LINK REF="REF-Varni-2003" TYPE="REFERENCE">Varni 2003</LINK>).<SUP>2</SUP> Scores range from 0 to 100, with higher scores indicating a better quality of life.<BR/>
<SUP>3</SUP> Unclear risk of selection bias for allocation concealment.<BR/>
<SUP>4</SUP> Only one study with 111 participants.<BR/>
<SUP>5</SUP> Only one study with 116 participants.</P>
</FOOTNOTES>
</SOF_TABLE>
<SOF_TABLE ID="SOF-02" MODIFIED="2015-06-05 13:07:03 -0400" MODIFIED_BY="[Empty name]" NO="2" READONLY="YES">
<TITLE MODIFIED="2015-06-05 13:07:03 -0400" MODIFIED_BY="[Empty name]">Bracing compared with observation (cohort studies) for idiopathic scoliosis in adolescents</TITLE>
<TABLE COLS="7" ROWS="11">
<TR>
<TD COLSPAN="7">
<P>
<B>Brace compared with observation (cohort studies) for idiopathic scoliosis in adolescents</B>
</P>
</TD>
</TR>
<TR>
<TD COLSPAN="7">
<P>
<B>Patient or population:</B> adolescents with idiopathic scoliosis<BR/>
<B>Settings:</B>
<BR/>
<B>Intervention:</B> brace<BR/>
<B>Comparison: </B>observation (cohort studies)</P>
</TD>
</TR>
<TR>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>Outcomes</P>
</TH>
<TH ALIGN="LEFT" COLSPAN="2" VALIGN="TOP">
<P>Illustrative comparative risks* (95% CI)</P>
</TH>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>Relative effect<BR/>(95% CI)</P>
</TH>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>No of participants<BR/>(studies)</P>
</TH>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>Quality of the evidence<BR/>(GRADE)</P>
</TH>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>Comments</P>
</TH>
</TR>
<TR>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>Assumed risk</P>
</TH>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>Corresponding risk</P>
</TH>
</TR>
<TR>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>
<B>Observation (cohort studies)</B>
</P>
</TH>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>
<B>Brace</B>
</P>
</TH>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>
<B>Quality of life </B>
<BR/>PedsQL score<SUP>1</SUP>
<BR/>Follow-up: 2 years</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>The mean quality of life in the control groups was<BR/>
<B>83.3 ± 13.3 (0-100)</B>
<SUP>2</SUP>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>The mean quality of life in the intervention groups was<BR/>
<B>0.1 higher</B>
<BR/>(3.9 lower to 4.1 higher)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>-</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>236<BR/>(1 study)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>&#8853;&#8861;&#8861;&#8861;<BR/>
<B>very low</B>
<SUP>3</SUP>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>Higher scores indicating a better quality of life</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<B>Risk of success </B>
<BR/>curves remaining below 50°<BR/>Follow-up: 2 years</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>479 per 1000</B>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>719 per 1000</B>
<BR/>(570 to 906)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<B>RR 1.5 </B>
<BR/>(1.19 to 1.89)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>242<BR/>(1 study)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>&#8853;&#8861;&#8861;&#8861;<BR/>
<B>very low</B>
<SUP>4</SUP>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Highly clinically relevant</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<B>Any adverse event</B>
<BR/>number of participants with at least 1 adverse event<BR/>Follow-up: 2 years</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>427 per 1000</B>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>542 per 1000</B>
<BR/>(410 to 713)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<B>RR 1.27 </B>
<BR/>(0.96 to 1.67)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>242<BR/>(1 study)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>&#8853;&#8861;&#8861;&#8861;<BR/>
<B>very low</B>
<SUP>4</SUP>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>-</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<B>Pulmonary disorders, disability, back pain, psychological issues, and cosmetic issues</B>
<BR/>subjective or objective</P>
</TD>
<TD>
<P>See comment</P>
</TD>
<TD>
<P>See comment</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Not estimable</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>0<BR/>(0)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>See comment</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>None of the included studies assessed these outcomes</P>
</TD>
</TR>
<TR>
<TD COLSPAN="7">
<P>*The basis for the <B>assumed risk</B> (e.g. the median control group risk across studies) is provided in footnotes. The <B>corresponding risk</B> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <B>relative effect</B> of the intervention (and its 95% CI).<BR/>
<B>CI:</B> confidence interval; <B>PedsQL:</B> Pediatric Quality of Life Inventory; <B>RR:</B> risk ratio.</P>
</TD>
</TR>
<TR>
<TD COLSPAN="7">
<P>GRADE Working Group grades of evidence<BR/>
<B>High quality:</B> Further research is very unlikely to change our confidence in the estimate of effect.<BR/>
<B>Moderate quality:</B> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<BR/>
<B>Low quality:</B> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<BR/>
<B>Very low quality:</B> We are very uncertain about the estimate.<BR/>
</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES>
<P>
<SUP>1</SUP> PedsQL, a generic quality-of-life instrument used in studies of acute and chronic illness (<LINK REF="REF-Varni-2001" TYPE="REFERENCE">Varni 2001</LINK>; <LINK REF="REF-Varni-2003" TYPE="REFERENCE">Varni 2003</LINK>).<BR/>
<SUP>2</SUP> Scores range from 0 to 100, with higher scores indicating a better quality of life.<BR/>
<SUP>3</SUP> Only one observational study with 236 participants.<SUP>4</SUP> Only one observational study with 242 participants.</P>
</FOOTNOTES>
</SOF_TABLE>
<SOF_TABLE ID="SOF-03" MODIFIED="2015-06-05 13:07:27 -0400" MODIFIED_BY="[Empty name]" NO="3" READONLY="YES">
<TITLE MODIFIED="2015-06-05 13:07:27 -0400" MODIFIED_BY="[Empty name]">Brace and exercise compared with observation in high degree curves (cohort study) for idiopathic scoliosis in adolescents</TITLE>
<TABLE COLS="7" ROWS="6">
<TR>
<TD COLSPAN="7">
<P>
<B>Brace and exercise compared with observation in high degree curves (cohort study) for idiopathic scoliosis in adolescents</B>
</P>
</TD>
</TR>
<TR>
<TD COLSPAN="7">
<P>
<B>Patient or population:</B> adolescents with idiopathic scoliosis<BR/>
<B>Settings:</B>
<BR/>
<B>Intervention:</B> brace and exercise<BR/>
<B>Comparison: </B>observation in high degree curves (cohort study)</P>
</TD>
</TR>
<TR>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>Outcomes</P>
</TH>
<TH ALIGN="LEFT" COLSPAN="2" VALIGN="TOP">
<P>Illustrative comparative risks* (95% CI)</P>
</TH>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>Relative effect<BR/>(95% CI)</P>
</TH>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>No of participants<BR/>(studies)</P>
</TH>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>Quality of the evidence<BR/>(GRADE)</P>
</TH>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>Comments</P>
</TH>
</TR>
<TR>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>Assumed risk</P>
</TH>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>Corresponding risk</P>
</TH>
</TR>
<TR>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>
<B>Observation in high degree curves (Cohort study)</B>
</P>
</TH>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>
<B>Brace and exercise</B>
</P>
</TH>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>
<B>Quality of life </B>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>See comment</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>See comment</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>Not estimable</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>0<BR/>(0)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>See comment</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>None of the included studies assessed this outcome</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P>
<B>Risk of success </B>
<BR/>no progression over 50°, no fusion, no waiting list for fusion</P>
</TD>
<TD COLSPAN="2" ROWSPAN="1">
<P>
<B>Study population</B>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P>
<B>RR 1.79 </B>
<BR/>(1.04 to 3.07)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P>57<BR/>(1 study)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P>&#8853;&#8861;&#8861;&#8861;<BR/>
<B>very low</B>
<SUP>1,2</SUP>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P>-</P>
</TD>
</TR>
<TR>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>444 per 1000</B>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>796 per 1000</B>
<BR/>(462 to 1000)</P>
</TD>
</TR>
<TR>
<TD COLSPAN="2" ROWSPAN="1">
<P>
<B>Moderate</B>
</P>
</TD>
</TR>
<TR>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>444 per 1000</B>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>795 per 1000</B>
<BR/>(462 to 1000)</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>
<B>Any adverse event</B>
<BR/>number of participants with at least 1 adverse event</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>See comment</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>See comment</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>Not estimable</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>0<BR/>(0)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>See comment</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>None of the included studies assessed this outcome</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P>
<B>Pulmonary disorders, disability, back pain, psychological issues, and cosmetic issues</B>
<BR/>subjective or objective</P>
</TD>
<TD COLSPAN="2" ROWSPAN="1">
<P>
<B>Study population</B>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P>Not estimable</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P>0<BR/>(0)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P>See comment</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P>None of the included studies assessed these outcomes</P>
</TD>
</TR>
<TR>
<TD ROWSPAN="1" VALIGN="TOP">
<P>See comment</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>See comment</P>
</TD>
</TR>
<TR>
<TD COLSPAN="2" ROWSPAN="1">
<P>
<B>Moderate</B>
</P>
</TD>
</TR>
<TR>
<TD ROWSPAN="1" VALIGN="TOP">
<P>-</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>-</P>
</TD>
</TR>
<TR>
<TD COLSPAN="7">
<P>*The basis for the <B>assumed risk</B> (e.g. the median control group risk across studies) is provided in footnotes. The <B>corresponding risk</B> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <B>relative effect</B> of the intervention (and its 95% CI).<BR/>
<B>CI:</B> confidence interval; <B>RR:</B> risk ratio.</P>
</TD>
</TR>
<TR>
<TD COLSPAN="7">
<P>GRADE Working Group grades of evidence<BR/>
<B>High quality:</B> Further research is very unlikely to change our confidence in the estimate of effect.<BR/>
<B>Moderate quality:</B> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<BR/>
<B>Low quality:</B> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<BR/>
<B>Very low quality:</B> We are very uncertain about the estimate.<BR/>
</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES>
<P>
<SUP>1</SUP> Lost at follow-up (19.3%), unbalanced between groups: 7.7% in the experimental group, 44.4% in the control group.<BR/>
<SUP>2</SUP> Only one study with 57 participants.</P>
</FOOTNOTES>
</SOF_TABLE>
<SOF_TABLE ID="SOF-04" MODIFIED="2015-06-16 09:27:49 -0400" MODIFIED_BY="[Empty name]" NO="4" READONLY="YES">
<TITLE MODIFIED="2015-06-05 13:07:44 -0400" MODIFIED_BY="[Empty name]">Rigid versus elastic brace (randomized controlled trial) for idiopathic scoliosis in adolescents</TITLE>
<TABLE COLS="7" ROWS="11">
<TR>
<TD COLSPAN="7">
<P>
<B>Rigid versus elastic brace (randomized controlled trial) for idiopathic scoliosis in adolescents</B>
</P>
</TD>
</TR>
<TR>
<TD COLSPAN="7">
<P>
<B>Patient or population:</B> adolescents with idiopathic scoliosis<BR/>
<B>Settings:</B>
<BR/>
<B>Intervention 1:</B> rigid brace<BR/>
<B>Intervention 2:</B> elastic brace</P>
</TD>
</TR>
<TR>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>Outcomes</P>
</TH>
<TH ALIGN="LEFT" COLSPAN="2" VALIGN="TOP">
<P>Illustrative comparative risks* (95% CI)</P>
</TH>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>Relative effect<BR/>(95% CI)</P>
</TH>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>No of participants<BR/>(studies)</P>
</TH>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>Quality of the evidence<BR/>(GRADE)</P>
</TH>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>Comments</P>
</TH>
</TR>
<TR>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>Assumed risk</P>
</TH>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>Corresponding risk</P>
</TH>
</TR>
<TR>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>
<B>Control</B>
</P>
</TH>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>
<B>Rigid versus elastic brace (RCT)</B>
</P>
</TH>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>
<B>Quality of life </B>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>See comment</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>See comment</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>Not estimable</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>0<BR/>(0)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>See comment</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>None of the included studies assessed this outcome</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<B>Risk of success </B>
<BR/>curves remaining below 50°<BR/>Follow-up: 4 years</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>682 per 1000</B>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>955 per 1000</B>
<BR/>(702 to 1000)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<B>RR 1.4 </B>
<BR/>(1.03 to 1.89)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>43<BR/>(1 study)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>&#8853;&#8853;&#8861;&#8861;<BR/>
<B>low</B>
<SUP>1</SUP>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>-</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>
<B>Any adverse event</B>
<BR/>number of participants with at least 1 adverse event</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>See comment</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>See comment</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>Not estimable</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>0<BR/>(0)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>See comment</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>None of the included studies assessed this outcome</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<B>Pulmonary disorders, disability, back pain, psychological issues, and cosmetic issues</B>
<BR/>subjective or objective</P>
</TD>
<TD VALIGN="TOP">
<P>See comment</P>
<P/>
</TD>
<TD VALIGN="TOP">
<P>See comment</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Not estimable</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>0<BR/>(0)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>See comment</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>None of the included studies assessed these outcomes</P>
</TD>
</TR>
<TR>
<TD COLSPAN="7">
<P>*The basis for the <B>assumed risk</B> (e.g. the median control group risk across studies) is provided in footnotes. The <B>corresponding risk</B> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <B>relative effect</B> of the intervention (and its 95% CI).<BR/>
<B>CI:</B> confidence interval; <B>RR:</B> risk ratio.</P>
</TD>
</TR>
<TR>
<TD COLSPAN="7">
<P>GRADE Working Group grades of evidence<BR/>
<B>High quality:</B> Further research is very unlikely to change our confidence in the estimate of effect.<BR/>
<B>Moderate quality:</B> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<BR/>
<B>Low quality:</B> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<BR/>
<B>Very low quality:</B> We are very uncertain about the estimate.<BR/>
</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES>
<P>
<SUP>1</SUP> only one study with 43 participants.</P>
</FOOTNOTES>
</SOF_TABLE>
</SOF_TABLES>
<ADDITIONAL_TABLES MODIFIED="2009-10-14 16:12:27 -0400" MODIFIED_BY="VEP  "/>
<ANALYSES_AND_DATA CALCULATED_DATA="YES" MODIFIED="2015-06-09 10:53:48 -0400" MODIFIED_BY="[Empty name]">
<COMPARISON ID="CMP-001" MODIFIED="2015-06-09 10:53:48 -0400" MODIFIED_BY="[Empty name]" NO="1">
<NAME>Brace versus observation (RCT)</NAME>
<CONT_OUTCOME CHI2="0.0" CI_END="3.4895359429317576" CI_START="-7.689535942931775" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="-2.1000000000000085" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-001.01" MODIFIED="2015-05-29 07:26:00 -0400" MODIFIED_BY="Anne Lawson" NO="1" P_CHI2="1.0" P_Q="1.0" P_Z="0.46151015733666234" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="50" TOTAL_2="61" UNITS="" WEIGHT="100.0" Z="0.7363624475371542">
<NAME>Quality of life (PedsQL scores)</NAME>
<GROUP_LABEL_1>
B
race</GROUP_LABEL_1>
<GROUP_LABEL_2>
O
bservation</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours observation</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours brace</GRAPH_LABEL_2>
<CONT_DATA CI_END="3.4895359429317576" CI_START="-7.689535942931775" EFFECT_SIZE="-2.1000000000000085" ESTIMABLE="YES" MEAN_1="79.1" MEAN_2="81.2" MODIFIED="2014-04-21 01:58:19 -0400" MODIFIED_BY="[Empty name]" ORDER="8" SD_1="15.9" SD_2="13.7" SE="2.8518564560478215" STUDY_ID="STD-Weinstein-2013b" TOTAL_1="50" TOTAL_2="61" WEIGHT="100.0"/>
</CONT_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="2.4952262016532583" CI_START="1.2894844337248355" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="1.793754538852578" ESTIMABLE="YES" EVENTS_1="38" EVENTS_2="27" I2="0.0" I2_Q="0.0" ID="CMP-001.02" LOG_CI_END="0.3971099221745769" LOG_CI_START="0.11041610383090703" LOG_EFFECT_SIZE="0.253763013002742" METHOD="MH" MODIFIED="2015-06-09 10:53:15 -0400" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="1.0" P_Q="1.0" P_Z="5.210995908074686E-4" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="51" TOTAL_2="65" WEIGHT="100.0" Z="3.4696692727258838">
<NAME>Risk of success at 2 years</NAME>
<GROUP_LABEL_1>Brace</GROUP_LABEL_1>
<GROUP_LABEL_2>Observation</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours observation</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours brace</GRAPH_LABEL_2>
<DICH_DATA CI_END="2.4952262016532583" CI_START="1.2894844337248355" EFFECT_SIZE="1.793754538852578" ESTIMABLE="YES" EVENTS_1="38" EVENTS_2="27" LOG_CI_END="0.3971099221745769" LOG_CI_START="0.11041610383090703" LOG_EFFECT_SIZE="0.253763013002742" MODIFIED="2013-10-26 06:56:15 -0400" MODIFIED_BY="[Empty name]" ORDER="19" O_E="0.0" SE="0.16840536805236037" STUDY_ID="STD-Weinstein-2013b" TOTAL_1="51" TOTAL_2="65" VAR="0.028360367988850957" WEIGHT="100.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="3.196333309794931" CI_START="1.111202995333696" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="1.8846153846153846" ESTIMABLE="YES" EVENTS_1="21" EVENTS_2="9" I2="0.0" I2_Q="0.0" ID="CMP-001.03" LOG_CI_END="0.5046520607098581" LOG_CI_START="0.045793403405533166" LOG_EFFECT_SIZE="0.2752227320576957" METHOD="MH" MODIFIED="2015-06-09 10:53:27 -0400" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="1.0" P_Q="1.0" P_Z="0.018714637610551803" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="26" TOTAL_2="21" WEIGHT="100.0" Z="2.351166896267325">
<NAME>Risk of success at 3 years</NAME>
<GROUP_LABEL_1>Brace</GROUP_LABEL_1>
<GROUP_LABEL_2>Observation</GROUP_LABEL_2>
<GRAPH_LABEL_1>

Favours observation</GRAPH_LABEL_1>
<GRAPH_LABEL_2>
F
avours brace</GRAPH_LABEL_2>
<DICH_DATA CI_END="3.196333309794931" CI_START="1.111202995333696" EFFECT_SIZE="1.8846153846153846" ESTIMABLE="YES" EVENTS_1="21" EVENTS_2="9" LOG_CI_END="0.5046520607098581" LOG_CI_START="0.045793403405533166" LOG_EFFECT_SIZE="0.2752227320576957" MODIFIED="2013-07-25 17:30:00 -0400" MODIFIED_BY="[Empty name]" ORDER="54" O_E="0.0" SE="0.26953584668754665" STUDY_ID="STD-Coillard-2012" TOTAL_1="26" TOTAL_2="21" VAR="0.07264957264957264" WEIGHT="100.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="1.9812188821664887" CI_START="0.8254754181520404" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="1.2788461538461537" ESTIMABLE="YES" EVENTS_1="19" EVENTS_2="12" I2="0.0" I2_Q="100.0" ID="CMP-001.04" LOG_CI_END="0.2969324584087603" LOG_CI_START="-0.08329585507214952" LOG_EFFECT_SIZE="0.1068183016683054" METHOD="MH" MODIFIED="2015-06-09 10:53:38 -0400" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="1.0" P_Q="0.0" P_Z="0.27079518628486365" Q="1.544316695116768E-32" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="26" TOTAL_2="21" WEIGHT="100.0" Z="1.1012332156065212">
<NAME>Risk of success at 5 years</NAME>
<GROUP_LABEL_1>Brace</GROUP_LABEL_1>
<GROUP_LABEL_2>Observation</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours observation</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours brace</GRAPH_LABEL_2>
<DICH_DATA CI_END="1.9812188821664884" CI_START="0.8254754181520405" EFFECT_SIZE="1.2788461538461537" ESTIMABLE="YES" EVENTS_1="19" EVENTS_2="12" LOG_CI_END="0.29693245840876026" LOG_CI_START="-0.08329585507214947" LOG_EFFECT_SIZE="0.1068183016683054" MODIFIED="2013-07-25 17:37:16 -0400" MODIFIED_BY="[Empty name]" ORDER="56" O_E="0.0" SE="0.2233479934991932" STUDY_ID="STD-Coillard-2012" TOTAL_1="26" TOTAL_2="21" VAR="0.04988432620011565" WEIGHT="100.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" I2_Q="0.0" ID="CMP-001.05" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="MH" MODIFIED="2015-06-09 10:53:48 -0400" MODIFIED_BY="[Empty name]" NO="5" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="0" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Any adverse event</NAME>
<GROUP_LABEL_1>Brace</GROUP_LABEL_1>
<GROUP_LABEL_2>Observation</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours brace</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours observation</GRAPH_LABEL_2>
</DICH_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-002" MODIFIED="2015-06-05 16:06:36 -0400" MODIFIED_BY="[Empty name]" NO="2">
<NAME>Brace versus observation (cohort studies)</NAME>
<CONT_OUTCOME CHI2="0.0" CI_END="4.101362697919271" CI_START="-3.901362697919282" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.09999999999999432" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-002.01" MODIFIED="2015-06-05 16:05:01 -0400" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Q="1.0" P_Z="0.9609333118591891" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="144" TOTAL_2="92" UNITS="" WEIGHT="100.0" Z="0.04898241255558092">
<NAME>Quality of life (PedsQL score)</NAME>
<GROUP_LABEL_1>Brace</GROUP_LABEL_1>
<GROUP_LABEL_2>Observation</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours observation</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours brace</GRAPH_LABEL_2>
<CONT_DATA CI_END="4.101362697919271" CI_START="-3.901362697919282" EFFECT_SIZE="0.09999999999999432" ESTIMABLE="YES" MEAN_1="82.0" MEAN_2="81.9" MODIFIED="2014-04-21 02:09:01 -0400" MODIFIED_BY="[Empty name]" ORDER="9" SD_1="17.0" SD_2="14.1" SE="2.0415490945147536" STUDY_ID="STD-Weinstein-2013a" TOTAL_1="144" TOTAL_2="92" WEIGHT="100.0"/>
</CONT_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="1.8925807901528204" CI_START="1.1902693806417641" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="1.5008933889219773" ESTIMABLE="YES" EVENTS_1="105" EVENTS_2="46" I2="0.0" I2_Q="0.0" ID="CMP-002.02" LOG_CI_END="0.27705442765357063" LOG_CI_START="0.07564526163342" LOG_EFFECT_SIZE="0.1763498446434953" METHOD="MH" MODIFIED="2015-06-05 16:05:17 -0400" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="1.0" P_Q="1.0" P_Z="5.986823075495959E-4" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="146" TOTAL_2="96" WEIGHT="100.0" Z="3.43221066856415">
<NAME>Risk of success at 2 years</NAME>
<GROUP_LABEL_1>Brace</GROUP_LABEL_1>
<GROUP_LABEL_2>Observation</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours observation</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours brace</GRAPH_LABEL_2>
<DICH_DATA CI_END="1.8925807901528204" CI_START="1.1902693806417641" EFFECT_SIZE="1.5008933889219773" ESTIMABLE="YES" EVENTS_1="105" EVENTS_2="46" LOG_CI_END="0.27705442765357063" LOG_CI_START="0.07564526163342" LOG_EFFECT_SIZE="0.1763498446434953" MODIFIED="2014-04-21 02:23:58 -0400" MODIFIED_BY="[Empty name]" ORDER="10" O_E="0.0" SE="0.11830874111168758" STUDY_ID="STD-Weinstein-2013a" TOTAL_1="146" TOTAL_2="96" VAR="0.013996958223432316" WEIGHT="100.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="2.1616453219881113" CI_START="1.4217558230333933" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="1.7530920751259735" ESTIMABLE="YES" EVENTS_1="89" EVENTS_2="59" I2="0.0" I2_Q="0.0" ID="CMP-002.03" LOG_CI_END="0.33478443737882607" LOG_CI_START="0.15282501565189419" LOG_EFFECT_SIZE="0.24380472651536014" METHOD="MH" MODIFIED="2015-06-05 16:05:35 -0400" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="1.0" P_Q="1.0" P_Z="1.502496671524177E-7" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="111" TOTAL_2="129" WEIGHT="100.0" Z="5.252253262794545">
<NAME>Risk of success at 3 years</NAME>
<GROUP_LABEL_1>Brace</GROUP_LABEL_1>
<GROUP_LABEL_2>Observation</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours observation</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours brace</GRAPH_LABEL_2>
<DICH_DATA CI_END="2.1616453219881113" CI_START="1.4217558230333933" EFFECT_SIZE="1.7530920751259735" ESTIMABLE="YES" EVENTS_1="89" EVENTS_2="59" LOG_CI_END="0.33478443737882607" LOG_CI_START="0.15282501565189419" LOG_EFFECT_SIZE="0.24380472651536014" MODIFIED="2014-04-21 02:43:57 -0400" MODIFIED_BY="[Empty name]" ORDER="11" O_E="0.0" SE="0.1068838650360639" STUDY_ID="STD-Nachemson-1995" TOTAL_1="111" TOTAL_2="129" VAR="0.011424160605047522" WEIGHT="100.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="2.8972170143805434" CI_START="1.6952869918409887" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="2.2162162162162162" ESTIMABLE="YES" EVENTS_1="82" EVENTS_2="43" I2="0.0" I2_Q="0.0" ID="CMP-002.04" LOG_CI_END="0.46198102700150906" LOG_CI_START="0.2292432296319343" LOG_EFFECT_SIZE="0.3456121283167217" METHOD="MH" MODIFIED="2015-06-05 16:05:47 -0400" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="1.0" P_Q="1.0" P_Z="5.848464449356464E-9" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="111" TOTAL_2="129" WEIGHT="100.0" Z="5.821034071619718">
<NAME>Risk of success at 4 years</NAME>
<GROUP_LABEL_1>Brace</GROUP_LABEL_1>
<GROUP_LABEL_2>Observation</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours observation</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours brace</GRAPH_LABEL_2>
<DICH_DATA CI_END="2.8972170143805434" CI_START="1.6952869918409887" EFFECT_SIZE="2.2162162162162162" ESTIMABLE="YES" EVENTS_1="82" EVENTS_2="43" LOG_CI_END="0.46198102700150906" LOG_CI_START="0.2292432296319343" LOG_EFFECT_SIZE="0.3456121283167217" MODIFIED="2014-04-21 02:54:01 -0400" MODIFIED_BY="[Empty name]" ORDER="12" O_E="0.0" SE="0.13671133424556556" STUDY_ID="STD-Nachemson-1995" TOTAL_1="111" TOTAL_2="129" VAR="0.01868998891120275" WEIGHT="100.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="1.6691036742940968" CI_START="0.9617006519807425" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="1.2669562312061478" ESTIMABLE="YES" EVENTS_1="79" EVENTS_2="41" I2="0.0" I2_Q="0.0" ID="CMP-002.05" LOG_CI_END="0.22248331317743197" LOG_CI_START="-0.01696008952575742" LOG_EFFECT_SIZE="0.10276161182583728" METHOD="MH" MODIFIED="2015-06-05 16:06:03 -0400" MODIFIED_BY="[Empty name]" NO="5" P_CHI2="1.0" P_Q="1.0" P_Z="0.09250867377447057" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="146" TOTAL_2="96" WEIGHT="100.0" Z="1.6823103572545715">
<NAME>Any adverse event</NAME>
<GROUP_LABEL_1>Brace</GROUP_LABEL_1>
<GROUP_LABEL_2>Observation</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours brace</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours observation</GRAPH_LABEL_2>
<DICH_DATA CI_END="1.6691036742940968" CI_START="0.9617006519807425" EFFECT_SIZE="1.2669562312061478" ESTIMABLE="YES" EVENTS_1="79" EVENTS_2="41" LOG_CI_END="0.22248331317743197" LOG_CI_START="-0.01696008952575742" LOG_EFFECT_SIZE="0.10276161182583728" MODIFIED="2014-04-21 07:18:08 -0400" MODIFIED_BY="[Empty name]" ORDER="13" O_E="0.0" SE="0.14065024001181253" STUDY_ID="STD-Weinstein-2013a" TOTAL_1="146" TOTAL_2="96" VAR="0.019782490015380474" WEIGHT="100.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="1.1030798651322944" CI_START="0.474258548173877" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.7232876712328767" ESTIMABLE="YES" EVENTS_1="33" EVENTS_2="30" I2="0.0" I2_Q="0.0" ID="CMP-002.06" LOG_CI_END="0.04260695734553178" LOG_CI_START="-0.323984832518819" LOG_EFFECT_SIZE="-0.14068893758664364" METHOD="MH" MODIFIED="2015-06-05 16:06:36 -0400" MODIFIED_BY="[Empty name]" NO="6" P_CHI2="1.0" P_Q="1.0" P_Z="0.13248555538480947" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="146" TOTAL_2="96" WEIGHT="100.0" Z="1.5043722108182431">
<NAME>Adverse event back pain</NAME>
<GROUP_LABEL_1>Brace</GROUP_LABEL_1>
<GROUP_LABEL_2>Observation</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours brace</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours observation</GRAPH_LABEL_2>
<DICH_DATA CI_END="1.1030798651322944" CI_START="0.474258548173877" EFFECT_SIZE="0.7232876712328767" ESTIMABLE="YES" EVENTS_1="33" EVENTS_2="30" LOG_CI_END="0.04260695734553178" LOG_CI_START="-0.323984832518819" LOG_EFFECT_SIZE="-0.14068893758664364" MODIFIED="2014-04-21 07:22:27 -0400" MODIFIED_BY="[Empty name]" ORDER="14" O_E="0.0" SE="0.21533783202494589" STUDY_ID="STD-Weinstein-2013a" TOTAL_1="146" TOTAL_2="96" VAR="0.046370381901203815" WEIGHT="100.0"/>
</DICH_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-003" MODIFIED="2015-06-05 16:07:38 -0400" MODIFIED_BY="[Empty name]" NO="3">
<NAME>Brace and exercise versus observation in high degree curves (cohort study)</NAME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-003.01" MODIFIED="2015-06-05 16:06:52 -0400" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="0" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="0" TOTAL_2="0" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Quality of life</NAME>
<GROUP_LABEL_1>Brace</GROUP_LABEL_1>
<GROUP_LABEL_2>Observation</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours b
race</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours o
bservation</GRAPH_LABEL_2>
</CONT_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="230.22715516236943" CI_START="1.0043074978206583" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="15.205882352941174" ESTIMABLE="YES" EVENTS_1="23" EVENTS_2="0" I2="0.0" I2_Q="0.0" ID="CMP-003.02" LOG_CI_END="2.362156547102792" LOG_CI_START="0.0018667050005824323" LOG_EFFECT_SIZE="1.1820116260516873" METHOD="MH" MODIFIED="2015-06-05 16:07:10 -0400" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="1.0" P_Q="1.0" P_Z="0.04963871756684794" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="33" TOTAL_2="10" WEIGHT="99.99999999999999" Z="1.9630641754620672">
<NAME>Risk of success per protocol at 2-9 years</NAME>
<GROUP_LABEL_1>Brace</GROUP_LABEL_1>
<GROUP_LABEL_2>Observation</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours observation</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours brace</GRAPH_LABEL_2>
<DICH_DATA CI_END="230.22715516236943" CI_START="1.0043074978206583" EFFECT_SIZE="15.205882352941176" ESTIMABLE="YES" EVENTS_1="23" EVENTS_2="0" LOG_CI_END="2.362156547102792" LOG_CI_START="0.0018667050005824323" LOG_EFFECT_SIZE="1.1820116260516873" MODIFIED="2014-04-22 03:11:07 -0400" MODIFIED_BY="[Empty name]" ORDER="1" O_E="0.0" SE="1.3864459368739874" STUDY_ID="STD-Lusini-2013" TOTAL_1="33" TOTAL_2="10" VAR="1.9222323358743885" WEIGHT="99.99999999999999"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="3.070680111170151" CI_START="1.0416567531475356" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="1.7884615384615385" ESTIMABLE="YES" EVENTS_1="31" EVENTS_2="8" I2="0.0" I2_Q="0.0" ID="CMP-003.03" LOG_CI_END="0.4872345760686968" LOG_CI_START="0.017724633769575136" LOG_EFFECT_SIZE="0.25247960491913596" METHOD="MH" MODIFIED="2015-06-05 16:07:27 -0400" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="1.0" P_Q="1.0" P_Z="0.035035612713853345" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="39" TOTAL_2="18" WEIGHT="100.0" Z="2.107946554014152">
<NAME>Risk of success intention to treat at 2-9 years</NAME>
<GROUP_LABEL_1>Brace</GROUP_LABEL_1>
<GROUP_LABEL_2>Observation</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours observation</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours brace</GRAPH_LABEL_2>
<DICH_DATA CI_END="3.070680111170152" CI_START="1.0416567531475354" EFFECT_SIZE="1.7884615384615385" ESTIMABLE="YES" EVENTS_1="31" EVENTS_2="8" LOG_CI_END="0.48723457606869697" LOG_CI_START="0.017724633769575043" LOG_EFFECT_SIZE="0.25247960491913596" MODIFIED="2014-04-22 03:12:17 -0400" MODIFIED_BY="[Empty name]" ORDER="2" O_E="0.0" SE="0.2757924642182013" STUDY_ID="STD-Lusini-2013" TOTAL_1="39" TOTAL_2="18" VAR="0.07606148331954785" WEIGHT="100.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" I2_Q="0.0" ID="CMP-003.04" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="MH" MODIFIED="2015-06-05 16:07:38 -0400" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="0" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Any adverse event</NAME>
<GROUP_LABEL_1>Brace</GROUP_LABEL_1>
<GROUP_LABEL_2>Observation</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours b
race</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours o
bservation</GRAPH_LABEL_2>
</DICH_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-004" MODIFIED="2015-06-05 16:08:26 -0400" MODIFIED_BY="[Empty name]" NO="4">
<NAME>Rigid versus elastic brace (RCT)</NAME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-004.01" MODIFIED="2015-06-05 16:07:56 -0400" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="0" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="0" TOTAL_2="0" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Quality of life</NAME>
<GROUP_LABEL_1>Rigid brace</GROUP_LABEL_1>
<GROUP_LABEL_2>Elastic brace</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours rigid brace</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours elastic brace</GRAPH_LABEL_2>
</CONT_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="1.8875001485543124" CI_START="1.0337065089562212" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="1.3968253968253967" ESTIMABLE="YES" EVENTS_1="20" EVENTS_2="15" I2="0.0" I2_Q="0.0" ID="CMP-004.02" LOG_CI_END="0.2758869944820553" LOG_CI_START="0.014397250911118497" LOG_EFFECT_SIZE="0.14514212269658688" METHOD="MH" MODIFIED="2015-06-05 16:08:12 -0400" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="1.0" P_Q="1.0" P_Z="0.029570996218518008" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="21" TOTAL_2="22" WEIGHT="100.0" Z="2.1757896064312146">
<NAME>Risk of success at 4 years</NAME>
<GROUP_LABEL_1>Rigid brace</GROUP_LABEL_1>
<GROUP_LABEL_2>Elastic brace</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours elastic brace</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours rigid brace</GRAPH_LABEL_2>
<DICH_DATA CI_END="1.8875001485543124" CI_START="1.0337065089562212" EFFECT_SIZE="1.3968253968253967" ESTIMABLE="YES" EVENTS_1="20" EVENTS_2="15" LOG_CI_END="0.2758869944820553" LOG_CI_START="0.014397250911118497" LOG_EFFECT_SIZE="0.14514212269658688" MODIFIED="2014-04-22 03:20:26 -0400" MODIFIED_BY="[Empty name]" ORDER="15" O_E="0.0" SE="0.1536003697686747" STUDY_ID="STD-Wong-2008" TOTAL_1="21" TOTAL_2="22" VAR="0.023593073593073596" WEIGHT="100.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" I2_Q="0.0" ID="CMP-004.03" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="MH" MODIFIED="2015-06-05 16:08:26 -0400" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="0" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Any adverse event</NAME>
<GROUP_LABEL_1>Rigid brace</GROUP_LABEL_1>
<GROUP_LABEL_2>Elastic brace</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours rigid brace</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours elastic brace</GRAPH_LABEL_2>
</DICH_OUTCOME>
</COMPARISON>
</ANALYSES_AND_DATA>
<FIGURES MODIFIED="2015-06-16 09:48:39 -0400" MODIFIED_BY="[Empty name]">
<FIGURE FILENAME="Flowchart.png" FILE_TYPE="PNG" ID="FIG-01" MODIFIED="2015-06-16 09:48:39 -0400" MODIFIED_BY="[Empty name]" NO="1" SHORT_VERSION_FIGURE="YES" TYPE="OTHER">
<CAPTION>
<P>Study flow diagram.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAeEAAAKWCAYAAAB+hSHqAABPF0lEQVR42u2dD2TV7f//PyTJJJG5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</FILE>
</FIGURE>
<FIGURE FILENAME="Risk of bias summary.png" FILE_TYPE="PNG" ID="FIG-02" MODIFIED="2015-05-30 17:18:53 -0400" MODIFIED_BY="Anne Lawson" NO="2" SHORT_VERSION_FIGURE="YES" TYPE="QUALITY_TABLE_PLOT">
<CAPTION>
<P>Methodological quality summary: review authors' judgements about each methodological quality item for each included study.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAlwAAAO0CAIAAAD/Hn+8AABDzklEQVR42u3dsW4Uy7q38ZGQEIED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</FILE>
</FIGURE>
<FIGURE FILENAME="Risk of bias graph.png" FILE_TYPE="PNG" ID="FIG-03" MODIFIED="2015-05-30 17:18:53 -0400" MODIFIED_BY="Anne Lawson" NO="3" SHORT_VERSION_FIGURE="YES" TYPE="QUALITY_GRAPH_PLOT">
<CAPTION>
<P>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAA80AAAHhCAMAAABjmayjAAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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</FILE>
</FIGURE>
</FIGURES>
<FEEDBACK/>
<APPENDICES MODIFIED="2015-06-05 13:54:31 -0400" MODIFIED_BY="Shireen Harbin">
<APPENDIX ID="APP-01" MODIFIED="2015-06-05 13:10:04 -0400" MODIFIED_BY="[Empty name]" NO="1">
<TITLE MODIFIED="2015-06-05 13:10:04 -0400" MODIFIED_BY="[Empty name]">MEDLINE and EMBASE search strategies</TITLE>
<APPENDIX_BODY MODIFIED="2015-05-30 16:43:19 -0400" MODIFIED_BY="Anne Lawson">
<SUBSECTION>
<HEADING LEVEL="3">MEDLINE and MEDLINE Non-Indexed and In-Process Citations</HEADING>
<P>Last searched 17 February 2015</P>
<P>1 Comparative Study/</P>
<P>2 exp Evaluation Studies/</P>
<P>3 exp Follow-Up Studies/</P>
<P>4 exp Prospective Studies/</P>
<P>5 exp Cross-Over Studies/</P>
<P>6 exp Epidemiologic Studies/</P>
<P>7 exp Case-Control Studies/</P>
<P>8 exp Cohort Studies/</P>
<P>9 exp Cross-Sectional Studies/</P>
<P>10 (cohort adj (study or studies)).mp.</P>
<P>11 cohort analy$.mp.</P>
<P>12 (follow up adj (study or studies)).mp.</P>
<P>13 (observational adj (study or studies)).mp.</P>
<P>14 longitudinal.mp.</P>
<P>15 retrospective.mp.</P>
<P>16 cross sectional.mp.</P>
<P>17 control$.mp.</P>
<P>18 prospective$.mp.</P>
<P>19 volunteer.mp.</P>
<P>20 or/1-19</P>
<P>21 randomized controlled trial.pt.</P>
<P>22 controlled clinical trial.pt.</P>
<P>23 randomized.ab,ti.</P>
<P>24 placebo.ab,ti.</P>
<P>25 drug therapy.fs.</P>
<P>26 randomly.ab,ti.</P>
<P>27 trial.ab,ti.</P>
<P>28 groups.ab,ti.</P>
<P>29 or/21-27</P>
<P>30 (animals not (humans and animals)).sh.</P>
<P>31 29 not 30</P>
<P>32 Animals/</P>
<P>33 Humans/</P>
<P>34 32 not (32 and 33)</P>
<P>35 29 not 34</P>
<P>36 20 not 34</P>
<P>37 35 or 36 or 31</P>
<P>38 exp Spinal Diseases/</P>
<P>39 exp Scoliosis/</P>
<P>40 scoliosis.mp.</P>
<P>41 or/38-40</P>
<P>42 exp Braces/</P>
<P>43 brace$.mp.</P>
<P>44 bracing.mp.</P>
<P>45 exp Orthotic Devices/</P>
<P>46 exp Orthopedic Equipment/</P>
<P>47 limit 46 to yr="1902 - 1975"</P>
<P>48 or/42-45</P>
<P>49 47 or 48 (</P>
<P>50 exp Adolescent/</P>
<P>51 adolescen$.mp.</P>
<P>52 50 or 51</P>
<P>53 41 and 48 and 52</P>
<P>54 37 and 53</P>
<P>55 limit 54 to yr=2013-2015</P>
<P>56 limit 54 to ed=20131009-20150217</P>
<P>57 55 or 56</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">EMBASE</HEADING>
<P>Last searched 17 February 2015. For this search, the animal study filter was updated and line 51 was changed from 34 and 51 to 34 or 51. See previous strategy below.</P>
<P>1 exp Clinical Study/</P>
<P>2 exp Case Control Study/</P>
<P>3 exp Family Study/</P>
<P>4 exp Longitudinal Study/</P>
<P>5 exp Retrospective Study/</P>
<P>6 exp Prospective Study/</P>
<P>7 exp Cohort Analysis/</P>
<P>8 (cohort adj (study or studies)).mp. [mp=title, abstract, subject headings, heading word, drug trade name, original title, device manufacturer, drug manufacturer, device trade name, keyword]</P>
<P>9 (case control adj (study or studies)).mp. [mp=title, abstract, subject headings, heading word, drug trade name, original title, device manufacturer, drug manufacturer, device trade name, keyword]</P>
<P>10 (follow up adj (study or studies)).mp. [mp=title, abstract, subject headings, heading word, drug trade name, original title, device manufacturer, drug manufacturer, device trade name, keyword]</P>
<P>11 (observational adj (study or studies)).mp. [mp=title, abstract, subject headings, heading word, drug trade name, original title, device manufacturer, drug manufacturer, device trade name, keyword]</P>
<P>12 (epidemiologic$ adj (study or studies)).mp. [mp=title, abstract, subject headings, heading word, drug trade name, original title, device manufacturer, drug manufacturer, device trade name, keyword]</P>
<P>13 (cross sectional adj (study or studies)).mp. [mp=title, abstract, subject headings, heading word, drug trade name, original title, device manufacturer, drug manufacturer, device trade name, keyword]</P>
<P>14 exp Comparative Study/</P>
<P>15 evaluation study.mp.</P>
<P>16 follow-up study.mp. or exp Follow Up/</P>
<P>17 Crossover Procedure/</P>
<P>18 prospective$.mp.</P>
<P>19 exp VOLUNTEER/</P>
<P>20 or/1-19</P>
<P>21 Clinical Article/</P>
<P>22 exp Clinical Study/</P>
<P>23 Clinical Trial/</P>
<P>24 Controlled Study/</P>
<P>25 Randomized Controlled Trial/</P>
<P>26 Major Clinical Study/</P>
<P>27 Double Blind Procedure/</P>
<P>28 Multicenter Study/</P>
<P>29 Single Blind Procedure/</P>
<P>30 Phase 3 Clinical Trial/</P>
<P>31 Phase 4 Clinical Trial/</P>
<P>32 crossover procedure/</P>
<P>33 placebo/</P>
<P>34 or/21-33</P>
<P>35 allocat$.mp.</P>
<P>36 assign$.mp.</P>
<P>37 blind$.mp.</P>
<P>38 (clinic$ adj25 (study or trial)).mp.</P>
<P>39 compar$.mp.</P>
<P>40 control$.mp.</P>
<P>41 cross?over.mp.</P>
<P>42 factorial$.mp.</P>
<P>43 follow?up.mp.</P>
<P>44 placebo$.mp.</P>
<P>45 prospectiv$.mp.</P>
<P>46 random$.mp.</P>
<P>47 ((singl$ or doubl$ or trebl$ or tripl$) adj25 (blind$ or mask$)).mp.</P>
<P>48 trial.mp.</P>
<P>49 (versus or vs).mp.</P>
<P>50 or/35-49</P>
<P>51 34 or 50</P>
<P>52 20 or 51</P>
<P>53 exp animals/ or exp invertebrate/ or animal experiment/ or animal model/ or animal tissue/ or animal cell/ or nonhuman/</P>
<P>54 human/ or normal human/ or human cell/</P>
<P>55 53 and 54</P>
<P>56 53 not 55</P>
<P>57 52 not 56</P>
<P>58 exp SPINE/</P>
<P>59 exp Spine Disease/</P>
<P>60 exp SCOLIOSIS/</P>
<P>61 exp Idiopathic Scoliosis/</P>
<P>62 scoliosis.mp.</P>
<P>63 or/58-62</P>
<P>64 exp Brace/</P>
<P>65 brace$.mp.</P>
<P>66 bracing.mp.</P>
<P>67 exp ORTHOTICS/</P>
<P>68 exp orthopedic equipment/</P>
<P>69 or/64-68</P>
<P>70 Adolescent/</P>
<P>71 adolescen#.mp.</P>
<P>72 70 or 71</P>
<P>73 63 and 69 and 72</P>
<P>74 57 and 73</P>
<P>75 limit 74 to yr=2013-2015</P>
<P>76 limit 74 to em=201340-201507</P>
<P>77 75 or 76</P>
<P>Previous search strategy for 2012 and 2013</P>
<P>1 exp Clinical Study/</P>
<P>2 exp Case Control Study/</P>
<P>3 exp Family Study/</P>
<P>4 exp Longitudinal Study/</P>
<P>5 exp Retrospective Study/</P>
<P>6 exp Prospective Study/</P>
<P>7 exp Cohort Analysis/</P>
<P>8 (cohort adj (study or studies)).mp.</P>
<P>9 (case control adj (study or studies)).mp.</P>
<P>10 (follow up adj (study or studies)).mp.</P>
<P>11 (observational adj (study or studies)).mp.</P>
<P>12 (epidemiologic$ adj (study or studies)).mp.</P>
<P>13 (cross sectional adj (study or studies)).mp.</P>
<P>14 exp Comparative Study/</P>
<P>15 evaluation study.mp.</P>
<P>16 follow-up study.mp. or exp Follow Up/</P>
<P>17 Crossover Procedure/</P>
<P>18 prospective$.mp.</P>
<P>19 exp VOLUNTEER/</P>
<P>20 or/1-19</P>
<P>21 Clinical Article/</P>
<P>22 exp Clinical Study/</P>
<P>23 Clinical Trial/</P>
<P>24 Controlled Study/</P>
<P>25 Randomized Controlled Trial/</P>
<P>26 Major Clinical Study/</P>
<P>27 Double Blind Procedure/</P>
<P>28 Multicenter Study/</P>
<P>29 Single Blind Procedure/</P>
<P>30 Phase 3 Clinical Trial/</P>
<P>31 Phase 4 Clinical Trial/</P>
<P>32 crossover procedure/</P>
<P>33 placebo/</P>
<P>34 or/21-33</P>
<P>35 allocat$.mp.</P>
<P>36 assign$.mp.</P>
<P>37 blind$.mp.</P>
<P>38 (clinic$ adj25 (study or trial)).mp.</P>
<P>39 compar$.mp.</P>
<P>40 control$.mp.</P>
<P>41 cross?over.mp.</P>
<P>42 factorial$.mp.</P>
<P>43 follow?up.mp.</P>
<P>44 placebo$.mp.</P>
<P>45 prospectiv$.mp.</P>
<P>46 random$.mp.</P>
<P>47 ((singl$ or doubl$ or trebl$ or tripl$) adj25 (blind$ or mask$)).mp.</P>
<P>48 trial.mp.</P>
<P>49 (versus or vs).mp.</P>
<P>50 or/35-49</P>
<P>51 34 and 50</P>
<P>52 20 or 51</P>
<P>53 Human/</P>
<P>54 Nonhuman/</P>
<P>55 exp ANIMAL/</P>
<P>56 Animal Experiment/</P>
<P>57 54 or 55 or 56</P>
<P>58 53 not 57</P>
<P>59 52 not 57</P>
<P>60 58 or 59</P>
<P>61 exp SPINE/</P>
<P>62 exp Spine Disease/</P>
<P>63 exp SCOLIOSIS/</P>
<P>64 exp Idiopathic Scoliosis/</P>
<P>65 scoliosis.mp.</P>
<P>66 or/61-65</P>
<P>67 exp Brace/</P>
<P>68 brace$.mp.</P>
<P>69 bracing.mp.</P>
<P>70 exp ORTHOTICS/</P>
<P>71 exp orthopedic equipment/</P>
<P>72 or/67-71</P>
<P>73 Adolescent/</P>
<P>74 adolescen#.mp.</P>
<P>75 73 or 74</P>
<P>76 66 and 72 and 75</P>
<P>77 52 and 76</P>
</SUBSECTION>
</APPENDIX_BODY>
</APPENDIX>
<APPENDIX ID="APP-02" MODIFIED="2015-05-30 16:43:19 -0400" MODIFIED_BY="Anne Lawson" NO="2">
<TITLE MODIFIED="2014-06-06 16:24:49 -0400" MODIFIED_BY="Shireen Harbin">CENTRAL and CINAHL search strategies</TITLE>
<APPENDIX_BODY MODIFIED="2015-05-30 16:43:19 -0400" MODIFIED_BY="Anne Lawson">
<SUBSECTION>
<HEADING LEVEL="3">CENTRAL</HEADING>
<P>Last searched 17 February 2015.</P>
<P>#1 MeSH descriptor: [Scoliosis] this term only</P>
<P>#2 scoliosis</P>
<P>#3 #1 or #2</P>
<P>#4 MeSH descriptor: [Braces] this term only</P>
<P>#5 braces in Trials</P>
<P>#6 bracing in Trials</P>
<P>#7 #4 or #5 or #6</P>
<P>#8 #3 and #7</P>
<P>#9 #8 Publication Year from 2013 to 2015, in Trials</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">CINAHL</HEADING>
<P>Last searched 18 February 2015.</P>
<P>S14 S13 Limiters - Published Date: 20131001-20150231</P>
<P>S13 S12 and S9 and S5</P>
<P>S12 S11 or S10</P>
<P>S11 adolescen*</P>
<P>S10 (MH "Adolescence+")</P>
<P>S9 S8 or S7 or S6</P>
<P>S8 "bracing*"</P>
<P>S7 "brace*"</P>
<P>S6 (MH "Orthoses+")</P>
<P>S5 S4 or S3 or S2 or S1</P>
<P>S4 "scoliosis"</P>
<P>S3 (MH "Scoliosis")</P>
<P>S2 (MH "Spinal Diseases+")</P>
<P>S1 (MH "Spine+")</P>
</SUBSECTION>
</APPENDIX_BODY>
</APPENDIX>
<APPENDIX ID="APP-03" MODIFIED="2015-06-05 13:54:31 -0400" MODIFIED_BY="Shireen Harbin" NO="3" NOTES="&lt;p&gt;Typo spotted in search strategy&lt;/p&gt;&lt;p&gt;&lt;span class=&quot;marker&quot;&gt;Refererence Manager&lt;/span&gt;&lt;/p&gt;" NOTES_MODIFIED="2015-06-05 13:54:31 -0400" NOTES_MODIFIED_BY="Shireen Harbin">
<TITLE MODIFIED="2015-05-30 17:52:23 -0400" MODIFIED_BY="Anne Lawson">PsycINFO, PEDro, Back Group Trials Register, clinical trials registries, and PubMed search strategies</TITLE>
<APPENDIX_BODY MODIFIED="2015-06-05 13:54:31 -0400" MODIFIED_BY="Shireen Harbin">
<SUBSECTION>
<HEADING LEVEL="3">PsycINFO</HEADING>
<P>Last searched 17 February 2015.</P>
<OL>
<LI>scoliosis.mp.</LI>
<LI>braces.mp.</LI>
<LI>bracing.mp.</LI>
<LI>2 or 3</LI>
<LI>1 and 4</LI>
<LI>limit 5 to yr=2013-2015</LI>
</OL>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">PEDro</HEADING>
<P>Last searched 17 February 2015. For this search, the method section was left blank. In the previous searches in 2012 and 2013, the method section was limited to clinical trial.</P>
<P>Abstract &amp; Title: scoliosis</P>
<P>AND</P>
<P>Method: left blank</P>
<P>AND</P>
<P>Published since: 2013</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Back Group's Trials Register</HEADING>
<P>Cochrane Register of Studies (CRS)</P>
<P>Last searched 18 February 2015. The purpose of this search was to identify studies not in CENTRAL, therefore only studies not in CENTRAL and dated 2013 and onward were selected.</P>
<P>#1 (scoliosis AND brac*) AND (INREGISTER)</P>
<P>Reference Manager</P>
<P>2012: All non-indexed text fields: (scoliosis AND brac*), published since 2008</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">ClinicalTrials.gov</HEADING>
<P>Last searched 17 February 2015.</P>
<P>Search term: scoliosis</P>
<P>AND</P>
<P>Intervention: brace or bracing</P>
<P>AND received from 10/10/2013 to 02/17/2015</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">WHO ICTRP</HEADING>
<P>Last searched 17 February 2015.</P>
<P>Title: brace or bracing</P>
<P>AND</P>
<P>Condition: scoliosis</P>
<P>Date of registration is between 01/10/2013-17/02/2015</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">PubMed</HEADING>
<P>Last searched 17 February 2015.</P>
<P>((((braces or bracing))) AND scoliosis) AND ("2013/10/01"[Date - Publication] : "3000"[Date - Publication])</P>
</SUBSECTION>
</APPENDIX_BODY>
</APPENDIX>
<APPENDIX ID="APP-04" MODIFIED="2015-05-30 16:43:19 -0400" MODIFIED_BY="Anne Lawson" NO="4">
<TITLE MODIFIED="2009-10-14 16:10:56 -0400" MODIFIED_BY="VEP  ">Journals handsearched</TITLE>
<APPENDIX_BODY MODIFIED="2015-05-30 16:43:19 -0400" MODIFIED_BY="Anne Lawson">
<TABLE COLS="4" ROWS="22">
<TR>
<TH>
<P>Journal</P>
</TH>
<TH>
<P>Language</P>
</TH>
<TH>
<P>From</P>
</TH>
<TH>
<P>To</P>
</TH>
</TR>
<TR>
<TD>
<P>
<I>Acta Orthopaedica and Traumatologica Hellenica</I>
</P>
</TD>
<TD>
<P>Greek</P>
</TD>
<TD>
<P>1948</P>
</TD>
<TD>
<P>2013</P>
</TD>
</TR>
<TR>
<TD>
<P>
<I>Annales Academiae Medicae Silesiensis</I>
</P>
</TD>
<TD>
<P>Polish</P>
</TD>
<TD>
<P>1997</P>
</TD>
<TD>
<P>2013</P>
</TD>
</TR>
<TR>
<TD>
<P>
<I>Annales de Kinésithérapie</I>
</P>
</TD>
<TD>
<P>French</P>
</TD>
<TD>
<P>1978</P>
</TD>
<TD>
<P>2007</P>
</TD>
</TR>
<TR>
<TD>
<P>
<I>Cahiers de Kinésithérapie</I>
</P>
</TD>
<TD>
<P>French</P>
</TD>
<TD>
<P>1978</P>
</TD>
<TD>
<P>1997</P>
</TD>
</TR>
<TR>
<TD>
<P>
<I>Chinesiologia Scientifica</I>
</P>
</TD>
<TD>
<P>Italian</P>
</TD>
<TD>
<P>1978</P>
</TD>
<TD>
<P>2013</P>
</TD>
</TR>
<TR>
<TD>
<P>
<I>Chirurgia Narzadow Ruchu i Ortopedia Polska</I>
</P>
</TD>
<TD>
<P>Polish</P>
</TD>
<TD>
<P>1997</P>
</TD>
<TD>
<P>2013</P>
</TD>
</TR>
<TR>
<TD>
<P>
<I>Fizjoterapia</I>
</P>
</TD>
<TD>
<P>Polish</P>
</TD>
<TD>
<P>1993</P>
</TD>
<TD>
<P>2013</P>
</TD>
</TR>
<TR>
<TD>
<P>
<I>Fizjoterapia Polska</I>
</P>
</TD>
<TD>
<P>Polish</P>
</TD>
<TD>
<P>2001</P>
</TD>
<TD>
<P>2013</P>
</TD>
</TR>
<TR>
<TD>
<P>
<I>Ginnastica Medica, Medicina Fisica e Riabilitazione</I>
</P>
</TD>
<TD>
<P>Italian</P>
</TD>
<TD>
<P>1953</P>
</TD>
<TD>
<P>2013</P>
</TD>
</TR>
<TR>
<TD>
<P>
<I>Journal of Japanese Orthopaedic Association</I>
</P>
</TD>
<TD>
<P>Japanese</P>
</TD>
<TD>
<P>1963</P>
</TD>
<TD>
<P>1995</P>
</TD>
</TR>
<TR>
<TD>
<P>
<I>Journal of Japanese Scoliosis Research Society</I>
</P>
</TD>
<TD>
<P>Japanese</P>
</TD>
<TD>
<P>1988</P>
</TD>
<TD>
<P>2006</P>
</TD>
</TR>
<TR>
<TD>
<P>
<I>Journal of Japanese Spine Society</I>
</P>
</TD>
<TD>
<P>Japanese</P>
</TD>
<TD>
<P>1990</P>
</TD>
<TD>
<P>2007</P>
</TD>
</TR>
<TR>
<TD>
<P>
<I>Kinésithérapie Scientifique</I>
</P>
</TD>
<TD>
<P>French</P>
</TD>
<TD>
<P>1978</P>
</TD>
<TD>
<P>2007</P>
</TD>
</TR>
<TR>
<TD>
<P>
<I>Kultura Fizyczna</I>
</P>
</TD>
<TD>
<P>Polish</P>
</TD>
<TD>
<P>1997</P>
</TD>
<TD>
<P>2013</P>
</TD>
</TR>
<TR>
<TD>
<P>
<I>Kwartalnik Ortopedyczny</I>
</P>
</TD>
<TD>
<P>Polish</P>
</TD>
<TD>
<P>1991</P>
</TD>
<TD>
<P>2013</P>
</TD>
</TR>
<TR>
<TD>
<P>
<I>Medycyna Manualna</I>
</P>
</TD>
<TD>
<P>Polish</P>
</TD>
<TD>
<P>1997</P>
</TD>
<TD>
<P>2013</P>
</TD>
</TR>
<TR>
<TD>
<P>
<I>Ortopedia Traumatologia Rehabilitacja</I>
</P>
</TD>
<TD>
<P>Polish</P>
</TD>
<TD>
<P>1999</P>
</TD>
<TD>
<P>2013</P>
</TD>
</TR>
<TR>
<TD>
<P>
<I>Postepy Rehabilitacji</I>
</P>
</TD>
<TD>
<P>Polish</P>
</TD>
<TD>
<P>1997</P>
</TD>
<TD>
<P>2013</P>
</TD>
</TR>
<TR>
<TD>
<P>
<I>Rehabilitacja Medyczna</I>
</P>
</TD>
<TD>
<P>Polish</P>
</TD>
<TD>
<P>1997</P>
</TD>
<TD>
<P>2013</P>
</TD>
</TR>
<TR>
<TD>
<P>
<I>Rehabilitacja w Praktyce</I>
</P>
</TD>
<TD>
<P>Polish</P>
</TD>
<TD>
<P>2006</P>
</TD>
<TD>
<P>2013</P>
</TD>
</TR>
<TR>
<TD>
<P>
<I>Résonances Européennes Du Rachis</I>
</P>
</TD>
<TD>
<P>French</P>
</TD>
<TD>
<P>1994</P>
</TD>
<TD>
<P>2010</P>
</TD>
</TR>
</TABLE>
</APPENDIX_BODY>
</APPENDIX>
<APPENDIX ID="APP-05" MODIFIED="2015-05-30 16:43:19 -0400" MODIFIED_BY="Anne Lawson" NO="5">
<TITLE MODIFIED="2009-10-14 16:10:15 -0400" MODIFIED_BY="VEP  ">Conference proceedings handsearched</TITLE>
<APPENDIX_BODY MODIFIED="2015-05-30 16:43:19 -0400" MODIFIED_BY="Anne Lawson">
<TABLE COLS="5" ROWS="16">
<TR>
<TH>
<P>Society</P>
</TH>
<TH>
<P>Language</P>
</TH>
<TH>
<P>From</P>
</TH>
<TH>
<P>To</P>
</TH>
<TH>
<P>Single years</P>
</TH>
</TR>
<TR>
<TD>
<P>American Physical Therapy Association</P>
</TD>
<TD>
<P>English</P>
</TD>
<TD>
<P>-</P>
</TD>
<TD>
<P>-</P>
</TD>
<TD>
<P>1991; 1992</P>
</TD>
</TR>
<TR>
<TD>
<P>Back Pain Society</P>
</TD>
<TD>
<P>English</P>
</TD>
<TD>
<P>-</P>
</TD>
<TD>
<P> -</P>
</TD>
<TD>
<P>1990</P>
</TD>
</TR>
<TR>
<TD>
<P>British Scoliosis Society</P>
</TD>
<TD>
<P>English</P>
</TD>
<TD>
<P> -</P>
</TD>
<TD>
<P> -</P>
</TD>
<TD>
<P>1992; 1999; 2000; 2006</P>
</TD>
</TR>
<TR>
<TD>
<P>Chartered Society of Physiotherapists</P>
</TD>
<TD>
<P>English</P>
</TD>
<TD>
<P> -</P>
</TD>
<TD>
<P> -</P>
</TD>
<TD>
<P>1994; 1999; 2000; 2006</P>
</TD>
</TR>
<TR>
<TD>
<P>European Spinal Defomities Society</P>
</TD>
<TD>
<P>English</P>
</TD>
<TD>
<P> -</P>
</TD>
<TD>
<P> -</P>
</TD>
<TD>
<P>1994</P>
</TD>
</TR>
<TR>
<TD>
<P>Groupe Europeen Kinesitherapique de travail de scoliose</P>
</TD>
<TD>
<P>French</P>
</TD>
<TD>
<P>-</P>
</TD>
<TD>
<P>-</P>
</TD>
<TD>
<P>1991; 1992</P>
</TD>
</TR>
<TR>
<TD>
<P>International Research Society of Spinal Deformities published in the research into spinal deformities series</P>
</TD>
<TD>
<P>English</P>
</TD>
<TD>
<P>1996</P>
</TD>
<TD>
<P>2013</P>
</TD>
<TD>
<P> -</P>
</TD>
</TR>
<TR>
<TD>
<P>Phillip Zorab Symposium</P>
</TD>
<TD>
<P>English</P>
</TD>
<TD>
<P> -</P>
</TD>
<TD>
<P> -</P>
</TD>
<TD>
<P>1979</P>
</TD>
</TR>
<TR>
<TD>
<P>Polskie Towarzystwo Ortopedyczne i Traumatologiczne (Polish Orthopedic and Traumatologic Society)</P>
</TD>
<TD>
<P>Polish</P>
</TD>
<TD>
<P>1978</P>
</TD>
<TD>
<P>2006</P>
</TD>
<TD>
<P>-</P>
</TD>
</TR>
<TR>
<TD>
<P>Quebec Scoliosis Society</P>
</TD>
<TD>
<P>French/English</P>
</TD>
<TD>
<P> -</P>
</TD>
<TD>
<P>-</P>
</TD>
<TD>
<P>1994</P>
</TD>
</TR>
<TR>
<TD>
<P>Scoliosis Research Society - SRS Meeting abstracts</P>
</TD>
<TD>
<P>English</P>
</TD>
<TD>
<P>2001</P>
</TD>
<TD>
<P>2012</P>
</TD>
<TD>
<P>-</P>
</TD>
</TR>
<TR>
<TD>
<P>Società Italiana di chirurgia vertebrale - GIS</P>
</TD>
<TD>
<P>Italian</P>
</TD>
<TD>
<P>1978</P>
</TD>
<TD>
<P>2012</P>
</TD>
<TD>
<P>-</P>
</TD>
</TR>
<TR>
<TD>
<P>Society on Scoliosis Orthoapedic and Rehabilitation Treatment - SOSORT Meeting abstracts</P>
</TD>
<TD>
<P>English</P>
</TD>
<TD>
<P>2003</P>
</TD>
<TD>
<P>2013</P>
</TD>
<TD>
<P>-</P>
</TD>
</TR>
<TR>
<TD>
<P>Surface Topography and Spinal Deformity meetings</P>
</TD>
<TD>
<P>English</P>
</TD>
<TD>
<P>1980</P>
</TD>
<TD>
<P>1994</P>
</TD>
<TD>
<P> -</P>
</TD>
</TR>
<TR>
<TD>
<P>World Confederation of Physical Therapy</P>
</TD>
<TD>
<P>English</P>
</TD>
<TD>
<P> -</P>
</TD>
<TD>
<P> -</P>
</TD>
<TD>
<P>1991; 1995</P>
</TD>
</TR>
</TABLE>
</APPENDIX_BODY>
</APPENDIX>
<APPENDIX ID="APP-06" MODIFIED="2015-06-05 13:10:27 -0400" MODIFIED_BY="[Empty name]" NO="6">
<TITLE MODIFIED="2015-06-05 13:10:27 -0400" MODIFIED_BY="[Empty name]">Assessment of clinical relevance</TITLE>
<APPENDIX_BODY MODIFIED="2015-05-29 07:36:11 -0400" MODIFIED_BY="Anne Lawson">
<P>1.    Are the patients described in detail so that you can decide whether they are comparable to those that you see in your practice?</P>
<P>2.    Are the interventions and treatment settings described well enough so that you can provide the same for your patients?</P>
<P>3.    Were all clinically relevant outcomes measured and reported?</P>
<P>4.    Is the size of the effect clinically important?</P>
<P>5.    Are the likely treatment benefits worth the potential harms?</P>
</APPENDIX_BODY>
</APPENDIX>
<APPENDIX ID="APP-07" MODIFIED="2015-06-05 13:24:33 -0400" MODIFIED_BY="[Empty name]" NO="7">
<TITLE MODIFIED="2015-06-05 13:11:21 -0400" MODIFIED_BY="[Empty name]">Criteria for risk of bias assessment for randomized controlled trials (RCTs) and controlled clinical trials (CCTs)</TITLE>
<APPENDIX_BODY MODIFIED="2015-06-05 13:24:24 -0400" MODIFIED_BY="[Empty name]">
<SUBSECTION>
<HEADING LEVEL="3">Random sequence generation (selection bias)</HEADING>
<SUBSECTION>
<HEADING LEVEL="4">Selection bias (biased allocation to interventions) due to inadequate generation of a randomized sequence</HEADING>
<P>There is a low risk of selection bias if the investigators describe a random component in the sequence generation process such as: referring to a random number table, using a computer random number generator, coin tossing, shuffling cards or envelopes, throwing dice, drawing of lots, minimization (minimization may be implemented without a random element, and this is considered to be equivalent to being random).</P>
<P>There is a high risk of selection bia<I>s</I> if the investigators describe a non-random component in the sequence generation process, such as: sequence generated by odd or even date of birth, date (or day) of admission, hospital or clinic record number; or allocation by judgement of the clinician, preference of the participant, results of a laboratory test or a series of tests, or availability of the intervention.</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Allocation concealment (selection bias)</HEADING>
<SUBSECTION>
<HEADING LEVEL="4">Selection bias (biased allocation to interventions) due to inadequate concealment of allocations prior to assignment</HEADING>
<P>There is a low risk of selection bias if the participants and investigators enrolling participants could not foresee assignment because one of the following, or an equivalent method, was used to conceal allocation: central allocation (including telephone, web-based, and pharmacy-controlled randomization); sequentially numbered drug containers of identical appearance; or sequentially numbered, opaque, sealed envelopes.</P>
<P>There is a high risk of bias if participants or investigators enrolling participants could possibly foresee assignments and thus introduce selection bias, such as allocation based on: using an open random allocation schedule (e.g. a list of random numbers), assignment envelopes were used without appropriate safeguards (e.g. if envelopes were unsealed or non-opaque or not sequentially numbered), alternation or rotation, date of birth, case record number, or other explicitly unconcealed procedures.</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Blinding of participants</HEADING>
<SUBSECTION>
<HEADING LEVEL="4">Performance bias due to knowledge of the allocated interventions by participants during the study</HEADING>
<P>There is a low risk of performance bias if blinding of participants was ensured and it was unlikely that the blinding could have been broken; or if there was no blinding or incomplete blinding, but the review authors judge that the outcome is not likely to be influenced by lack of blinding.</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Blinding of personnel/care providers (performance bias)</HEADING>
<SUBSECTION>
<HEADING LEVEL="4">Performance bias due to knowledge of the allocated interventions by personnel/care providers during the study</HEADING>
<P>There is a low risk of performance bias if blinding of personnel was ensured and it was unlikely that the blinding could have been broken; or if there was no blinding or incomplete blinding, but the review authors judge that the outcome is not likely to be influenced by lack of blinding.</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Blinding of outcome assessor (detection bias)</HEADING>
<SUBSECTION>
<HEADING LEVEL="4">Detection bias due to knowledge of the allocated interventions by outcome assessors</HEADING>
<P>There is low risk of detection bias if the blinding of the outcome assessment was ensured and it was unlikely that the blinding could have been broken; or if there was no blinding or incomplete blinding, but the review authors judge that the outcome is not likely to be influenced by lack of blinding, or:</P>
<UL>
<LI>for participant-reported outcomes in which the particpant was the outcome assessor (e.g. pain, disability): there is a low risk of bias for outcome assessors if there is a low risk of bias for participant blinding (<LINK REF="REF-Boutron-2005" TYPE="REFERENCE">Boutron 2005</LINK>);</LI>
<LI>for outcome criteria that are clinical or therapeutic events that will be determined by the interaction between participants and care providers (e.g. co-interventions, length of hospitalization, treatment failure), in which the care provider is the outcome assessor: there is a low risk of bias for outcome assessors if there is a low risk of bias for care providers (<LINK REF="REF-Boutron-2005" TYPE="REFERENCE">Boutron 2005</LINK>);</LI>
<LI>for outcome criteria that are assessed from data from medical forms: there is a low risk of bias if the treatment or adverse effects of the treatment could not be noticed in the extracted data (<LINK REF="REF-Boutron-2005" TYPE="REFERENCE">Boutron 2005</LINK>).</LI>
</UL>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Incomplete outcome data (attrition bias)</HEADING>
<SUBSECTION>
<HEADING LEVEL="4">Attrition bias due to amount, nature, or handling of incomplete outcome data</HEADING>
<P>There is a low risk of attrition bias if there were no missing outcome data; reasons for missing outcome data were unlikely to be related to the true outcome (for survival data, censoring unlikely to be introducing bias); missing outcome data were balanced in numbers, with similar reasons for missing data across groups; for dichotomous outcome data, the proportion of missing outcomes compared with the observed event risk was not enough to have a clinically relevant impact on the intervention effect estimate; for continuous outcome data, the plausible effect size (difference in means or standardized difference in means) among missing outcomes was not enough to have a clinically relevant impact on observed effect size, or missing data were imputed using appropriate methods (if drop-outs are very large, imputation using even 'acceptable' methods may still suggest a high risk of bias) (<LINK REF="REF-van-Tulder-2003" TYPE="REFERENCE">van Tulder 2003</LINK>). The percentage of withdrawals and drop-outs should not exceed 20% for short-term follow-up and 30% for long-term follow-up and should not lead to substantial bias (these percentages are commonly used but arbitrary, not supported by literature) (<LINK REF="REF-van-Tulder-2003" TYPE="REFERENCE">van Tulder 2003</LINK>).</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Selective reporting (reporting bias)</HEADING>
<SUBSECTION>
<HEADING LEVEL="4">Reporting bias due to selective outcome reporting</HEADING>
<P>There is low risk of reporting bias if the study protocol is available and all of the study's pre-specified (primary and secondary) outcomes that are of interest in the review have been reported in the pre-specified way, or if the study protocol is not available but it is clear that the published reports include all expected outcomes, including those that were pre-specified (convincing text of this nature may be uncommon).</P>
<P>There is a high risk of reporting bias if not all of the study's pre-specified primary outcomes have been reported; one or more primary outcomes is reported using measurements, analysis methods or subsets of the data (e.g. subscales) that were not pre-specified; one or more reported primary outcomes were not pre-specified (unless clear justification for their reporting is provided, such as an unexpected adverse effect); one or more outcomes of interest in the review are reported incompletely so that they cannot be entered in a meta-analysis; the study report fails to include results for a key outcome that would be expected to have been reported for such a study.</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Group similarity at baseline (selection bias)</HEADING>
<P>Bias due to dissimilarity at baseline for the most important prognostic indicators.</P>
<P>There is low risk of bia<I>s</I> if groups are similar at baseline for demographic factors, value of main outcome measure(s), and important prognostic factors (examples in the field of back and neck pain are duration and severity of complaints, vocational status, percentage of people with neurological symptoms) (<LINK REF="REF-van-Tulder-2003" TYPE="REFERENCE">van Tulder 2003</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Co-interventions (performance bias)</HEADING>
<SUBSECTION>
<HEADING LEVEL="4">Bias because co-interventions were different across groups</HEADING>
<P>There is low risk of bias if there were no co-interventions or they were similar between the index and control groups (<LINK REF="REF-van-Tulder-2003" TYPE="REFERENCE">van Tulder 2003</LINK>).</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Compliance (performance bias)</HEADING>
<SUBSECTION>
<HEADING LEVEL="4">Bias due to inappropriate compliance with interventions across groups</HEADING>
<P>There is low risk of bias if compliance with the interventions was acceptable, based on the reported intensity/dosage, duration, number and frequency for both the index and control intervention(s). For single-session interventions (e.g. surgery), this item is irrelevant (<LINK REF="REF-van-Tulder-2003" TYPE="REFERENCE">van Tulder 2003</LINK>).</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Intention-to-treat-analysis</HEADING>
<P>There is low risk of bias if all randomized participants were reported/analysed in the group to which they were allocated by randomization.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Timing of outcome assessments (detection bias)</HEADING>
<SUBSECTION>
<HEADING LEVEL="4">Bias because important outcomes were not measured at the same time across groups</HEADING>
<P>There is low risk of bias if all important outcome assessments for all intervention groups were measured at the same time (<LINK REF="REF-van-Tulder-2003" TYPE="REFERENCE">van Tulder 2003</LINK>).</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Other bias</HEADING>
<SUBSECTION>
<HEADING LEVEL="4">Bias due to problems not covered elsewhere in the table</HEADING>
<P>There is a low risk of bias if the study appears to be free of other sources of bias not addressed elsewhere (e.g. study funding).</P>
</SUBSECTION>
</SUBSECTION>
</APPENDIX_BODY>
</APPENDIX>
<APPENDIX ID="APP-08" MODIFIED="2015-05-30 16:43:19 -0400" MODIFIED_BY="Anne Lawson" NO="8">
<TITLE MODIFIED="2009-04-20 18:06:03 -0400" MODIFIED_BY="[Empty name]">Criteria for the risk of bias assessment of observational studies</TITLE>
<APPENDIX_BODY MODIFIED="2015-05-30 16:43:19 -0400" MODIFIED_BY="Anne Lawson">
<SUBSECTION>
<HEADING LEVEL="3">Selection bias</HEADING>
<P>
<B>Representativeness of the exposed cohort: </B>assess whether the sample is truly representative of the average adolescents with scoliosis; somewhat representative of the average adolescents with scoliosis; selected group of adolescents with scoliosis; no description of the derivation of the cohort. This item was added in the 'Risk of bias' table as 'other source of bias'.</P>
<P>
<B>Selection of the non-exposed cohort:</B> assess whether the sample has been drawn from the same community as the exposed cohort; drawn from a different source/community, "no description of the derivation of the non exposed cohort'. This item was added in the 'Risk of bias' table as 'other source of bias'.</P>
<P>
<B>Ascertainment of exposure:</B> information in the study was obtained from a secure record (e.g. clinical records); structured interview; written self report; no description. This item was added in the 'Risk of bias' table as 'other source of bias'.</P>
<P>
<B>Comparability of cohorts on the basis of the design or analysis:</B> either exposed and non-exposed participants must be matched in the design or confounders (or both) must be adjusted for in the analysis. Statements of no differences between groups or that differences were not statistically significant are not sufficient for establishing comparability. If the risk ratio for the exposure of interest is adjusted for the confounders listed, then the groups will be considered to be comparable on each variable used in the adjustment. Were most important prognostic factors matched? Yes/No. Were unmatched important prognostic factors adjusted for? Yes/No. This item was assessed in the 'Risk of bias' table under the item 'group similar at baseline'.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Attrition bias</HEADING>
<P>
<B>Complete follow-up:</B> assess if: all participants accounted for; participants lost to follow-up unlikely to introduce bias (lost to follow-up 5%); participants lost to follow-up greater than 5% and description provided of those lost. This item was assessed in the 'Risk of bias' table under the item 'incomplete outcome data'.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Detection bias</HEADING>
<P>
<B>Independent blind assessment:</B> independent or blind assessment stated in the paper, or confirmation of the outcome by reference to secure records (x-rays, medical records, etc.), record linkage, or self report; or no blinding; no description. This item was assessed in the 'Risk of bias' table under the item 'blinding of outcome assessor'.</P>
</SUBSECTION>
</APPENDIX_BODY>
</APPENDIX>
<APPENDIX ID="APP-09" MODIFIED="2015-06-05 13:10:58 -0400" MODIFIED_BY="[Empty name]" NO="9">
<TITLE MODIFIED="2015-06-05 13:10:58 -0400" MODIFIED_BY="[Empty name]">Clinical characteristics of the included studies</TITLE>
<APPENDIX_BODY MODIFIED="2015-05-30 16:43:19 -0400" MODIFIED_BY="Anne Lawson">
<TABLE COLS="9" ROWS="26">
<TR>
<TH>
<P/>
</TH>
<TH>
<P>Coillard</P>
</TH>
<TH>
<P>Lou</P>
</TH>
<TH>
<P>Lusini</P>
</TH>
<TH>
<P>Nachemson</P>
</TH>
<TH COLSPAN="2">
<P>Weinstein*</P>
</TH>
<TH>
<P>Wong</P>
</TH>
<TH>
<P>Total</P>
</TH>
</TR>
<TR>
<TD>
<P>Type of study</P>
</TD>
<TD>
<P>RCT</P>
</TD>
<TD>
<P>RCT</P>
</TD>
<TD>
<P>QRCT</P>
</TD>
<TD>
<P>QRCT</P>
</TD>
<TD>
<P>QRCT</P>
</TD>
<TD>
<P>(RCT arm)</P>
</TD>
<TD>
<P>RCT</P>
</TD>
<TD>
<P>-</P>
</TD>
</TR>
<TR>
<TD>
<P>Population</P>
</TD>
<TD>
<P>68</P>
</TD>
<TD>
<P>12</P>
</TD>
<TD>
<P>57</P>
</TD>
<TD>
<P>240</P>
</TD>
<TD>
<P>242</P>
</TD>
<TD>
<P>116</P>
</TD>
<TD>
<P>43</P>
</TD>
<TD>
<P>662</P>
</TD>
</TR>
<TR>
<TD>
<P>Total braced</P>
</TD>
<TD>
<P>36</P>
</TD>
<TD>
<P>12</P>
</TD>
<TD>
<P>39</P>
</TD>
<TD>
<P>111</P>
</TD>
<TD>
<P>242</P>
</TD>
<TD>
<P>51</P>
</TD>
<TD>
<P>43</P>
</TD>
<TD>
<P>483</P>
</TD>
</TR>
<TR>
<TD>
<P>Brace active</P>
</TD>
<TD>
<P>36</P>
</TD>
<TD>
<P>6</P>
</TD>
<TD>
<P>39</P>
</TD>
<TD>
<P>111</P>
</TD>
<TD>
<P>146</P>
</TD>
<TD>
<P>51</P>
</TD>
<TD>
<P>22</P>
</TD>
<TD>
<P>360</P>
</TD>
</TR>
<TR>
<TD>
<P>Brace control</P>
</TD>
<TD>
<P>-</P>
</TD>
<TD>
<P>6</P>
</TD>
<TD>
<P>-</P>
</TD>
<TD>
<P>-</P>
</TD>
<TD>
<P>96</P>
</TD>
<TD>
<P>-</P>
</TD>
<TD>
<P>21</P>
</TD>
<TD>
<P>123</P>
</TD>
</TR>
<TR>
<TD>
<P>Observation</P>
</TD>
<TD>
<P>32</P>
</TD>
<TD>
<P>-</P>
</TD>
<TD>
<P>18</P>
</TD>
<TD>
<P>83</P>
</TD>
<TD>
<P>-</P>
</TD>
<TD>
<P>65</P>
</TD>
<TD>
<P>-</P>
</TD>
<TD>
<P>133</P>
</TD>
</TR>
<TR>
<TD>
<P>Electrical stimulation</P>
</TD>
<TD>
<P>-</P>
</TD>
<TD>
<P>-</P>
</TD>
<TD>
<P>-</P>
</TD>
<TD>
<P>46</P>
</TD>
<TD>
<P>-</P>
</TD>
<TD>
<P>-</P>
</TD>
<TD>
<P>--</P>
</TD>
<TD>
<P>46</P>
</TD>
</TR>
<TR>
<TD COLSPAN="9">
<P>Gender</P>
</TD>
</TR>
<TR>
<TD>
<P>Males</P>
</TD>
<TD>
<P>7</P>
</TD>
<TD>
<P>2</P>
</TD>
<TD>
<P>11</P>
</TD>
<TD>
<P>0</P>
</TD>
<TD>
<P>24</P>
</TD>
<TD>
<P>15</P>
</TD>
<TD>
<P>0</P>
</TD>
<TD>
<P>44</P>
</TD>
</TR>
<TR>
<TD>
<P>Females</P>
</TD>
<TD>
<P>40</P>
</TD>
<TD>
<P>10</P>
</TD>
<TD>
<P>46</P>
</TD>
<TD>
<P>240</P>
</TD>
<TD>
<P>221</P>
</TD>
<TD>
<P>101</P>
</TD>
<TD>
<P>43</P>
</TD>
<TD>
<P>600</P>
</TD>
</TR>
<TR>
<TD COLSPAN="9">
<P>Age</P>
</TD>
</TR>
<TR>
<TD>
<P>Mean</P>
</TD>
<TD>
<P>12.02</P>
</TD>
<TD>
<P>12.05</P>
</TD>
<TD>
<P>15.03</P>
</TD>
<TD>
<P>12.07</P>
</TD>
<TD>
<P>12.07</P>
</TD>
<TD>
<P>12.07</P>
</TD>
<TD>
<P>12.05</P>
</TD>
<TD>
<P>-</P>
</TD>
</TR>
<TR>
<TD>
<P>SD</P>
</TD>
<TD>
<P>02.02</P>
</TD>
<TD>
<P>01.07</P>
</TD>
<TD>
<P>01.10</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P>01.01</P>
</TD>
<TD>
<P>01.01</P>
</TD>
<TD>
<P>00.08</P>
</TD>
<TD>
<P>-</P>
</TD>
</TR>
<TR>
<TD>
<P>Min</P>
</TD>
<TD>
<P>10</P>
</TD>
<TD>
<P>10</P>
</TD>
<TD>
<P>10</P>
</TD>
<TD>
<P>10</P>
</TD>
<TD>
<P>10</P>
</TD>
<TD>
<P>10</P>
</TD>
<TD>
<P>10.06</P>
</TD>
<TD>
<P>-</P>
</TD>
</TR>
<TR>
<TD>
<P>Max</P>
</TD>
<TD>
<P>ND</P>
</TD>
<TD>
<P>ND</P>
</TD>
<TD>
<P>ND</P>
</TD>
<TD>
<P>15</P>
</TD>
<TD>
<P>15</P>
</TD>
<TD>
<P>15</P>
</TD>
<TD>
<P>13.08</P>
</TD>
<TD>
<P>-</P>
</TD>
</TR>
<TR>
<TD COLSPAN="9">
<P>Bone age</P>
</TD>
</TR>
<TR>
<TD>
<P>Risser min</P>
</TD>
<TD>
<P>0</P>
</TD>
<TD>
<P>NR</P>
</TD>
<TD>
<P>0</P>
</TD>
<TD>
<P>0</P>
</TD>
<TD>
<P>0</P>
</TD>
<TD>
<P>0</P>
</TD>
<TD>
<P>0</P>
</TD>
<TD>
<P>-</P>
</TD>
</TR>
<TR>
<TD>
<P>Risser max</P>
</TD>
<TD>
<P>2</P>
</TD>
<TD>
<P>NR</P>
</TD>
<TD>
<P>4</P>
</TD>
<TD>
<P>4</P>
</TD>
<TD>
<P>2</P>
</TD>
<TD>
<P>2</P>
</TD>
<TD>
<P>2</P>
</TD>
<TD>
<P>-</P>
</TD>
</TR>
<TR>
<TD COLSPAN="9">
<P>Cobb degrees</P>
</TD>
</TR>
<TR>
<TD>
<P>Mean</P>
</TD>
<TD>
<P>21</P>
</TD>
<TD>
<P>33</P>
</TD>
<TD>
<P>52.5</P>
</TD>
<TD>
<P>-</P>
</TD>
<TD>
<P>30.4</P>
</TD>
<TD>
<P>30.5</P>
</TD>
<TD>
<P>24.3</P>
</TD>
<TD>
<P>-</P>
</TD>
</TR>
<TR>
<TD>
<P>SD</P>
</TD>
<TD>
<P>4.5</P>
</TD>
<TD>
<P>6</P>
</TD>
<TD>
<P>NR</P>
</TD>
<TD>
<P>-</P>
</TD>
<TD>
<P>6</P>
</TD>
<TD>
<P>6</P>
</TD>
<TD>
<P>2.7</P>
</TD>
<TD>
<P>-</P>
</TD>
</TR>
<TR>
<TD>
<P>Min</P>
</TD>
<TD>
<P>15</P>
</TD>
<TD>
<P>NR</P>
</TD>
<TD>
<P>45</P>
</TD>
<TD>
<P>20</P>
</TD>
<TD>
<P>20</P>
</TD>
<TD>
<P>20</P>
</TD>
<TD>
<P>20</P>
</TD>
<TD>
<P>-</P>
</TD>
</TR>
<TR>
<TD>
<P>Max</P>
</TD>
<TD>
<P>30</P>
</TD>
<TD>
<P>NR</P>
</TD>
<TD>
<P>93</P>
</TD>
<TD>
<P>35</P>
</TD>
<TD>
<P>40</P>
</TD>
<TD>
<P>40</P>
</TD>
<TD>
<P>30</P>
</TD>
<TD>
<P>-</P>
</TD>
</TR>
<TR>
<TD COLSPAN="9">
<P>max: maximum; min: minimum; ND: not defined; NR: information not retrievable in the study; QRCT: Quasi RCT, i.e. prospective controlled trial; RCT: randomized controlled trial; SD: standard deviation.</P>
<P/>
<P/>
<P/>
</TD>
</TR>
<TR>
<TD COLSPAN="9">
<P>* The entire study by Weinstein is a QRCT, since it includes 2 arms, 1 RCT, the other QRCT.</P>
</TD>
</TR>
</TABLE>
</APPENDIX_BODY>
</APPENDIX>
</APPENDICES>
<EXTENSIONS>
<EXTENSION ID="FLOW_1" NAME="FIGURE" REVMAN_VERSION="5.1.0" TYPE="FLOWCHART">
<ALIAS ALIAS_ID="1">
<FLOWCHARTBOX TEXT="&lt;p&gt; studies included in quantitative synthesis (meta-analysis): 0&lt;/p&gt;" WIDTH="120">
<FLOWCHARTBOX TEXT="&lt;p&gt;studies included in qualitative synthesis: 7&lt;/p&gt;" WIDTH="120">
<FLOWCHARTBOX TEXT="&lt;p&gt;full-text articles assessed for eligibility: 143&lt;/p&gt;" WIDTH="120">
<FLOWCHARTBOX TEXT="&lt;p&gt;records screened: 859&lt;/p&gt;" WIDTH="120">
<FLOWCHARTBOX TEXT="&lt;p&gt;records after duplicates removed: 859&lt;/p&gt;">
<FLOWCHARTBOX TEXT="&lt;p&gt;2479 records identified through database searching&lt;/p&gt;" WIDTH="120"/>
<FLOWCHARTBOX TEXT="&lt;p&gt;53 additional records identified through other sources&lt;/p&gt;" WIDTH="120"/>
</FLOWCHARTBOX>
<OUT TEXT="&lt;p&gt;records excluded: 716&lt;/p&gt;" WIDTH="120"/>
</FLOWCHARTBOX>
<OUT TEXT="&lt;p&gt;full-text articles excluded, with reasons: 136&lt;/p&gt;&lt;p&gt;&lt;/p&gt;" WIDTH="120"/>
</FLOWCHARTBOX>
<OUT TEXT="&lt;p&gt;studies awaiting classification: 2&lt;/p&gt;"/>
</FLOWCHARTBOX>
</FLOWCHARTBOX>
</ALIAS>
</EXTENSION>
</EXTENSIONS>
</COCHRANE_REVIEW>